References - Dermatology

^ "Hair loss, balding, hair shedding. DermNet NZ". http://dermnetnz.org/hair-nails-sweat/hair-loss.html. Retrieved on 2007-12-07. 
^ "Chemotherapy and hair loss: What to expect during treatment - MayoClinic.com". http://www.mayoclinic.com/health/hair-loss/CA00037. Retrieved on 2007-12-07. 
^ http://www.keratin.com/aq/aq010.shtml
^ a b [Naylor PFD. "The Skin Surface and Friction", British Journal of Dermatology. 1955;67:239-248.]
^ a b [Naylor PFD. "Experimental Friction Blisters", British Journal of Dermatology. 1955;67:327-342.]
^ a b [Sulzberger MB, Cortese TA, Fishman L, Wiley HS. "Studies on Blisters Produced by Friction", Journal of Investigative Dermatology. 1966;47:456-465.]
^ [Carlson JM. "The Friction Factor", OrthoKinetic Review. Nov/Dec 2001;1(7):1-3.]
^ [Hanna T, Carlson JM. "Freedom from Friction", OrthoKinetic Review. Mar/Apr 2004;4(2):34-35.]
^ http://www.goengo.com/facts_studies_blisters101.aspx
^ http://www.backpackgeartest.org/reviews/Health%20%26%20Safety/First%20Aid%20Kits/ENGO%20Blister%20Prevention%20Patches/
^ http://www.webmd.com/skin-problems-and-treatments/guide/understanding-blister-treatment
^ http://vonhof.typepad.com/happy_feet/2008/12/preventing-infection-from-blisters.html
^ http://www.tradoc.army.mil/tpubs/pams/p600-4.pdf Department of the Army TRADOC Pam 600-4, Initial Entry Training Soldier's Handbook.
·  ^ Haggstrom AN, Drolet BA, Baselga E, et al (September 2006). "Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment". Pediatrics 118 (3): 882–7. doi:10.1542/peds.2006-0413. PMID 16950977. http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=16950977. 

·  ^ Mulliken JB, Glowacki J (March 1982). "Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics". Plast. Reconstr. Surg. 69 (3): 412–22. PMID 7063565. 

·  ^ Kleinman ME, Greives MR, Churgin SS, et al (December 2007). "Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma". Arterioscler. Thromb. Vasc. Biol. 27 (12): 2664–70. doi:10.1161/ATVBAHA.107.150284. PMID 17872454. http://atvb.ahajournals.org/cgi/content/full/27/12/2664. 

·  ^ Barnés CM, Huang S, Kaipainen A, et al (December 2005). "Evidence by molecular profiling for a placental origin of infantile hemangioma". Proc. Natl. Acad. Sci. U.S.A. 102 (52): 19097–102. doi:10.1073/pnas.0509579102. PMID 16365311. 

·  ^ North PE, Waner M, Brodsky MC (April 2002). "Are infantile hemangiomas of placental origin?". Ophthalmology 109 (4): 633–4. doi:10.1016/S0161-6420(02)01071-0. PMID 11949625. http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(02)01071-0. 

·  ^ Pittman KM, Losken HW, Kleinman ME, et al (November 2006). "No evidence for maternal-fetal microchimerism in infantile hemangioma: a molecular genetic investigation". J. Invest. Dermatol. 126 (11): 2533–8. doi:10.1038/sj.jid.5700516. PMID 16902414. http://www.nature.com/jid/journal/v126/n11/abs/5700516a.html. 

·  ^ Oza VS, Wang E, Berenstein A, et al (April 2008). "PHACES association: a neuroradiologic review of 17 patients". AJNR Am J Neuroradiol 29 (4): 807–13. doi:10.3174/ajnr.A0937. PMID 18223093. http://www.ajnr.org/cgi/pmidlookup?view=long&pmid=18223093. 

·  ^ Heyer GL, Dowling MM, Licht DJ, et al (February 2008). "The cerebral vasculopathy of PHACES syndrome". Stroke 39 (2): 308–16. doi:10.1161/STROKEAHA.107.485185. PMID 18174492. http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=18174492. 

·  ^ Wilson MW, Hoehn ME, Haik BG, Rieman M, Reiss U (May 2007). "Low-dose cyclophosphamide and interferon alfa 2a for the treatment of capillary hemangioma of the orbit". Ophthalmology 114 (5): 1007–11. doi:10.1016/j.ophtha.2006.11.031. PMID 17337066. http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(06)01612-5. 

·  ^ Léauté-Labrèze C et al. (June 2008). "Propranolol for Severe Hemangiomas of Infancy". New England Journal of Medicine 358 (24): 2649–2651. doi:10.1056/NEJMc0708819. PMID 18550886. http://content.nejm.org/cgi/content/full/358/24/2649.

^ "Hyperpigmentation". Dermatalogic Disease Database. American Osteopathic College of Dermatology. http://www.aocd.org/skin/dermatologic_diseases/hyperpigmentation.html. Retrieved on 2006-03-08. 
http://en.wikipedia.org/wiki/Hypopigmentation

Andrew D, Craig AD (2001). "Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch". Nat. Neurosci. 4 (1): 72–7. doi:10.1038/82924. PMID 11135647. http://www.nature.com/neuro/journal/v4/n1/full/nn0101_72.html. 
National Cancer Institute (2003) "Pruritus" Retrieved Aug. 22, 2005.
·  ^ a b c d e f g Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M (2006). "The neurobiology of itch". Nat. Rev. Neurosci. 7 (7): 535–47. doi:10.1038/nrn1950. PMID 16791143. 

·  ^ Greaves MW, Khalifa N (2004). "Itch: more than skin deep". Int. Arch. Allergy Immunol. 135 (2): 166–72. doi:10.1159/000080898. PMID 15375326. 

·  ^ a b c d e Twycross R, Greaves MW, Handwerker H, et al (2003). "Itch: scratching more than the surface". QJM 96 (1): 7–26. doi:10.1093/qjmed/hcg002. PMID 12509645. http://qjmed.oxfordjournals.org/cgi/content/full/96/1/7. 

·  ^ a b Ward L, Wright E, McMahon SB (1996). "A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain". Pain 64 (1): 129–38. doi:10.1016/0304-3959(95)00080-1. PMID 8867255. 

·  ^ Yosipovitch G, Greaves MW, Schmelz M (2003). "Itch". Lancet 361 (9358): 690–4. doi:10.1016/S0140-6736(03)12570-6. PMID 12606187. 

·  ^ Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE (1997). "Specific C-receptors for itch in human skin". J. Neurosci. 17 (20): 8003–8. PMID 9315918. http://www.jneurosci.org/cgi/content/full/17/20/8003. 

·  ^ Bernhard JD (2005). "Itch and pruritus: what are they, and how should itches be classified?". Dermatol Ther 18 (4): 288–91. doi:10.1111/j.1529-8019.2005.00040.x. PMID 16296999. 

·  ^ Nilsson HJ, Levinsson A, Schouenborg J (1997). "Cutaneous field stimulation (CFS): a new powerful method to combat itch". Pain 71 (1): 49–55. doi:10.1016/S0304-3959(97)03339-3. PMID 9200173. 

·  ^ Yosipovitch G, Fast K, Bernhard JD (2005). "Noxious heat and scratching decrease histamine-induced itch and skin blood flow". J. Invest. Dermatol. 125 (6): 1268–72. doi:10.1111/j.0022-202X.2005.23942.x. PMID 16354198. http://www.nature.com/jid/journal/v125/n6/full/5603667a.html. 

·  ^ Green AD, Young KK, Lehto SG, Smith SB, Mogil JS (2006). "Influence of genotype, dose and sex on pruritogen-induced scratching behavior in the mouse". Pain 124 (1-2): 50–8. doi:10.1016/j.pain.2006.03.023. PMID 16697529. 

·  ^ Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M (2000). "Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study". Br. J. Dermatol. 142 (6): 1114–20. doi:10.1046/j.1365-2133.2000.03535.x. PMID 10848733. 

·  ^ eMedicine - Hyperparathyroidism : Article by James LaBagnara

·  ^ Botero F. Pruritus as a manifestation of systemic disorders. Cutis. 1978; 21:873-880.

·  ^ Hercogová J (2005). "Topical anti-itch therapy". Dermatologic therapy 18 (4): 341–3. doi:10.1111/j.1529-8019.2005.00033.x (inactive 2008-06-22). PMID 16297007. 

·  ^ Botero F. Pruritus as a manifestation of systemic disorders. Cutis. 1978; 21:873-880.

·  ^ Karsak M, Gaffal E, Date R, et al (2007). "Attenuation of allergic contact dermatitis through the endocannabinoid system". Science 316 (5830): 1494–7. doi:10.1126/science.1142265. PMID 17556587.

·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.

·  ^ Saario R, Kalliomaki JL (Dec 1985), "Palmar erythema in rheumatoid arthritis", Clin Rheumatol. 4 (4): 449–51, doi:10.1007/BF02031898, PMID 3830522

·  ^ Mitchell, J., Curran, C., and Myers, R. (1947) Some Psychosomatic Aspects of Allergic Diseases. Psychosomatic Medicine: 9(3), 184-191. [1]

·  ^ Uguz, F., Engin, B., and Yilmaz, E. (2008a) Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria. Journal of Psychosomatic Research, 64: 225-229. [2]

·  ^ Engin, B., Uguz, F., Yilmaz, E., Özdemir, M., and Mevlitoglu, I. (2007) The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. Journal of the EuropeanAcademy of Dermatology and Venereology, 22(1): 36-40. [3]

·  ^ Yang, H., Sun, C., Wu, Y., and Wang, J. (2005) Stress, insomnia, and chronic idiopathic urticaria: a case-control study. Journal of the Formos Medical Association, 104(4): 254-263. [4]

·  ^ Chung, M., Symons, C., Gilliam, J., and Kaminski, E. (2008b) The relationship between post-traumatic stress resulting from past traumas, coping strategies and chronic idiopathic urticaria (CIU). Poster presented at the British Psychological Society Annual Conference.

·  ^ Life Events and Chronic Idiopathic Urticaria research project, University of Plymouth, England. [5]

·  ^ Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE (April 1996). "Helicobacter pylori infection and chronic urticaria". J. Am. Acad. Dermatol. 34 (4): 685–6. PMID 8601663. http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(96)80086-7. 

·  ^ Champion RH, Roberts SO, Carpenter RG, Roger JH (1969). "Urticaria and angio-oedema. A review of 554 patients". Br. J. Dermatol. 81 (8): 588–97. PMID 5801331. 

·  ^ "Prescribing Information Dexedrine". GlaxoSmithKline. June 2006. http://dailymed.nlm.nih.gov/dailymed/fdaDrugXsl.cfm?id=1215&type=display. 

·  ^ angioedema at Dorland's Medical Dictionary

·  ^ "Hives (Urticaria and Angioedema)". 2006-03-01. http://www.webmd.com/allergies/guide/hives-urticaria-angioedema. Retrieved on 2007-08-24. 

·  ^ Greaves MW, Tan KT (2007). "Chronic Urticaria: Recent Advances". Clin Rev Allergy Immunol 33 (1-2): 134–143. doi:10.1007/s12016-007-0038-3. PMID 18094952. 

·  ^ Lee EE, Maibach HI (2001). "Treatment of urticaria. An evidence-based evaluation of antihistamines". Am J Clin Dermatol 2 (1): 27–32. PMID 11702618. 

·  ^ "World Health Organisation assigns CUV1647 generic name" (PDF). Clinuvel. 2008. http://www.clinuvel.com/resources/pdf/asx_announcements/2008/20080617WHOGenericName.pdf. Retrieved on 2008-06-17. 

·  ^ McDonald, Kate (2007-04-13). "Tackling skin cancer in organ transplant patients". Australian Life Scientist. http://www.biotechnews.com.au/index.php/id;444900667. Retrieved on 2007-12-24. 

·  ^ "Clinuvel gets green light". Biotechnews.com.au (LifeScientist). 2007-06-11. http://www.biotechnews.com.au/index.php/id;1708412693;fp;16;fpid;1. Retrieved on 2008-06-13. 

·  ^ Baron, ED; Taylor, CR (2007-03-29). "Urticaria, Solar". WebMD. http://www.emedicine.com/derm/topic448.htm. Retrieved on 2007-12-26. 

·  ^ de Martino M, Peruzzi M, Galli L, Lega L, Zammarchi E, Vierucci A (1992). "Food-additive intolerance and its correlation with atopy in children with recurrent or intermittent urticaria-angioedema". Pediatric Allergy and Immunology 3 (1): 33–38. doi:10.1111/j.1399-3038.1992.tb00024.x. http://www3.interscience.wiley.com/journal/119332669/abstract.

^ Understanding Horse Nutrition.Com on buckwheat
http://en.wikipedia.org/wiki/Photosensitivity

^ Boyd MA, Menon P, Graves S, Gordon DL (March 2007). "A febrile illness with generalized papular rash involving the palms and soles". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 44 (5): 704, 755–6. doi:10.1086/511637. PMID 17278064. http://www.journals.uchicago.edu/doi/abs/10.1086/511637?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov.  Scholar search
·  ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ Case 5-2009: A 47-year-old woman with a rash and numbness and pain in the legs, N Engl J Med 2009;360:711-20

·  ^ Sneddon I (April 1965). "Cerebro-Vascular Lesions And Livedo Reticularis". Br J Dermatol 77: 180–5. doi:10.1111/j.1365-2133.1965.tb14628.x. PMID 14278790. 

·  ^ Gibbs M, English J, Zirwas M (2005). "Livedo reticularis: an update". J Am Acad Dermatol 52 (6): 1009–19. doi:10.1016/j.jaad.2004.11.051. PMID 15928620. 

·  ^ Feldaker M, Hines E, Kierland R (1955). "Livedo reticularis with summer ulcerations". AMA Arch Derm 72 (1): 31–42. PMID 14387292. 

·  ^ Golden R (March 1963). "Livedo reticularis in systemic lupus erythematosus". Arch Dermatol 87: 299–301. PMID 13948706. 

·  ^ Sigmund W, Shelley W (1954). "Cutaneous manifestations of acute pancreatitis, with special reference to livedo reticularis". N Engl J Med 251 (21): 851–3. PMID 13214346. 

·  ^ Langhof H, Braun G, Matzkowski H (1957). "[Livedo reticularis due to cold gelation of the blood by gamma-plasmacytoma.]". Arch Klin Exp Dermatol 205 (4): 343–50. PMID 13522017. 

·  ^ Kazmier F, Sheps S, Bernatz P, Sayre G (1966). "Livedo reticularis and digital infarcts: a syndrome due to cholesterol emboli arising from atheromatous abdominal aortic aneurysms". Vasc Dis 3 (1): 12–24. PMID 5903590. 

·  ^ Stewart W, Lauret P, Testart J, Thomine E, Boulliê M, Leroy D (1977). "[Cutaneous cholesterol emboli (author's transl)]". Ann Dermatol Venereol 104 (1): 5–8. PMID 843026. 

·  ^ Fleischer A, Resnick S (1990). "Livedo reticularis". Dermatol Clin 8 (2): 347–54. PMID 2191805.

^ http://www.kinesiotaping.co.uk/lymphoedema/edema.jsp
^ Szuba A, Achalu R, Rockson SG (2002). "Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression". Cancer 95 (11): 2260–7. doi:10.1002/cncr.10976. PMID 12436430.  However, in recent years some health professionals have begun to raise concern that compression pumps can cause genital swelling when used on persons with leg lymphedema.
^ PDF document
^ "Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis". World Health Organization technical report series 821: 1–71. 1992. PMID 1441569. 
^ http://whqlibdoc.who.int/hq/2001/WHO_CDS_CPE_CEE_2001.26a.pdf.
^ Benoit Blondeau; Lawrence L Tretbar; Morgan, Cheryl E.; Simon J. Simonian (2007). Lymphedema: Diagnosis and Treatment. Springer. ISBN 1-84628-548-8. 
^ Ward LC (2006). "Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring". Lymphat Res Biol 4 (1): 51–6. doi:10.1089/lrb.2006.4.51. PMID 16569209. 
^ Photos courtesy of Amy's Lymphedema Story
·  ^ Raynaud disease at Dorland's Medical Dictionary

·  ^ AndersonME, Moore TL, Lunt M, Herrick AL (2007). "The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon". Rheumatology (Oxford) 46 (3): 533–8. doi:10.1093/rheumatology/kel330. PMID 17018538. http://rheumatology.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17018538. 

·  ^ Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M (2006). "Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance". Arthritis Rheum. 54 (6): 1974–81. doi:10.1002/art.21912. PMID 16732585. 

·  ^ Gayraud M (2007). "Raynaud's phenomenon". Joint Bone Spine 74 (1): e1–8. doi:10.1016/j.jbspin.2006.07.002. PMID 17218139. http://linkinghub.elsevier.com/retrieve/pii/S1297-319X(06)00246-6. 

·  ^ Barclay, Laurie (2004-04-09). "Raynaud's Phenomenon of the Nipple May Cause Painful Breastfeeding". Medscape. medscape.com. http://www.medscape.com/viewarticle/473219. Retrieved on 2009-03-21. 

·  ^ Kumar, Vinay; Nelso Fausto, Abul Abbas (2004). Robbins & Cotran Pathologic Basis of Desease. Saunders. pp. 542. ISBN 0721601871. 

·  ^ Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M (1981). "Nifedipine and Raynaud's phenomenon". Ann. Intern. Med. 94 (4 pt 1): 546. PMID 7212523. 

·  ^ Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M (1982). "[Controlled study of nifedipine in the treatment of Raynaud's phenomenon]" (in French). Rev Rhum Mal Osteoartic 49 (5): 337–43. PMID 6285445. 

·  ^ Smith CR, Rodeheffer RJ (1985). "Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers". Am. J. Cardiol. 55 (3): 154B–157B. doi:10.1016/0002-9149(85)90625-3. PMID 3881908. 

·  ^ Pancera P, Sansone S, Secchi S, Covi G, Lechi A (1997). "The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon". J. Intern. Med. 242 (5): 373–6. doi:10.1046/j.1365-2796.1997.00219.x. PMID 9408065. 

·  ^ Dziadzio M, Denton CP, Smith R, et al (1999). "Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial" (PDF). Arthritis Rheum. 42 (12): 2646–55. doi:10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T. PMID 10616013. http://www3.interscience.wiley.com/cgi-bin/fulltext/78503570/PDFSTART. 

·  ^ Waldo R (1979). "Prazosin relieves Raynaud's vasospasm". JAMA 241 (10): 1037. doi:10.1001/jama.241.10.1037. PMID 762741. 

·  ^ Fries R, Shariat K, von Wilmowsky H, Böhm M (2005). "Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy". Circulation 112 (19): 2980–5. doi:10.1161/CIRCULATIONAHA.104.523324 (inactive 2008-06-21). PMID 16275885. http://circ.ahajournals.org/cgi/content/full/112/19/2980. 

·  ^ Wang WH, Lai CS, Chang KP, et al (2006). "Peripheral sympathectomy for Raynaud's phenomenon: a salvage procedure". Kaohsiung J. Med. Sci. 22 (10): 491–9. PMID 17098681. http://health.elsevier.com/ajws_pubmed/pubmed_switch.asp?journal_issn=1607-551X&art_pub_year=2006&%20art_pub_month=10&art_pub_vol=22&art_sp=491. 

·  ^ Muir AH, Robb R, McLaren M, Daly F, Belch JJ (2002). "The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial". Vasc Med 7 (4): 265–7. doi:10.1191/1358863x02vm455oa. PMID 12710841. 

·  ^ Tucker AT, Pearson RM, Cooke ED, Benjamin N (Nov 13 1999). "Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: a randomised trial". Lancet 354 (9191): 1670–5. doi:10.1016/S0140-6736(99)04095-7. PMID 10568568.

·  ^ Mitchell, J., Curran, C., and Myers, R. (1947) Some Psychosomatic Aspects of Allergic Diseases. Psychosomatic Medicine: 9(3), 184-191. [1]

·  ^ Uguz, F., Engin, B., and Yilmaz, E. (2008a) Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria. Journal of Psychosomatic Research, 64: 225-229. [2]

·  ^ Engin, B., Uguz, F., Yilmaz, E., Özdemir, M., and Mevlitoglu, I. (2007) The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. Journal of the EuropeanAcademy of Dermatology and Venereology, 22(1): 36-40. [3]

·  ^ Yang, H., Sun, C., Wu, Y., and Wang, J. (2005) Stress, insomnia, and chronic idiopathic urticaria: a case-control study. Journal of the Formos Medical Association, 104(4): 254-263. [4]

·  ^ Chung, M., Symons, C., Gilliam, J., and Kaminski, E. (2008b) The relationship between post-traumatic stress resulting from past traumas, coping strategies and chronic idiopathic urticaria (CIU). Poster presented at the British Psychological Society Annual Conference.

·  ^ Life Events and Chronic Idiopathic Urticaria research project, University of Plymouth, England. [5]

·  ^ Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE (April 1996). "Helicobacter pylori infection and chronic urticaria". J. Am. Acad. Dermatol. 34 (4): 685–6. PMID 8601663. http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(96)80086-7. 

·  ^ Champion RH, Roberts SO, Carpenter RG, Roger JH (1969). "Urticaria and angio-oedema. A review of 554 patients". Br. J. Dermatol. 81 (8): 588–97. PMID 5801331. 

·  ^ "Prescribing Information Dexedrine". GlaxoSmithKline. June 2006. http://dailymed.nlm.nih.gov/dailymed/fdaDrugXsl.cfm?id=1215&type=display. 

·  ^ angioedema at Dorland's Medical Dictionary

·  ^ "Hives (Urticaria and Angioedema)". 2006-03-01. http://www.webmd.com/allergies/guide/hives-urticaria-angioedema. Retrieved on 2007-08-24. 

·  ^ Greaves MW, Tan KT (2007). "Chronic Urticaria: Recent Advances". Clin Rev Allergy Immunol 33 (1-2): 134–143. doi:10.1007/s12016-007-0038-3. PMID 18094952. 

·  ^ Lee EE, Maibach HI (2001). "Treatment of urticaria. An evidence-based evaluation of antihistamines". Am J Clin Dermatol 2 (1): 27–32. PMID 11702618. 

·  ^ "World Health Organisation assigns CUV1647 generic name" (PDF). Clinuvel. 2008. http://www.clinuvel.com/resources/pdf/asx_announcements/2008/20080617WHOGenericName.pdf. Retrieved on 2008-06-17. 

·  ^ McDonald, Kate (2007-04-13). "Tackling skin cancer in organ transplant patients". Australian Life Scientist. http://www.biotechnews.com.au/index.php/id;444900667. Retrieved on 2007-12-24. 

·  ^ "Clinuvel gets green light". Biotechnews.com.au (LifeScientist). 2007-06-11. http://www.biotechnews.com.au/index.php/id;1708412693;fp;16;fpid;1. Retrieved on 2008-06-13. 

·  ^ Baron, ED; Taylor, CR (2007-03-29). "Urticaria, Solar". WebMD. http://www.emedicine.com/derm/topic448.htm. Retrieved on 2007-12-26. 

·  ^ de Martino M, Peruzzi M, Galli L, Lega L, Zammarchi E, Vierucci A (1992). "Food-additive intolerance and its correlation with atopy in children with recurrent or intermittent urticaria-angioedema". Pediatric Allergy and Immunology 3 (1): 33–38. doi:10.1111/j.1399-3038.1992.tb00024.x. http://www3.interscience.wiley.com/journal/119332669/abstract.

^ Varicose veins Mount Sinai Hospital, New York
^ Merck Manual Home Edition, 2nd ed.
^ NHS Direct
^ Weiss RA, Weiss MA (October 1993). "Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy". J Dermatol Surg Oncol 19 (10): 947–51. PMID 8408914. http://openurl.ebscohost.com/linksvc/linking.aspx?genre=article&sid=PubMed&issn=0148-0812&title=J%20Dermatol%20Surg%20Oncol&volume=19&issue=10&spage=947&atitle=Doppler%20ultrasound%20findings%20in%20reticular%20veins%20of%20the%20thigh%20subdermic%20lateral%20venous%20system%20and%20implications%20for%20sclerotherapy.&aulast=Weiss&date=1993. 
^ Goldman M. Sclerotherapy, Treatment of Varicose and Telangiectatic Leg Veins. Hardcover Text, 2nd Ed, 1995
^ Ng M, Andrew T, Spector T, Jeffery S (2005). "Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs.". J Med Genet 42 (3): 235–9. doi:10.1136/jmg.2004.024075. PMID 15744037. 
^ Claude Franceschi Physiopathologie Hémodynamique de l'Insuffisance veineuse in Chirurgie des veines des Membres Inférieurs, page 49, 1996, AERCV editions 23 rue Royale 75008 Paris France
^ Campbell B (August 2006). "Varicose veins and their management". BMJ 333 (7562): 287–92. doi:10.1136/bmj.333.7562.287. PMID 16888305. 
^ Curri SB et al. Changes of cutaneous microcirculation from elasto-compression in chronic venous insufficiency. In Davy A and Stemmer R, editors: Phlebology '89, Montrouge, France, 1989, John Libbey Eurotext.
^ "Open Surgery Is Still The Best Technique To Ablate The Great Saphenous Vein," Vascular, Vol. 14 (November 2006), Suppl. 1, p. S. 25
^ Systematic review of foam sclerotherapy for varicose veins.Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Br J Surg. 2007 Aug;94(8):925-36
^ van Rij AM, Chai J, Hill GB, Christie RA (December 2004). "Incidence of deep vein thrombosis after varicose vein surgery". Br J Surg 91 (12): 1582–5. doi:10.1002/bjs.4701. PMID 15386324. 
^ Hammarsten J, Pedersen P, Cederlund CG, Campanello M (August 1990). "Long saphenous vein saving surgery for varicose veins. A long-term follow-up". Eur J Vasc Surg 4 (4): 361–4. doi:10.1016/S0950-821X(05)80867-9. PMID 2204548. http://www.nlm.nih.gov/medlineplus/varicoseveins.html. 
^ claude Franceschi, Cure CHIVA, 1988, Editions de L'Armançon, 21390 Precy-Sous-Thil France
^ [1]
^ Maeso J, Juan J, Escribano J, et al (November 2001). "Comparison of clinical outcome of stripping and CHIVA for treatment of varicose veins in the lower extremities". Ann Vasc Surg 15 (6): 661–5. doi:10.1007/s10016-001-0009-8. PMID 11769147. 
^ Zamboni P, Cisno C, Marchetti F, et al (April 2003). "Minimally invasive surgical management of primary venous ulcers vs. compression treatment: a randomized clinical trial". Eur J Vasc Endovasc Surg 25 (4): 313–8. doi:10.1053/ejvs.2002.1871. PMID 12651168. 
^ a b Carandina S, Mari C, De Palma M, et al (February 2008). "Varicose vein stripping vs haemodynamic correction (CHIVA): a long term randomised trial". Eur J Vasc Endovasc Surg 35 (2): 230–7. doi:10.1016/j.ejvs.2007.09.011. PMID 17964822. 
^ a b c Lurie F (February 2009). "Venous haemodynamics: what we know and don't know". Phlebology 24 (1): 3–7. doi:10.1258/phleb.2008.008055. PMID 19155334. 
^ Goldman M, Sclerotherapy Treatment of varicose and telangiectatic leg vein, Hardcover Text, 2nd Ed, 1995
^ "Veins & Lymphatics," L. K. Pak et al, in Lange's Current Surgical Diagnosis & Treatment, 11th ed., McGraw-Hill,
^ Tisi PV, Beverley C, Rees A (2006). "Injection sclerotherapy for varicose veins". Cochrane Database Syst Rev (4): CD001732. doi:10.1002/14651858.CD001732.pub2. PMID 17054141. 
^ Paul Thibault, Sclerotherapy and Ultrasound-Guided Sclerotherapy, The Vein Book / editor, John J. Bergan, 2007.
^ Padbury A, Benveniste G L, Foam echosclerotherapy of the small saphenous vein, Australian and New Zealand Journal of Phlebology Vol 8, Number 1 (December 2004)
^ Kanter A, Thibault P (July 1996). "Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy". Dermatol Surg 22 (7): 648–52. doi:10.1016/1076-0512(96)00173-2. PMID 8680788. http://openurl.ebscohost.com/linksvc/linking.aspx?genre=article&sid=PubMed&issn=1076-0512&title=Dermatol%20Surg&volume=22&issue=7&spage=648&atitle=Saphenofemoral%20incompetence%20treated%20by%20ultrasound-guided%20sclerotherapy.&aulast=Kanter&date=1996. 
^ http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001732/abstract.html
^ Rigby KA, Palfreyman SJ, Beverley C, Michaels JA (2004). "Surgery versus sclerotherapy for the treatment of varicose veins". Cochrane Database Syst Rev (4): CD004980. doi:10.1002/14651858.CD004980. PMID 15495134. http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004980/abstract.html. 
^ Michaels JA, Campbell WB, Brazier JE, et al (April 2006). "Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial)". Health Technol Assess 10 (13): 1–196, iii–iv. PMID 16707070. http://www.hta.ac.uk/execsumm/summ1013.htm. 
^ William R. Finkelmeier, Sclerotherapy, Ch. 12, ACS Surgery: Principles & Practice, 2004, WebMD (hardcover book)
^ Scurr JR, Fisher RK, Wallace SB (2007). "Anaphylaxis Following Foam Sclerotherapy: A Life Threatening Complication of Non Invasive Treatment For Varicose Veins". EJVES Extra 13 (6): 87–89. doi:10.1016/j.ejvsextra.2007.02.005. 
^ Medical Services Advisory Committee, ELA for varicose veins. MSAC application 1113, Dept of Health and Ageing, Commonwealth of Australia, 2008.
^ Elmore FA, Lackey D (2008). "Effectiveness of ELA in eliminating superficial venous reflux". Phlebology 23 (1): 21–31. doi:10.1258/phleb.2007.007019. PMID 18361266. http://openurl.ebscohost.com/linksvc/linking.aspx?genre=article&sid=PubMed&issn=0268-3555&title=Phlebology&volume=23&issue=1&spage=21&atitle=Effectiveness%20of%20endovenous%20laser%20treatment%20in%20eliminating%20superficial%20venous%20reflux.&aulast=Elmore&date=2008. 
^ Rautio TT, Perälä JM, Wiik HT, Juvonen TS, Haukipuro KA (June 2002). "Endovenous obliteration with radiofrequency-resistive heating for greater saphenous vein insufficiency: a feasibility study". J Vasc Interv Radiol 13 (6): 569–75. doi:10.1016/S1051-0443(07)61649-2. PMID 12050296. http://openurl.ebscohost.com/linksvc/linking.aspx?genre=article&sid=PubMed&issn=1051-0443&title=J%20Vasc%20Interv%20Radiol&volume=13&issue=6&spage=569&atitle=Endovenous%20obliteration%20with%20radiofrequency-resistive%20heating%20for%20greater%20saphenous%20vein%20insufficiency:%20a%20feasibility%20study.&aulast=Rautio&date=2002. 
^ Lurie F, Creton D, Eklof B, et al (January 2005). "Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up". Eur J Vasc Endovasc Surg 29 (1): 67–73. doi:10.1016/j.ejvs.2004.09.019. PMID 15570274. 
^ Kenneth Myers, An opinion —surgery for small saphenous reflux is obsolete!" Australian and New Zealand Journal of Phlebology, Vol 8, Number 1 (December 2004)
·  ^ "Vasculitis - Definition from the Merriam-Webster Online Dictionary". http://www.merriam-webster.com/dictionary/Vasculitis. Retrieved on 2009-01-08. 

·  ^ "Glossary of dermatopathological terms. DermNet NZ". http://dermnetnz.org/pathology/pathology-glossary.html. Retrieved on 2009-01-08. 

·  ^ Vasculitis at Dorland's Medical Dictionary

·  ^ Jennette JC, Falk RJ, Andrassy K, et al (1994). "Nomenclature of systemic vasculitides. Proposal of an international consensus conference". Arthritis Rheum. 37 (2): 187–92. doi:10.1002/art.1780370206. PMID 8129773.

·  ^ a b c Snyder RJ (2005). "Treatment of nonhealing ulcers with allografts". Clin. Dermatol. 23 (4): 388–95. doi:10.1016/j.clindermatol.2004.07.020. PMID 16023934. 

^ a b c d e f g h i j Brem H, Kirsner RS, Falanga V (2004). "Protocol for the successful treatment of venous ulcers". Am. J. Surg. 188 (1A Suppl): 1–8. doi:10.1016/S0002-9610(03)00284-8. PMID 15223495. 

·  ^ a b c Mustoe T (2004). "Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy". Am. J. Surg. 187 (5A): 65S–70S. doi:10.1016/S0002-9610(03)00306-4. PMID 15147994. 

·  ^ a b c Moreo K (2005). "Understanding and overcoming the challenges of effective case management for patients with chronic wounds". The Case manager 16 (2): 62–3, 67. doi:10.1016/j.casemgr.2005.01.014. PMID 15818347. 

·  ^ a b c d Stanley AC, Lounsbury KM, Corrow K, et al (2005). "Pressure elevation slows the fibroblast response to wound healing". J. Vasc. Surg. 42 (3): 546–51. doi:10.1016/j.jvs.2005.04.047. PMID 16171604. 

·  ^ a b "eMedicine - Reperfusion Injury in Stroke : Article by Wayne M Clark, MD". http://www.emedicine.com/neuro/topic602.htm. Retrieved on 2007-08-05. 

·  ^ a b Nelson EA, Cullum N, Jones J (2006). "Venous leg ulcers". Clinical evidence (15): 2607–26. PMID 16973096. http://clinicalevidence.com/ceweb/conditions/wnd/1902/1902.jsp. 

·  ^ Taylor JE, Laity PR, Hicks J, et al (2005). "Extent of iron pick-up in deforoxamine-coupled polyurethane materials for therapy of chronic wounds". Biomaterials 26 (30): 6024–33. doi:10.1016/j.biomaterials.2005.03.015. PMID 15885771. 

·  ^ Nelson EA, Harper DR, Prescott RJ, Gibson B, Brown D, Ruckley CV (2006). "Prevention of recurrence of venous ulceration: randomized controlled trial of class 2 and class 3 elastic compression". J. Vasc. Surg. 44 (4): 803–8. doi:10.1016/j.jvs.2006.05.051. PMID 17012004. 

·  ^ Palfreyman SJ, Nelson EA, Lochiel R, Michaels JA (2006). "Dressings for healing venous leg ulcers". Cochrane database of systematic reviews (Online) 3: CD001103. doi:10.1002/14651858.CD001103.pub2. PMID 16855958. 

·  ^ Palfreyman S, Nelson EA, Michaels JA (2007). "Dressings for venous leg ulcers: systematic review and meta-analysis". BMJ 335 (7613): 244. doi:10.1136/bmj.39248.634977.AE. PMID 17631512. 

·  ^ Jull A, Arroll B, Parag V, Waters J (2007). "Pentoxifylline for treating venous leg ulcers". Cochrane database of systematic reviews (Online) (3): CD001733. doi:10.1002/14651858.CD001733.pub2. PMID 17636683. 

·  ^ Mustoe T. 2005. Dermal ulcer healing: Advances in understanding. Presented at meeting: Tissue repair and ulcer/wound healing: molecular mechanisms, therapeutic targets and future directions. Paris, France, March 17-18, 2005. Available.

·  ^ Jones JE, Nelson EA (2007). "Skin grafting for venous leg ulcers". Cochrane database of systematic reviews (Online) (2): CD001737. doi:10.1002/14651858.CD001737.pub3. PMID 17443510. 

·  ^ Gohel MS, Barwell JR, Taylor M, et al (2007). "Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial". BMJ 335 (7610): 83. doi:10.1136/bmj.39216.542442.BE. PMID 17545185.

^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 517. ISBN 0721629210.
^ Rauch F, Glorieux FH (2004). "Osteogenesis imperfecta". Lancet 363 (9418): 1377–85. doi:10.1016/S0140-6736(04)16051-0. PMID 15110498. 
^ "Osteogenesis Imperfecta Foundation: Fast Facts". http://www.oif.org/site/PageServer?pagename=FastFacts. Retrieved on 2007-07-05. 
^ Glorieux FH, Rauch F, Plotkin H, et al (2000). "Type V osteogenesis imperfecta: a new form of brittle bone disease". J. Bone Miner. Res. 15 (9): 1650–8. doi:10.1359/jbmr.2000.15.9.1650. PMID 10976985. 
^ a b Genetics Home Reference: Genetic Conditions > Osteogenesis imperfecta (Reviewed November 2007)
^ Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998). "Cyclic administration of pamidronate in children with severe osteogenesis imperfecta". N. Engl. J. Med. 339 (14): 947–52. doi:10.1056/NEJM199810013391402. PMID 9753709. 
^ DiMeglio LA, Peacock M (2006). "Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta". J. Bone Miner. Res. 21 (1): 132–40. doi:10.1359/JBMR.051006. PMID 16355282. 
^ Chevrel G, Schott AM, Fontanges E, et al (2006). "Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial". J. Bone Miner. Res. 21 (2): 300–6. doi:10.1359/JBMR.051015. PMID 16418786. 
^ "Chicago Shriners Hospital - Osteogenesis imperfecta". http://www.shriners.com/Hospitals/Chicago/conditions/OI.aspx. Retrieved on 2007-07-05. 
^ K. Buday, Beiträge zur Lehre von der Osteogenesis imperfecta (1895)
^ Sillence DO, Senn A, Danks DM (1979). "Genetic heterogeneity in osteogenesis imperfecta". J. Med. Genet. 16 (2): 101–16. doi:10.1136/jmg.16.2.101. PMID 458828. 
^ "Osteogenesis Imperfecta Foundation: Glossary". http://www.oif.org/site/PageServer?pagename=Glossary. Retrieved on 2007-07-05. 
^ synd/1743 at Who Named It?
^ Viljoen D, Beighton P (1987). "Osteogenesis imperfecta type III: an ancient mutation in Africa?". Am. J. Med. Genet. 27 (4): 907–12. doi:10.1002/ajmg.1320270417. PMID 3425600. 
^ Cast: Michael J. Anderson
^ Michael J. Anderson - Trailer - Showtimes - Cast - Movies - New York Times
^ Julie Fernandez - founder of The Disability Foundation
^ [1]
^ Michel Petrucciani:Victory of the Spirit - International Herald Tribune
^ Secret History: The Strangest Viking | The Nation's Favourite Food | Arts critics | Guardian Unlimited Arts
^ [2][dead link]
^ Motivational keynote speaker, conferences and meetings, colleges and universities, corporations, school districts, government agencies, workshops, improve performance, motivation, keynote speaker, meeting planners, Stress management, change, personal development, staff development, educational, youth leadership, school assembly speaker, workshops, conferences, public speaker, motivation, motivational speaker, professional speaker, inspiration, trainer, self-help, personal development, inspirational speaker,consultant, speech coach, motivator, Terry Healey, At Face Value, cancer, fibrosarcoma>
^ [3]
^ Dallas - Movies - Willing and able
^ Henri de Toulouse-Lautrec > Biography > Chronology
^ Noble figure | Extracts | Guardian Unlimited Books
^ [4]
^ "The Vikings," Frank. R. Donovan, author; Sir Thomas D. Kendrick, consultant; Horizan Caravel Books, by the editors of Horizan Magazine, Fourth Edition, American Heritage Publishing Co.: New York, 1964, LCC# 64-17106, pp. 44-45; 145, 148.
^ "Point of Origin". http://www.erheadquarters.com/episodes/05/5109.htm. Retrieved on 2007-07-05. 
^ "Working with Hollywood to Deliver Your Message to Millions". http://www.rwjf.org/files/publications/other/YourIssueReport.pdf. Retrieved on 2007-07-05. 
^ "Scrubs -[scripts- "My Rite of Passage""]. http://scrubs.mopnt.com/scripts/502.php. Retrieved on 2007-07-05. 
^ "Bones" (2005) - Episode list
^ Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. (2003). "Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months.". Plast Reconstr Surg. 111 (2): 547–53 & 554–5. doi:10.1097/01.PRS.0000040466.55214.35. PMID 12560675.

^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 512. ISBN 0721629210.
^ "Uncovered: How U.S. Health System Can Fail Even the Insured --- A Woman Endures 16-Month Odyssey To Get a Diagnosis", John Carreyrou, Wall Street Journal, November 16, 2007
^ Lawrence EJ (2005). "The clinical presentation of Ehlers-Danlos syndrome". Adv Neonatal Care 5 (6): 301–14. doi:10.1016/j.adnc.2005.09.006. PMID 16338669. 
^ The Press Enterprise, Redlands mother stung by untrue suspicions presses for accountability in child abuse inquiries, 2008-04-03
^ Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998). "Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)". Am J Med Genet 77 (1): 31–7. doi:10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O. PMID 9557891. 
^ [[1]]
^ [2]
^ Medical dictionary
^ [3]
^ Scleroderma at Dorland's Medical Dictionary
^ MeSH Systemic+Scleroderma
^ MeSH Scleroderma,+Localized
^ Klippel, John H.. Primer On the Rheumatic Diseases 11ED. Atlanta, GA: Arthritis Foundation. ISBN 1-912423-16-2. 
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 169-172. ISBN 0721629210.
^ Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23:581-90.
^ Barnett A, Miller M, Littlejohn G. The Diagnosis and Classification of Scleroderma. Postgraduate Medical Journal. 1988; 64:121-125.
^ Fleischmajer,R., Sapadin, AN.Treatment of Scleroderma. Arch Dermatol. 2002; 138:99 - 104
^ Leighton, C. Drug Treatment of Scleroderma. Drugs. 2001; 61(3): 419-27.
^ A Brief History of Scleroderma, http://www.scleroderma.org/medical/other_articles/Coyle_2001_4.shtm
·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). Page 990. McGraw-Hill. ISBN 0071380760.

·  ^ Levine LA, Estrada CR, Storm DW, Matkov TG (2003). "Peyronie disease in younger men: characteristics and treatment results". J. Androl. 24 (1): 27–32. PMID 12514077. 

·  ^ Peyronie's disease at Who Named It?

·  ^ "Peyronie’s Disease". http://kidney.niddk.nih.gov/kudiseases/pubs/peyronie/index.htm. Retrieved on 2007-12-03. 

·  ^ "Peyronie's disease - MayoClinic.com". http://www.mayoclinic.com/health/peyronies-disease/DS00427. Retrieved on 2007-12-03. 

·  ^ http://www.mayoclinic.com/health/peyronies-disease/DS00427/DSECTION=causes

·  ^ http://www.mayoclinic.com/health/peyronies-disease/DS00427/DSECTION=causes

·  ^ Levine LA (2003). "Review of current nonsurgical management of Peyronie's disease". Int. J. Impot. Res. 15 Suppl 5: S113–20. doi:10.1038/sj.ijir.3901084. PMID 14551587. 

·  ^ Hauck EW, Diemer T, Schmelz HU, Weidner W (2006). "A critical analysis of nonsurgical treatment of Peyronie's disease". Eur. Urol. 49 (6): 987–97. doi:10.1016/j.eururo.2006.02.059. PMID 16698449. http://linkinghub.elsevier.com/retrieve/pii/S0302-2838(06)00304-6. 

·  ^ Mynderse LA, Monga M (2002). "Oral therapy for Peyronie's disease". Int. J. Impot. Res. 14 (5): 340–4. doi:10.1038/sj.ijir.3900869. PMID 12454684. http://www.nature.com/ijir/journal/v14/n5/full/3900869a.html. 

·  ^ Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ (2003). "Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease". BJU Int. 91 (6): 522–4. doi:10.1046/j.1464-410X.2003.04134.x. PMID 12656907. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1464-4096&date=2003&volume=91&issue=6&spage=522. 

·  ^ Carson CC (1997). "Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective?". Tech Urol 3 (3): 135–9. PMID 9422444. 

·  ^ Trost LW, Gur S, Hellstrom WJ (2007). "Pharmacological Management of Peyronie's Disease". Drugs 67 (4): 527–45. doi:10.2165/00003495-200767040-00004. PMID 17352513. 

·  ^ Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H (2000). "Iontophoresis for treatment of Peyronie's disease". J. Urol. 163 (1): 95–9. doi:10.1016/S0022-5347(05)67981-5. PMID 10604323. http://linkinghub.elsevier.com/retrieve/pii/S0022-5347(05)67981-5. 

·  ^ Ralph DJ, Minhas S (2004). "The management of Peyronie's disease". BJU Int. 93 (2): 208–15. doi:10.1111/j.1464-410X.2004.04587.x. PMID 14690485. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1464-4096&date=2004&volume=93&issue=2&spage=208. 

·  ^ Hellstrom WJ, Usta MF (2003). "Surgical approaches for advanced Peyronie's disease patients". Int. J. Impot. Res. 15 Suppl 5: S121–4. doi:10.1038/sj.ijir.3901085. PMID 14551588.

·  ^ a b c d e f g h i j k Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A (2005). "Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations". J. Med. Genet. 42 (12): 881–92. doi:10.1136/jmg.2004.030171. PMID 15894595. http://jmg.bmj.com/cgi/content/full/42/12/881. 

·  ^ Gheduzzi D, Sammarco R, Quaglino D, Bercovitch L, Terry S, Taylor W, Ronchetti I (2003). "Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum". Ultrastructural pathology 27 (6): 375–84. doi:10.1080/716100800. PMID 14660276. 

·  ^ Jiang Q, Uitto J (July 2006). "Pseudoxanthoma elasticum: a metabolic disease?". J. Invest. Dermatol. 126 (7): 1440–1. doi:10.1038/sj.jid.5700267. PMID 16778810. http://www.nature.com/jid/journal/v126/n7/full/5700267a.html. 

·  ^ Jiang Q, Endo M, Dibra F, Wang K, Uitto J (August 2008). "Pseudoxanthoma Elasticum Is a Metabolic Disease". J. Invest. Dermatol. Online first: 348. doi:10.1038/jid.2008.212. PMID 18685618. 

·  ^ Borst P, van de Wetering K, Schlingemann R (June 2008). "Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?" (PDF). Cell Cycle 7 (11): 1575–9. PMID 18469514. http://www.landesbioscience.com/journals/cc/article/BorstCC7-11.pdf. 

·  ^ Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J (2000). "Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter". Proc. Natl. Acad. Sci. U.S.A. 97 (11): 6001–6. doi:10.1073/pnas.100041297. PMID 10811882. http://www.pnas.org/cgi/content/full/97/11/6001.  Full text at PMC: 18548

·  ^ Bergen AA, PlompAS, Schuurman EJ, et al (2000). "Mutations in ABCC6 cause pseudoxanthoma elasticum". Nat. Genet. 25 (2): 228–31. doi:10.1038/76109. PMID 10835643. http://www.nature.com/ng/journal/v25/n2/full/ng0600_228.html. 

·  ^ a b Le Saux O, Urban Z, Tschuch C, et al (2000). "Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum". Nat. Genet. 25 (2): 223–7. doi:10.1038/76102. PMID 10835642. http://www.nature.com/ng/journal/v25/n2/full/ng0600_223.html. 

·  ^ Struk B, Cai L, Zäch S, et al (2000). "Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum". J. Mol. Med. 78 (5): 282–6. doi:10.1007/s001090000114. PMID 10954200. http://www.springerlink.com/content/dm2k620uh35vuhb1/fulltext.html. 

·  ^ Schulz V, Hendig D, Szliska C, Götting C, Kleesiek K (2005). "Novel mutations in the ABCC6 gene of German patients with pseudoxanthoma elasticum". Hum. Biol. 77 (3): 367–84. doi:10.1353/hub.2005.0054. PMID 16392638. 

·  ^ Pfendner EG, Vanakker OM, Terry SF, et al (2007). "Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum". J. Med. Genet. 44 (10): 621–8. doi:10.1136/jmg.2007.051094. PMID 17617515. http://jmg.bmj.com/cgi/content/full/44/10/621. 

·  ^ Trip MD, Smulders YM, Wegman JJ, et al (2002). "Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease". Circulation 106 (7): 773–5. doi:10.1161/01.CIR.0000028420.27813.C0. PMID 12176944. http://circ.ahajournals.org/cgi/content/full/106/7/773. 

·  ^ Vanakker OM, Martin L, Gheduzzi D, Leroy BP, Loeys BL, Guerci VI, Matthys D, Terry SF, Coucke PJ, Pasquali-Ronchetti I, De Paepe A. (2007). "Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity.". J Invest Dermatol. 127 (3): 581–7. doi:10.1038/sj.jid.5700610. PMID 17110937. http://www.nature.com/jid/journal/v127/n3/full/5700610a.html. 

·  ^ Finger RP, Charbel Issa P, Ladewig M, Holz FG, Scholl HP (April 2008). "Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum". Br J Ophthalmol 92 (4): 483–7. doi:10.1136/bjo.2007.129916. PMID 18369065. 

·  ^ Bhatnagar P, Freund KB, Spaide RF, et al (September 2007). "Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum". Retina (Philadelphia, Pa.) 27 (7): 897–902. doi:10.1097/IAE.0b013e31809ff5df. PMID 17891014. 

·  ^ Darrier FJ (1896). "Pseudoxanthoma elasticum" (in German). Monatschr Prakt Dermatol 23: 609–17. 

·  ^ synd/1059 at Who Named It?

·  ^ Terry SF, Terry PF, Rauen KA, Uitto J, Bercovitch LG (2007). "Advocacy groups as research organizations: the PXE International example". Nat. Rev. Genet. 8 (2): 157–64. doi:10.1038/nrg1991. PMID 17230202. 

·  ^ Terry SF (2003). "Learning genetics". Health Aff (Millwood) 22 (5): 166–71. doi:10.1377/hlthaff.22.5.166. PMID 14515892. http://content.healthaffairs.org/cgi/content/full/22/5/166.

^ a b FAQ, Foundation for Ichthyosis & Related Skin Types (F.I.R.S.T)
^ Ichthyosis, John Hopkins Health Information Library
^ Okulicz JF, Schwartz RA (2003). "Hereditary and acquired ichthyosis vulgaris". International Journal of Dermatology 42 (2): 95-8. PMID 12708996. 
^ Types of Ichthyosis, Foundation for Ichthyosis & Related Skin Types (F.I.R.S.T)
^ Sundberg, John P., Handbook of Mouse Mutations with Skin and Hair Abnormalities, Page 333, Published by CRC Press, 1994, ISBN 0849383722
^ Gross, Thelma Lee, Veterinary Dermatopathology, Page 174-179, Published by Blackwell Publishing, 2004, ISBN 0632064528
·  ^ http://www.emedicine.com/derm/topic365.htm#section~clinical see causes

·  ^ Shai A, Vardy D, Zvulunov A (2002). "[Psoriasis, biblical afflictions and patients' dignity]" (in Hebrew). Harefuah 141 (5): 479–82, 496. PMID 12073533. 

·  ^ Glickman FS (1986). "Lepra, psora, psoriasis". J. Am. Acad. Dermatol. 14 (5 Pt 1): 863–6. doi:10.1016/S0190-9622(86)70101-1. PMID 3519699. 

·  ^ "Application to dermatology of International Classification of Disease (ICD-10) - ICD sorted by code: L40.000 - L41.000", The International League of Dermatological Societies

·  ^ "Erythrodermic psoriasis", New Zealand Dermatological Society

·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.

·  ^ "Psoriasis Update -Skin & Aging". http://www.skinandaging.com/article/5394. Retrieved on 2007-07-28. 

·  ^ Louden BA, Pearce DJ, Lang W, Feldman SR (2004). "A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients". Dermatol. Online J. 10 (2): 7. PMID 15530297. 

·  ^ "Coping With Psoriasis" Parade.com

·  ^ Gelfand JM et al (2005). "Prevalence and Treatment of Psoriasis in the United Kingdom". Arch. Dermatol. 141 (12): 1537–1541. doi:10.1001/archderm.141.12.1537. PMID 16365254. 

·  ^ "BENCHMARK SURVEY ON PSORIASIS AND PSORIATIC ARTHRITIS: SUMMARY OF TOP-LINE RESULTS" (PDF). NATIONAL PSORIASIS FOUNDATION. http://www.psoriasis.org/files/pdfs/press/npfsurvey.pdf. 

·  ^ Krueger G, Ellis CN (2005). "Psoriasis--recent advances in understanding its pathogenesis and treatment". J. Am. Acad. Dermatol. 53 (1 Suppl 1): S94–100. doi:10.1016/j.jaad.2005.04.035. PMID 15968269. 

·  ^ Zenz R, Eferl R, Kenner L, et al (2005). "Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins". Nature 437 (7057): 369–75. doi:10.1038/nature03963. PMID 16163348. 

·  ^ [1] Psoriasis Triggers at Psoriasis Net. SkinCarePhysicians.com 9-28-05. American Academy of Dermatology, 2008.

·  ^ Behnam SM, Behnam SE, Koo JY (2005). "Smoking and psoriasis". Skinmed 4 (3): 174–6. doi:10.1111/j.1540-9740.2005.03716.x. PMID 15891254. http://www.lejacq.com/articleDetail.cfm?pid=SKINmed_4;3:174. 

·  ^ [2][3] Fife, Jeffes, Koo, Waller. Unraveling the Paradoxes of HIV-associated Psoriasis: A Review of T-cell Subsets and Cytokine Profiles. 5-18-07. Retrieved 5-13-08.

·  ^ Ortonne JP, Lebwohl M, Em Griffiths C (2003). "Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis". Eur J Dermatol 13 (2): 117–23. PMID 12695125. http://www.john-libbey-eurotext.fr/medline.md?issn=1167-1122&vol=13&iss=2&page=117. 

·  ^ Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (November 1999). "The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients". J. Invest. Dermatol. 113 (5): 752–9. doi:10.1046/j.1523-1747.1999.00749.x. PMID 10571730. 

·  ^ [4] A Case Report of Severe Psoriasis in a Patient with AIDS: The Role of the HIV Virus and the Therapeutic Challenges Involved. Vol: 13 No 2, 2002. National Skin Center. Retrieved 05-13-08.

·  ^ "Psoriasis Medical Breakthroughs" Parade.com

·  ^ Lofholm PW (2000). "The psoriasis treatment ladder: a clinical overview for pharmacists". US Pharm 25 (5): 26–47. http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/apr00pro.cfm&pub_id=8&article_id=511. 

·  ^ "Research Findings Register: summary number 637". http://www.refer.nhs.uk/ViewRecord.asp?ID=637&Print=1. Retrieved on 2007-07-22. 

·  ^ "Irishman hits on 'cure' for psoriasis". Belfast Telegraph. December 12, 2007. http://www.belfasttelegraph.co.uk/news/local-national/article3247531.ece. Retrieved on 2007-12-13. 

·  ^ Ozçelik S, Polat HH, Akyol M, Yalçin AN, Ozçelik D, Marufihah M (June 2000). "Kangal hot spring with fish and psoriasis treatment". J. Dermatol. 27 (6): 386–90. PMID 10920584. 

·  ^ Grassberger M, Hoch W (December 2006). "Ichthyotherapy as alternative treatment for patients with psoriasis: a pilot study". Evid Based Complement Alternat Med 3 (4): 483–8. doi:10.1093/ecam/nel033. PMID 17173112. 

·  ^ Ereaux L, Craig G (October 1949). "The Oral Administration Of Undecylenic Acid In The Treatment Of Psoriasis" (PDF). Canad. M. A. J. 61: 361–4. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1591667&blobtype=pdf. Retrieved on 2007-01-05.  - see page 4/364 of link

·  ^ Namazi MR (2005). "Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition". Journal of the EuropeanAcademy of Dermatology and Venereology : JEADV 19 (3): 319–22. doi:10.1111/j.1468-3083.2004.01184.x. PMID 15857457. 

·  ^ Fowler CJ (2005). "Pharmacological properties and therapeutic possibilities for drugs acting upon endocannabinoid receptors". Current drug targets. CNS and neurological disorders 4 (6): 685–96. doi:10.2174/156800705774933041. PMID 16375686. 

·  ^ Wilkinson JD, Williamson EM (2007). "Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis". J. Dermatol. Sci. 45 (2): 87–92. doi:10.1016/j.jdermsci.2006.10.009. PMID 17157480. 

·  ^ Nickoloff BJ, Nestle FO (2004). "Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities". J. Clin. Invest. 113 (12): 1664–75. doi:10.1172/JCI200422147. PMID 15199399. 

·  ^ White PJ, Atley LM, Wraight CJ (2004). "Antisense oligonucleotide treatments for psoriasis". Expert opinion on biological therapy 4 (1): 75–81. doi:10.1517/14712598.4.1.75. PMID 14680470. 

·  ^ Heller M. (2007) Positive results for ABT-874 in the treatment of psoriasis J Drugs Dermatol

·  ^ Cambridge Antibody Technology | ABT-874

·  ^ [Tas S, Avci O. Rapid clearance of psoriatic skin lesions induced by topical cyclopamine. Dermatology 2004;209:126-31]

·  ^ Science Daily, New Skin-healing Chemicals

·  ^ Indigo plant may treat chronic skin disease (Reuters)

·  ^ Giltaire, S; Herphelin F, Frankart A, Hérin M, Stoppie P, Poumay Y (11 December 2008). "The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes". Br J Dermatol. PMID 19120344. 

·  ^ Jobling R (2007). "A patient's journey:Psoriasis". Br Med J 334: 953–4. doi:10.1136/bmj.39184.615150.802. PMID 17478850. 

·  ^ Olsen JH, Frentz G, Møller H (1993). "[Psoriasis and cancer]" (in Danish). Ugeskr. Laeg. 155 (35): 2687–91. PMID 8212383.

·  ^ Alai, Nili. "Keratosis Pilaris (KP)". MedicineNet. http://www.medicinenet.com/keratosis_pilaris/article.htm. Retrieved on 2008-10-06. 

·  ^ Berman, Kevin. "Keratosis pilaris". MedlinePlus. http://www.nlm.nih.gov/medlineplus/ency/article/001462.htm. Retrieved on 2008-19-06. 

·  ^ Alai, Nili; Arash Michael Saemi,Raul Del Rosario. "Keratosis Pilaris". eMedicine. http://www.emedicine.com/derm/topic211.htm. Retrieved on 2008-19-20. 

·  ^ Smith, Karen (Nov. 2008). "Keratosis Pilaris, KP, Chicken Skin". Keratosis Pilaris Help. http://www.helpforkp.com/. Retrieved on 2008-11-10.

^ Odom, Richard B.; Davidsohn, Israel; James, William D.; Henry, John Bernard; Berger, Timothy G.; Clinical diagnosis by laboratory methods; Dirk M. Elston (2006). Andrews' diseases of the skin: clinical dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 
^ a b c d e f g h i j k l Zoe Diana Draelos (August 30, 2007), Alopecia Areata. MedicineNet.com. Retrieved on December 2, 2007.
^ American Academy of Dermatology
^ McElwee KJ, Boggess D, Olivry T, et al (1998). "Comparison of alopecia areata in human and nonhuman mammalian species". Pathobiology 66 (2): 90–107. doi:10.1159/000028002. PMID 9645633. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=pat66090. 
^ a b c d e f g Alopecia Areata at Merck Manual of Diagnosis and Therapy Professional Edition
^ Marks, James G; Miller, Jeffery (2006). Lookingbill and Marks' Principles of Dermatology (4th ed.). Elsevier Inc. ISBN 1-4160-3185-5.
^ a b c d Skin Conditions: Alopecia Areata. WebMD. Retrieved on December 2, 2007.
^ Nöthen MM, Cichon S, Vogt IR, et al (February 1998). "A gene for universal congenital alopecia maps to chromosome 8p21-22". Am. J. Hum. Genet. 62 (2): 386–90. doi:10.1086/301717. PMID 9463324. PMC: 1376893. http://linkinghub.elsevier.com/retrieve/pii/S0002-9297(07)63503-4. 
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

^ a b c American Osteopathic College of Dermatology. Alopecia Areata. Dermatologic Disease Database. Aocd.org. Retrieved on December 3, 2007.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
Ferriman D, Gallwey JD (1961). "Clinical assessment of body hair growth in women". J. Clin. Endocrinol. Metab. 21: 1440–7. PMID 13892577.

^ a b Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
·  ^ lichen planus at Dorland's Medical Dictionary

·  ^ Penn State College of Medicine - Lichen Planus

·  ^ Issa Y, Brunton PA, Glenny AM, Duxbury AJ (November 2004). "Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (5): 553–65. doi:10.1016/S1079210404000216. PMID 15529127. http://linkinghub.elsevier.com/retrieve/pii/S1079210404000216. 

·  ^ Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P (March 2008). "The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial". Br. J. Dermatol. 158 (3): 573–7. doi:10.1111/j.1365-2133.2007.08370.x. PMID 18093246. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0007-0963&date=2008&volume=158&issue=3&spage=573. 

·  ^ Pavlotsky F, Nathansohn N, Kriger G, Shpiro D, Trau H (April 2008). "Ultraviolet-B treatment for cutaneous lichen planus: our experience with 50 patients". Photodermatol Photoimmunol Photomed 24 (2): 83–6. doi:10.1111/j.1600-0781.2008.00344.x. PMID 18353088.

^ "A Practical Guide to Scalp Disorders". Journal of Investigative Dermatology Symposium Proceedings. 2007-12. http://www.nature.com/jidsp/journal/v12/n2/abs/5650048a.html. Retrieved on 2009-02-06. 
^ DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL (2005). "Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity". J. Investig. Dermatol. Symp. Proc. 10 (3): 295–7. doi:10.1111/j.1087-0024.2005.10119.x. PMID 16382685. 
^ Ro BI, Dawson TL (2005). "The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff". J. Investig. Dermatol. Symp. Proc. 10 (3): 194–7. doi:10.1111/j.1087-0024.2005.10104.x. PMID 16382662. 
^ Ashbee HR, Evans EG (2002). "Immunology of diseases associated with Malassezia species". Clin. Microbiol. Rev. 15 (1): 21–57. doi:10.1128/CMR.15.1.21-57.2002. PMID 11781265. http://cmr.asm.org/cgi/content/full/15/1/21?view=long&pmid=11781265. 
^ Batra R, Boekhout T, Guého E, Cabañes FJ, Dawson TL, GuptaAK (2005). "Malassezia Baillon, emerging clinical yeasts". FEMS Yeast Res. 5 (12): 1101–13. doi:10.1016/j.femsyr.2005.05.006. PMID 16084129. 
^ a b Dawson TL (2006). "Malassezia and seborrheic dermatitis: etiology and treatment". Journal of cosmetic science 57 (2): 181–2. PMID 16758556. 
^ Gemmer CM, DeAngelis YM, Theelen B, Boekhout T, Dawson Jr TL (2002). "Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology". J. Clin. Microbiol. 40 (9): 3350–7. doi:10.1128/JCM.40.9.3350-3357.2002. PMID 12202578. 
^ Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL (2004). "Skin diseases associated with Malassezia species". J. Am. Acad. Dermatol. 51 (5): 785–98. doi:10.1016/j.jaad.2003.12.034. PMID 15523360. 
^ BBC NEWS | Health | Genetic code of dandruff cracked
^ Amy J. McMichael, Maria K. Hordinsky, Hair and Scalp Diseases, p. 73, http://books.google.com/books?hl=en&lr=&id=XqcalOZprkgC 
^ "Relief From Dandruff". http://www.thirdage.com/skin-hair-nails/relief-from-dandruff. Retrieved on 2008-11-15. 
^ Mayo Clinic (2006-11-27). "Dandruff". Mayo Clinic. http://www.mayoclinic.com/health/dandruff/DS00456/DSECTION=1. Retrieved on 2007-03-28. 
^ Use of Baking Soda as a Fungicide, By George Kuepper, Raeven Thomas, and Richard Earles, NCAT November 2001
^ Piérard-Franchimont C, Piérard GE, Vroome V, Lin GC, Appa Y (2000). "Comparative anti-dandruff efficacy between a tar and a non-tar shampoo". Dermatology (Basel) 200 (2): 181–4. doi:10.1159/000018362. PMID 10773717. 
^ Warner RR, Schwartz JR, Boissy Y, Dawson TL (2001). "Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo". J. Am. Acad. Dermatol. 45 (6): 897–903. doi:10.1067/mjd.2001.117849. PMID 11712036. 
^ McGrath J, Murphy GM (1991). "The control of seborrhoeic dermatitis and dandruff by antipityrosporal drugs". Drugs 41 (2): 178–84. doi:10.2165/00003495-199141020-00003. PMID 1709848. 
^ Prensner R (2003). "Does 5% tea tree oil shampoo reduce dandruff?". The Journal of family practice 52 (4): 285–6. PMID 12681088. http://www.jfponline.com/Pages.asp?AID=1437. 
^ Dubini F, Bellotti MG, Frangi A, Monti D, Saccomani L (2005). "In vitro antimycotic activity and nail permeation models of a piroctone olamine (octopirox) containing transungual water soluble technology". Arzneimittel-Forschung 55 (8): 478–83. PMID 16149717. 
^ Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE (2002). "A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis". Skin Pharmacol. Appl. Skin Physiol. 15 (6): 434–41. doi:10.1159/000066452. PMID 12476017. 
^ Rapaport M (1981). "A randomized, controlled clinical trial of four anti-dandruff shampoos". J. Int. Med. Res. 9 (2): 152–6. PMID 7014286. 
^ Bulmer AC, Bulmer GS (1999). "The antifungal action of dandruff shampoos". Mycopathologia 147 (2): 63–5. doi:10.1023/A:1007132830164. PMID 10967964. 
^ http://www.medicinenet.com/ketoconazole/article.htm
^ http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=019927&TABLE1=OB_Rx
^ a b Marks, James G; Miller, Jeffery (2006). Lookingbill and Marks' Principles of Dermatology (4th ed.). Elsevier Inc. Page 263. ISBN 1-4160-3185-5.
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ James WD, Berger TG, Odom RB. (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. p. 645. ISBN 0-7216-2921-0. 
^ Freedberg IM, Fitzpatrick TB. (2003). Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, Medical Pub. Division. p. 645. ISBN 0-07-138076-0. 
^ "Tinea Capitis: eMedicine Dermatology". http://emedicine.medscape.com/article/1091351-overview. Retrieved on 2009-04-19. 
^ Degreef H. (2008). "Clinical forms of dermatophytosis (ringworm infection)". Mycopathologia 166 (5–6): 257–65. doi:10.1007/s11046-008-9101-8. PMID 18478364. http://dx.doi.org/10.1007/s11046-008-9101-8. Retrieved on 2009-04-19. 
^ Ali S, Graham TA, Forgie SE. (2007). "The assessment and management of tinea capitis in children". Pediatric Emergency Care 23 (9): 662–65; quiz 666–8. doi:10.1097/PEC.0b013e31814efe06. PMID 17876261. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00006565-200709000-00014. 
^ Wigger-Alberti W, Elsner P. (1997). "[Fluorescence with Wood's light. Current applications in dermatologic diagnosis, therapy follow-up and prevention]" (in German). Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, Und Verwandte Gebiete 48 (8): 523–7. PMID 9378631. http://link.springer.de/link/service/journals/00105/bibs/7048008/70480523.htm. 
^ Slowinska M, Rudnicka L, Schwartz RA, Kowalska-Oledzka E, Rakowska A, Sicinska J, Lukomska M, Olszewska M, Szymanska E. (November 2008). "Comma hairs: a dermatoscopic marker for tinea capitis: a rapid diagnostic method". Journal of the AmericanAcademy of Dermatology 59 (5 Suppl): S77–9. doi:10.1016/j.jaad.2008.07.009. PMID 19119131. http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(08)00900-6. 
^ Xu X, Elder DA, Elenitsa R, Johnson BL, Murphy GE. (2008). Lever's Histopathology of the Skin. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-7363-6. 
^ Richardson, p. 88.
^ Gupta AK, Cooper EA. (2008). "Update in antifungal therapy of dermatophytosis". Mycopathologia 166 (5–6): 353–67. doi:10.1007/s11046-008-9109-0. PMID 18478357. http://dx.doi.org/10.1007/s11046-008-9109-0. 
^ Gupta AK, Summerbell RC (2000). "Tinea capitis". Medical Mycology : Official Publication of the International Society for Human and Animal Mycology 38 (4): 255–87. PMID 10975696. 
^ "US FDA approves oral granules for scalp ringworm | Deals | Regulatory News | Reuters". http://www.reuters.com/article/governmentFilingsNews/idUSN2820532120070928. Retrieved on 2009-04-19. 
^ Richardson, p. 83.
^ Richardson, pp. 83–84.
^ a b Richardson, p. 84.
Richardson M. (2003). Fungal Infection: Diagnosis and Management. Cambridge, MA: Blackwell Publishers. ISBN 1-4051-1578-5. 
·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.

·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

·  ^ Diefenbach, G.J., Reitman, D. & Williamson, D.A., (2000). "Trichotillomania: A challenge to research and practice". Clinical Psychology Review 20 (20): 289–309. doi:10.1016/S0272-7358(98)00083-X. 

·  ^ ChristensonGA, Mackenzie TB, Mitchell JE (1991). "Characteristics of 60 adult chronic hair pullers". The American journal of psychiatry 148 (3): 365–70. PMID 1992841. 

·  ^ a b Penzel (2003) The Hair-Pulling Problem: A Complete Guide to Trichotillomania; Oxford University Press, p. 3. ISBN 0-19-514942-4

·  ^ KeuthenNJ, Makris N, Schlerf JE, et al (2007). "Evidence for reduced cerebellar volumes in trichotillomania". Biol. Psychiatry 61 (3): 374–81. doi:10.1016/j.biopsych.2006.06.013. PMID 16945351. 

·  ^ ChristensonGA, Crow SJ (1996). "The characterization and treatment of trichotillomania". The Journal of clinical psychiatry 57 Suppl 8: 42–7; discussion 48–9. PMID 8698680. 

·  ^ VenturaDE, Herbella FA, Schettini ST, Delmonte C (2005). "Rapunzel syndrome with a fatal outcome in a neglected child". J. Pediatr. Surg. 40 (10): 1665–7. doi:10.1016/j.jpedsurg.2005.06.038. PMID 16227005. 

·  ^ Pul N, Pul M (1996). "The Rapunzel syndrome (trichobezoar) causing gastric perforation in a child: a case report". Eur. J. Pediatr. 155 (1): 18–9. PMID 8750804. 

·  ^ "Hairball kills teenager". hairgrowthnews.com. http://www.keratin.com/ar/ar012.shtml. Retrieved on 2007-08-11. 

·  ^ ChristensonGA, MacKenzie TB, Mitchell JE (1994). "Adult men and women with trichotillomania. A comparison of male and female characteristics". Psychosomatics 35 (2): 142–9. PMID 8171173. 

·  ^ Woods DW, Wetterneck CT, FlessnerCA (2006). "A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania". Behaviour research and therapy 44 (5): 639–56. doi:10.1016/j.brat.2005.05.006. PMID 16039603. 

·  ^ Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL (1989). "A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)". N. Engl. J. Med. 321 (8): 497–501. PMID 2761586. 

·  ^ ChristensonGA, Mackenzie TB, Mitchell JE, Callies AL (November 1991). "A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania". Am J Psychiatry 148 (11): 1566–71. PMID 1928474. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=1928474. 

·  ^ SahDE, Koo J, Price VH (2008). "Trichotillomania". Dermatol Ther 21 (1): 13–21. doi:10.1111/j.1529-8019.2008.00165.x. PMID 18318881. 

·  ^ "Entrez Gene: HOXB8 homeobox B8 [ Homo sapiens "]. National Center for Biotechnology Information. August 12, 2006. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=3218. Retrieved on 2007-11-13. 

·  ^ a b "Hair pulling disorder gene found". BBC News. 29 September 2006. http://news.bbc.co.uk/1/hi/health/5381232.stm. Retrieved on 2007-05-01. 

·  ^ ChristensonGA, Mackenzie TB, Mitchell JE (1991). "Characteristics of 60 adult chronic hair pullers". Am J Psychiatry. 148 (3): 365–70. 

·  ^ Howard Hughes Medical Institute (2008-05-01). Gene Targeting, Homeobox Genes, Development, and Behavior. Press release. http://www.hhmi.org/research/investigators/capecchi.html. Retrieved on 2008-07-12.

^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ Google Answers: Vertical Ridges, citing several different studies and experts. Accessed April 7, 2009.
^ Mayo Clinic: Vertical Ridges. Accessed April 7, 2009.
^ Ben-Dayan D, Mittelman M, Floru S, Djaldetti M (1994). "Transverse nail ridgings (Beau's lines) induced by chemotherapy". Acta Haematol. 91 (2): 89–90. PMID 7517608. 
^ Schwartz H (2006). "Clinical observation: Beau's lines on fingernails after deep saturation dives". Undersea Hyperb Med 33 (1): 5–10. PMID 16602251. http://archive.rubicon-foundation.org/5017. Retrieved on 2009-02-16. 
^ Fimbres AM, Shulman ST. Kawasaki Disease. Pediatr rev 2008;29;308-316.
^ a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

·  ^ a b Myers KA, Farquhar DR (2001). "The rational clinical examination: does this patient have clubbing?". JAMA 286: 341–7. doi:10.1001/jama.286.3.341. PMID 11466101. 

·  ^ Schamroth L (February 1976). "Personal experience". S. Afr. Med. J. 50 (9): 297–300. PMID 1265563. 

·  ^ SridharKS, Lobo CF, Altman RD (1998). "Digital clubbing and lung cancer" (PDF). Chest 114: 1535–37. doi:10.1378/chest.114.6.1535. PMID 9872183. http://www.chestjournal.org/cgi/reprint/114/6/1535. 

·  ^ Epstein O, Dick R, Sherlock S (1981). "Prospective study of periostitis and finger clubbing in primary biliary cirrhosis and other forms of chronic liver disease". Gut 22 (3): 203–6. doi:10.1136/gut.22.3.203. PMID 7227854. 

·  ^ Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly. 2003;133:163-9. PMID 12715285.

·  ^ -724565997 at GPnotebook

·  ^ a b Uppal S, Diggle CP, Carr IM, et al (June 2008). "Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy". Nat. Genet. 40 (6): 789–93. doi:10.1038/ng.153. PMID 18500342. 

·  ^ Vandemergel X, Renneboog B (July 2008). "Prevalence, aetiologies and significance of clubbing in a department of general internal medicine". Eur. J. Intern. Med. 19 (5): 325–9. doi:10.1016/j.ejim.2007.05.015. PMID 18549933.

^ a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ Kumar, Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005. Saunders.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 786-7. ISBN 0721629210.

·  ^ Towers AL, Clay CA, Sereika SM, McIntosh I, Greenspan SL (April 2005). "Skeletal integrity in patients with nail patella syndrome". J. Clin. Endocrinol. Metab. 90 (4): 1961–5. doi:10.1210/jc.2004-0997. PMID 15623820. http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=15623820.

^ Freedberg; et. al. (2003). Fitzpatrick's Dermatology in General Medicine (6th ed.). McGraw-Hill. pp. 660. ISBN 0071380760. 
·  ^ a b James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ Szepietowski JC, Salomon J (2007). "Do fungi play a role in psoriatic nails?". Mycoses 50 (6): 437–42. doi:10.1111/j.1439-0507.2007.01405.x. PMID 17944702. 

·  ^ "Impact 07 - Dermatology" (PDF). Bay Bio. 2007. http://www.baybio.org/pdf/IMPACT07_Derm.pdf. Retrieved on 2007-06-13. 

·  ^ Perea S, Ramos MJ, Garau M, Gonzalez A, Noriega AR, del Palacio A (2000). "Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain". J. Clin. Microbiol. 38 (9): 3226–30. PMID 10970362. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=87362. 

·  ^ Onychomycosis at eMedicine

·  ^ Szepietowski JC, Reich A (September 2008). "Stigmatisation in onychomycosis patients: a population-based study". Mycoses. doi:10.1111/j.1439-0507.2008.01618.x. PMID 18793262. 

·  ^ Chi CC, Wang SH, Chou MC (2005). "The causative pathogens of onychomycosis in southern Taiwan". Mycoses 48 (6): 413–20. doi:10.1111/j.1439-0507.2005.01152.x. PMID 16262878. 

·  ^ Karimzadegan-Nia M, Mir-Amin-Mohammadi A, Bouzari N, Firooz A (2007). "Comparison of direct smear, culture and histology for the diagnosis of onychomycosis". Australas. J. Dermatol. 48 (1): 18–21. doi:10.1111/j.1440-0960.2007.00320.x. PMID 17222296. 

·  ^ Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L (2003). "Comparison of diagnostic methods in the evaluation of onychomycosis". J. Am. Acad. Dermatol. 49 (2): 193–7. PMID 12894064. 

·  ^ PubMed

·  ^ Rodgers P, Bassler M (2001). "Treating onychomycosis". Am Fam Physician 63 (4): 663–72, 677–8. PMID 11237081. http://www.aafp.org/afp/20010215/663.html. 

·  ^ Baran R, Faergemann J, Hay RJ (2007). "Superficial white onychomycosis--a syndrome with different fungal causes and paths of infection". J. Am. Acad. Dermatol. 57 (5): 879–82. doi:10.1016/j.jaad.2007.05.026. PMID 17610995. 

·  ^ Crawford F, Hollis S (2007). "Topical treatments for fungal infections of the skin and nails of the foot". Cochrane Database Syst Rev (3): CD001434. doi:10.1002/14651858.CD001434.pub2. PMID 17636672. 

·  ^ Haugh M, Helou S, Boissel JP, Cribier BJ (2002). "Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials". Br. J. Dermatol. 147 (1): 118–21. PMID 12100193. 

·  ^ Mitchel L. Zoler (April 1, 2004). "Boosts drug entry into nails: urea, ciclopirox combo tested for onychomycosis.(Focus on Skin Disorders)". Internal Medical News. pp. 69. 

·  ^ Potter LP, Mathias SD, Raut M, Kianifard F, Landsman A, Tavakkol A (2007). "The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis". The Journal of dermatological treatment 18 (1): 46–52. PMID 17373090. 

·  ^ Baran R, Sigurgeirsson B, Berker DD, et al (2007). "A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement". British Journal of Dermatology 157: 149. doi:10.1111/j.1365-2133.2007.07974.x. PMID 17553051. 

·  ^ clinicaltrials.gov

·  ^ ClinicalTrials.gov NCT00459537

·  ^ NEXMED Medicines of the Future

·  ^ ClinicalTrials.gov NCT00356915

·  ^ ClinicalTrials.gov NCT00443820 and ClinicalTrials.gov NCT00443898

·  ^ Barak O, Loo DS (2007). "AN-2690, a novel antifungal for the topical treatment of onychomycosis". Curr Opin Investig Drugs 8 (8): 662–8. PMID 17668368. 

·  ^ ClinicalTrials.gov NCT00491764

·  ^ ClinicalTrials.gov NCT00356915

·  ^ NanoBio - Onychomycosis

·  ^ Dai T, Tegos GP, Rolz-Cruz G, Cumbie WE, Hamblin MR (June 2008). "Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis". Br. J. Dermatol. 158 (6): 1239–46. doi:10.1111/j.1365-2133.2008.08549.x. PMID 18410410. 

·  ^ Buck DS, Nidorf DM, Addino JG (1994). "Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole". J Fam Pract 38 (6): 601–5. PMID 8195735. 

·  ^ Nenoff P, Haustein UF, Brandt W (1996). "Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro". Skin Pharmacol. 9 (6): 388–94. PMID 9055360. 

·  ^ "Tea tree oil (Melaleuca alternifolia)". Drugs & Supplements. Mayo Clinic. May 1, 2006. http://www.mayoclinic.com/health/tea-tree-oil/NS_patient-teatreeoil#31C383D1-E7FF-0DBD-1B59A74BE7EB5F8D. Retrieved on 2008-01-29. 

·  ^ von Woedtke T, Schlüter B, Pflegel P, Lindequist U, Jülich WD (1999). "Aspects of the antimicrobial efficacy of grapefruit seed extract and its relation to preservative substances contained". Pharmazie 54 (6): 452–6. PMID 10399191. 

·  ^ Sakamoto S, Sato K, Maitani T, Yamada T (1996). "[Analysis of components in natural food additive "grapefruit seed extract" by HPLC and LC/MS]" (in Japanese). Eisei Shikenjo hōkoku. Bulletin of National Institute of Hygienic Sciences (114): 38–42. PMID 9037863. 

·  ^ Takeoka G, Dao L, Wong RY, Lundin R, Mahoney N (2001). "Identification of benzethonium chloride in commercial grapefruit seed extracts". J. Agric. Food Chem. 49 (7): 3316–20. PMID 11453769. 

·  ^ Takeoka GR, Dao LT, Wong RY, Harden LA (2005). "Identification of benzalkonium chloride in commercial grapefruit seed extracts". J. Agric. Food Chem. 53 (19): 7630–6. doi:10.1021/jf0514064. PMID 16159196. 

·  ^ Ganzera M, Aberham A, Stuppner H (2006). "Development and validation of an HPLC/UV/MS method for simultaneous determination of 18 preservatives in grapefruit seed extract". J. Agric. Food Chem. 54 (11): 3768–72. doi:10.1021/jf060543d. PMID 16719494.

^ a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
·  ^ Rigopoulos D, Larios G, Gregoriou S, Alevizos A (February 2008). "Acute and chronic paronychia". Am Fam Physician 77 (3): 339–46. PMID 18297959. 

·  ^ Rockwell PG (March 2001). "Acute and chronic paronychia". Am Fam Physician 63 (6): 1113–6. PMID 11277548. 

·  ^ a b c d "Doctor's advice Q: Whitlow (paronychia)". bbc.co.uk. http://www.bbc.co.uk/health/ask_the_doctor/whitlow.shtml. Retrieved on 2008-05-10. 

·  ^ Jacobs, J.R. (2006 June-July). "Pathophysiology and Management of Paronychia". collegehealth-e. http://www.collegehealth-e.org/3/n04.htm. 

·  ^ Lewis MA (2004). "Herpes simplex virus: an occupational hazard in dentistry". Int Dent J 54 (2): 103–11. doi:10.2956/indj.2004.54.2.103 (inactive 2008-08-12). PMID 15119801. http://www.atypon-link.com/FDI/doi/abs/10.2956/indj.2004.54.2.103. 

·  ^ Karen Allen, MD (2005-08-17). "eMedicine - Acrokeratosis Neoplastica". http://www.emedicine.com/derm/topic6.htm.

^ Selbst, SM, Attia, M (2006). Textbook Of Pediatric Emergency Medicine. Hagerstown, MD: Lippincott Williams & Wilkins. p. 1571 "Lacerations". ISBN 0781750741.

^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ Scheinfeld NS (April 2003). "Trachyonychia: a case report and review of manifestations, associations, and treatments". Cutis 71 (4): 299–302. PMID 12729094. 
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
·  ^ a b James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ a b "Yellow nail syndrome. DermNet NZ". http://www.dermnet.org.nz/hair-nails-sweat/yellow-nails.html. Retrieved on 2008-03-19.

·  ^ aphthous ulcer at Dorland's Medical Dictionary

·  ^ Jurge S, Kuffer R, Scully C, Porter SR (2006). "Mucosal disease series. Number VI. Recurrent aphthous stomatitis". Oral Dis 12 (1): 1–21. doi:10.1111/j.1601-0825.2005.01143.x. PMID 16390463. 

·  ^ Bruce AJ, Rogers RS (2003). "Acute oral ulcers". Dermatol Clin 21 (1): 1–15. doi:10.1016/S0733-8635(02)00064-5. PMID 12622264. 

·  ^ Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A, Tchorzewski H. (2005). "Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations". Immunol Lett. 99 (1): 57–62. doi:10.1016/j.imlet.2005.01.002. PMID 15894112. 

·  ^ Wray D, Ferguson M, Hutcheon W, Dagg J (1978). "Nutritional deficiencies in recurrent aphthae". J Oral Pathol 7 (6): 418–23. doi:10.1111/j.1600-0714.1978.tb01612.x. PMID 105102. 

·  ^ "Non Hodgkin's Lymphoma Cyberfamily — Side effects". NHL Cyberfamily. http://www.nhlcyberfamily.org/effects.htm. Retrieved on 2006-08-10. 

·  ^ http://www.patient.co.uk/showdoc/40024908/][http://www.health-disease.org/skin-disorders/aphthous-ulcer.htm

·  ^ http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/Mouth_ulcers?OpenDocument

·  ^ Herlofson B, Barkvoll P (1994). "Sodium lauryl sulfate and recurrent aphthous ulcers. A preliminary study" (PDF). Acta Odontol Scand 52 (5): 257–9. doi:10.3109/00016359409029036. PMID 7825393. http://www.wealthpartners.net/pdf/0535.pdf. 

·  ^ Herlofson B, Barkvoll P (1996). "The effect of two toothpaste detergents on the frequency of recurrent aphthous ulcers". Acta Odontol Scand 54 (3): 150–3. doi:10.3109/00016359609003515. PMID 8811135. 

·  ^ Chahine L, Sempson N, Wagoner C (1997). "The effect of sodium lauryl sulfate on recurrent aphthous ulcers: a clinical study". Compend Contin Educ Dent 18 (12): 1238–40. PMID 9656847. 

·  ^ Healy C, Paterson M, Joyston-Bechal S, Williams D, Thornhill M (1999). "The effect of a sodium lauryl sulfate-free dentifrice on patients with recurrent oral ulceration". Oral Dis 5 (1): 39–43. PMID 10218040. 

·  ^ a b Bucci P, Carile F, Sangianantoni A, D'Angio F, Santarelli A, Lo Muzio L. (2006). "Oral aphthous ulcers and dental enamel defects in children with celiac disease". Acta Paediatrica 95 (2): 203–7. doi:10.1080/08035250500355022. PMID 16449028. 

·  ^ Sedghizadeh PP, Shuler CF, Allen CM, Beck FM, Kalmar JR. (2002). "Celiac disease and recurrent aphthous stomatitis: a report and review of the literature". Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics 94 (4): 474–8. doi:10.1067/moe.2002.127581. PMID 12374923. 

·  ^ Volkov I, Rudoy I, Freud T, et al (2009). "Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial". J Am Board Fam Med 22 (1): 9–16. doi:10.3122/jabfm.2009.01.080113. PMID 19124628. 

·  ^ a b Rauch, D. "Canker sores: Treatment". MedlinePlus. http://www.nlm.nih.gov/medlineplus/ency/article/000998.htm#Treatment. Retrieved on 2008-05-08. 

·  ^ a b ped/2672 at eMedicine

·  ^ "Aphthous Mouth Ulcers". Patient UK. February 2007. http://www.patient.co.uk/showdoc/23068855/. Retrieved on 2008-05-09. 

·  ^ "Aphthous ulcer - Evidence: Evidence on topical analgesics". Clinical Knowledge Summaries (Prodigy). National Library for Health. http://cks.library.nhs.uk/aphthous_ulcer/evidence/supporting_evidence/topical_analgesics#. Retrieved on 2008-05-10. 

·  ^ a b "Aphthous ulcer - Management". Clinical Knowledge Summaries (Prodigy). National Library for Health. http://cks.library.nhs.uk/aphthous_ulcer/management/detailed_answers/managing_aphthous_ulcers#. Retrieved on 2008-05-09. 

·  ^ "12.3.1 Drugs for oral ulceration and inflammation". British National Formulary for Children. British Medical Association, the Royal Pharmaceutical Society of Great Britain , RoyalCollege of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group. 2006. pp. 601–4. 

·  ^ "Aphthous ulcer - Evidence: Evidence on antimicrobial mouthwash". Clinical Knowledge Summaries (Prodigy). National Library for Health. http://cks.library.nhs.uk/aphthous_ulcer/evidence/supporting_evidence/antimicrobial_mouthwash#. Retrieved on 2008-05-10. 

·  ^ Chang, L (2002-03-22). "Patch May Help Heal Canker Sores". WebMD. http://www.webmd.com/oral-health/news/20070322/patch-may-help-heal-canker-sores. Retrieved on 2008-05-08. 

·  ^ Scully C (July 2006). "Clinical practice. Aphthous ulceration". N. Engl. J. Med. 355 (2): 165–72. doi:10.1056/NEJMcp054630. PMID 16837680. 
Commented in:
"Clinical review - aphthous ulceration". Medicines Information Web Site (Trent and West Midlands regional Medicines Information services). 2006-07-13.

http://www.ukmicentral.nhs.uk/headline/database/printstory.asp?NewsID=5369. Retrieved on 2008-05-09. 

·  ^ Scully C, Shotts R (July 2000). "ABC of oral health. Mouth ulcers and other causes of orofacial soreness and pain". BMJ 321 (7254): 162–5. doi:10.1136/bmj.321.7254.162. PMID 10894697. http://www.bmj.com/cgi/content/full/321/7254/162. 

·  ^ Alidaee MR, Taheri A, Mansoori P, Ghodsi SZ (September 2005). "Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial". Br. J. Dermatol. 153 (3): 521–5. doi:10.1111/j.1365-2133.2005.06490.x. PMID 16120136. http://dermatology.cdlib.org/DOJvol8num2/original/antibiotics2/jain.html. 

·  ^ Studies mostly agree that antiseptic mouthwashes can help prevent recurrences:
* Meiller TF, Kutcher MJ, Overholser CD, Niehaus C, DePaola LG, Siegel MA (1991). "Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations". Oral Surg. Oral Med. Oral Pathol. 72 (4): 425–9. doi:10.1016/0030-4220(91)90553-O. PMID 1923440. 
* Skaare AB, Herlofson BB, Barkvoll P (1996). "Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU)". J. Clin. Periodontol. 23 (8): 778–81. doi:10.1111/j.1600-051X.1996.tb00609.x. PMID 8877665. 
But this is not accepted by all reports:
* Barrons RW (2001). "Treatment strategies for recurrent oral aphthous ulcers". Am J Health Syst Pharm 58 (1): 41–50; quiz 51–3. PMID 11194135. 

·  ^ Herlofson BB, Barkvoll P (1996). "The effect of two toothpaste detergents on the frequency of recurrent aphthous ulcers". Acta Odontol. Scand. 54 (3): 150–3. doi:10.3109/00016359609003515. PMID 8811135. 

·  ^ Chahine L, Sempson N, Wagoner C (1997). "The effect of sodium lauryl sulfate on recurrent aphthous ulcers: a clinical study". Compend Contin Educ Dent 18 (12): 1238–40. PMID 9656847. 

·  ^ Healy CM, Paterson M, Joyston-Bechal S, Williams DM, Thornhill MH (1999). "The effect of a sodium lauryl sulfate-free dentifrice on patients with recurrent oral ulceration". Oral Dis 5 (1): 39–43. PMID 10218040. 

·  ^ Wang SW, Li HK, He JS, Yin TA (1986). "[The trace element zinc and aphthosis. The determination of plasma zinc and the treatment of aphthosis with zinc]" (in French). Rev Stomatol Chir Maxillofac 87 (5): 339–43. PMID 3467416. 

·  ^ Orbak R, Cicek Y, Tezel A, Dogru Y (2003). "Effects of zinc treatment in patients with recurrent aphthous stomatitis". Dent Mater J 22 (1): 21–9. PMID 12790293. 

·  ^ Wray D (1982). "A double-blind trial of systemic zinc sulfate in recurrent aphthous stomatitis". Oral Surg. Oral Med. Oral Pathol. 53 (5): 469–72. doi:10.1016/0030-4220(82)90459-5. PMID 7048184.

·  ^ "Glossary,". http://medicalcenter.osu.edu/patientcare/healthcare_services/multiple_sclerosis/ms_glossary/Pages/index.aspx. Retrieved on 2009-03-28. 

·  ^ "Behcet Disease: Overview - eMedicine Dermatology". http://emedicine.medscape.com/article/1122381-overview. Retrieved on 2009-03-28. 

·  ^ a b synd/1863 at Who Named It?

·  ^ H. Behçet. Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Wochenschrift, Hamburg, 1937, 105(36): 1152-1163.

·  ^ Johns Hopkins Vasculitis Center (2004). Johns Hopkins Vasculitis Center Discusses Behcets Disease. Retrieved September 9, 2005.

·  ^ B. Adamandiades. Sur un cas d'iritis à hypopyon récidivant. Annales d'oculistique, Paris, 1931, 168: 271-278.

·  ^ Ravi Malhotra (2004), "Saudi Arabia", Practical Neurology 4: 184-185.

·  ^ S. Saleem (2005), Neuro-Behçet's Disease: NBD, Neurographics, Vol. 4, Issue 2, Article 1.

·  ^ Al-Araji A, Kidd DP (February 2009). "Neuro-Behçet's disease: epidemiology, clinical characteristics, and management". Lancet Neurol 8 (2): 192–204. doi:10.1016/S1474-4422(09)70015-8. PMID 19161910. http://linkinghub.elsevier.com/retrieve/pii/S1474-4422(09)70015-8. 

·  ^ "Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease". Lancet 335 (8697): 1078–80. May 1990. PMID 1970380. 

·  ^ http://www.nlm.nih.gov/medlineplus/behcetssyndrome.html

·  ^ Triolo et. al. (2002). Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease. Ann Rheum Dis. 2002 May;61(5):459-62. http://www.ncbi.nlm.nih.gov/pubmed/11959773?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

·  ^ Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001). "Effect of infliximab on sight-threatening panuveitis in Behcet's disease". Lancet 358 (9278): 295–6. doi:10.1016/S0140-6736(01)05497-6. PMID 11498218. 

·  ^ Sfikakis PP (2002). "Behcet's disease: a new target for anti-tumor necrosis factor treatment". Ann Rheum Dis 61 Suppl 2: ii51–3. PMID 12379622. 

·  ^ Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yazici H (2005). "Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study". J Rheumatol 32 (1): 98–105. PMID 15630733. 

·  ^ Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, Basaran E (2002). "Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study". Arch Dermatol 138 (4): 467–71. doi:10.1001/archderm.138.4.467. PMID 11939808. 

·  ^ Kotter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Gunaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stubiger N (2003). "Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis". Br J Ophthalmol 87 (4): 423–31. doi:10.1136/bjo.87.4.423. PMID 12642304. 

·  ^ Hamuryudan V, Ozyazgan Y, Fresko Y, Mat C, Yurdakul S, Yazici H (2002). "Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study". Isr Med Assoc J 4 (11 Suppl): 928–30. PMID 12455182. 

·  ^ Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H (2001). "A double-blind trial of colchicine in Behcet's syndrome". Arthritis Rheum 44 (11): 2686–92. doi:10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H. PMID 11710724. 

·  ^ Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H (1998). "Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial". Ann Intern Med 128 (6): 443–50. PMID 9499327. 

·  ^ Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka S, Kogure M, Mizushima Y (2003). "Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: a randomised, double-blind, placebo-controlled study". Drugs R D 4 (1): 19–28. doi:10.2165/00126839-200304010-00002. PMID 12568631. 

·  ^ Sharquie KE, Najim RA, Abu-RaghifAR (2002). "Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study". J Dermatol 29 (5): 267–79. PMID 12081158. 

·  ^ Ohno, S.; M. Ohguchi, S. Hirose, H. Matsuda, A. Wakisaka, M. Aizawa (1982). "Close association of HLA-Bw51 with Behcet's disease". Archives of Ophthalmology 100 (9): 1455–1458. 

·  ^ Durrani K, Papaliodis GN (2008). "The genetics of Adamantiades-Behcet's disease". Semin Ophthalmol 23 (1): 73–9. doi:10.1080/08820530701745264. PMID 18214795. 

·  ^ Hou S, Yang P, Du L, et al (July 2008). "SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease". Clin. Immunol.. doi:10.1016/j.clim.2008.06.006. PMID 18657476. 

·  ^ Ahn JK, Park YG (October 2007). "Human leukocyte antigen B27 and B51 double-positive Behçet uveitis". Arch. Ophthalmol. 125 (10): 1375–80. doi:10.1001/archopht.125.10.1375. PMID 17923546. 

·  ^ Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F (July 2006). "Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen". J. Invest. Dermatol. 126 (7): 1534–40. doi:10.1038/sj.jid.5700203. PMID 16514412. 

·  ^ www.nhs.uk/Conditions/Behcets-disease/Pages/introduction.aspx?url=Pages/what-is-it.aspx

·  ^ Escudier M, Bagan J, Scully C (March 2006). "Number VII Behçet's disease (Adamantiades syndrome)". Oral Dis 12 (2): 78–84. doi:10.1111/j.1601-0825.2005.01144.x. PMID 16476027.

^ black tongue and blue poo | PoopReport.com
^ Pepto-Bismol
·  John Pillinger, Flemming Andersen and Ulla Søderberg (6 July 2005). "Oral thrush (fungal infection in the mouth)". NetDoctor. http://www.netdoctor.co.uk/diseases/facts/oralthrush.htm. Retrieved on 2007-03-30.

·  ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ http://www.oralthrush.net/

·  ^ "Candida (yeast or thrush) infection on nipples". AskDrSears.com. 2006. http://www.askdrsears.com/html/2/T028100.asp. Retrieved on 2008-70-31.

^ http://www.geographictongue.org/
^ Geographic tongue (migrant glossitis) and psoriasis.
^ Migratory Glossitis (Geographic Tongue).
^ Leukoplakia, (pdf format) hosted by the American Academy of Oral and Maxillofacial Pathology. Page accessed on December 19, 2006.
^ http://www.mayoclinic.com/health/beta-carotene/NS_patient-betacarotene
Kumar, Vinay, Abdul Abbas, and Nelson Fausto. 2005. Robbins and Cotran Pathologic Basis of Disease. Philadelphia: Elsevier. ISBN 0-7216-0187-1

·  ^ lichen planus at Dorland's Medical Dictionary

·  ^ Penn State College of Medicine - Lichen Planus

·  ^ Issa Y, Brunton PA, Glenny AM, Duxbury AJ (November 2004). "Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (5): 553–65. doi:10.1016/S1079210404000216. PMID 15529127. http://linkinghub.elsevier.com/retrieve/pii/S1079210404000216. 

·  ^ Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P (March 2008). "The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial". Br. J. Dermatol. 158 (3): 573–7. doi:10.1111/j.1365-2133.2007.08370.x. PMID 18093246. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0007-0963&date=2008&volume=158&issue=3&spage=573. 

·  ^ Pavlotsky F, Nathansohn N, Kriger G, Shpiro D, Trau H (April 2008). "Ultraviolet-B treatment for cutaneous lichen planus: our experience with 50 patients". Photodermatol Photoimmunol Photomed 24 (2): 83–6. doi:10.1111/j.1600-0781.2008.00344.x. PMID 18353088.

1. Jean L. Bolognia, Joseph L. Jorizzo, and Ronald P. Rapini (2003). Dermatology. Mosby Press. Elsevier Science

2. Rapelanoro R, Mortureux P, Couprie B, Maleville J, Taieb A (1996). Neonatal Malassezia furfur pustulosis. Archives of Dermatology 62 37-41.

^ eMedicine - Acne Vulgaris : Article by Julie C Harper
^ James WD (2005). "Clinical practice. Acne". N Engl J Med 352 (14): 1463–72. PMID 15814882. 
^ Anderson, Laurence. 2006. Looking Good, the Australian guide to skin care, cosmetic medicine and cosmetic surgery. AMPCo. Sydney. ISBN 0 85557 044 X.
^ Thiboutot, Diane M.; Strauss, John S. (2003). "Diseases of the sebaceous glands". in Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher. Fitzpatrick's dermatology in general medicine (6th ed.). New York: McGraw-Hill. pp. 672–87. ISBN 0-07-138076-0. 
^ a b Goodman G (2006). "Acne and acne scarring - the case for active and early intervention" (PDF). Aust Fam Physician 35 (7): 503–4. PMID 16820822. http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2006issues/afp200607/20060705goodman.pdf. 
^ Purvis D, Robinson E, Merry S, Watson P (2006). "Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students". J Paediatr Child Health 42 (12): 793–6. doi:10.1111/j.1440-1754.2006.00979.x. PMID 17096715. 
One study has estimated the incidence of suicidal ideation in patients with acne as 7.1% :
* Picardi A, Mazzotti E, Pasquini P (2006). "Prevalence and correlates of suicidal ideation among patients with skin disease". J Am Acad Dermatol 54 (3): 420–6. doi:10.1016/j.jaad.2005.11.1103. PMID 16488292. 
^ acne at Dorland's Medical Dictionary
^ acne vulgaris at Dorland's Medical Dictionary
^ acne rosacea at Dorland's Medical Dictionary
^ Simpson, Nicholas B.; Cunliffe, William J. (2004). "Disorders of the sebaceous glands". in Burns, Tony; Breathnach, Stephen; Cox, Neil; Griffiths, Christopher. Rook's textbook of dermatology (7th ed.). Malden, Mass.: Blackwell Science. pp. 43.1–75. ISBN 0-632-06429-3. 
^ F. Ballangera, P. Baudrya, J.M. N'Guyenb, A. Khammaria, B. Dréno Heredity: A Prognostic Factor for Acne 5/2/2005
^ US Dept Health and Human Services January 2005
^ Chiu, Annie, Chon, Susan Y., Kimball, Alexa B. (July 2003). “The Response of Skin Disease to Stress: Changes in the Severity of Acne Vulgaris as Affected by Examination Stress” (abstract at http://archderm.ama-assn.org/cgi/content/abstract/139/7/897). Archives of Dermatology 139 (7).
^ National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (January 2006).“Questions and Answers about Acne” (http://www.niams.nih.gov/Health_Info/Acne/default.asp), p. 5.
^ Yosipovitch, Gil, Tang, Mark, Dawn, Aerlyn G., Chen, Mark, Goh, Chee Leok, Chan, Yiong Huak, Seng, Lim Fong (March 2007). “Study of Psychological Stress, Sebum Production and Acne Vulgaris in Adolescents” (http://adv.medicaljournals.se/article/full/10.2340/00015555-0231). Acta Dermato-Venereologica 87(2), pp. 135-39.
^ National Guideline Clearinghouse 11/12/2007
^ http://www.erowid.org/chemicals/amphetamines/amphetamines_effects.shtml
^ Kruszelnicki, Karl S. (June 8, 2004), “Chocolate-Flavoured Acne” (http://www.abc.net.au/science/articles/2004/06/08/1110361.htm). ABC Science.
^ Porter, Leah L. (June 2006). “Benefits of Cocoa Polyphenols.” (http://www.chocolateusa.org/pdfs/PMCA_article_June06_MC.pdf). The Manufacturing Confectioner, p. 52.
^ “Sweet News for Managing Blood Sugar.” allchocolate.com. http://www.allchocolate.com/health/basics/glycemic_effects.aspx. Retrieved April 3, 2009.
^ U.S. Department of Agriculture, Agricultural Research Center, Nutrient Data Library. "Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods – 2007." http//www.ars.usda.gov/nutrientdata/ORAC
^ “The Chocolate and Acne Myth.” The Acne Resource Center Online. http://www.acne-resource.org/acne-articles/chocolate-myth.html. Retrieved April 3, 2009.
^ Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD (2005). "High school dietary dairy intake and teenage acne". J Am Acad Dermatol 52 (2): 207–14. doi:10.1016/j.jaad.2004.08.007. PMID 15692464. 
^ Adebamowo CA, Spiegelman D, Berkey CS, et al (May 2008). "Milk consumption and acne in teenaged boys". J. Am. Acad. Dermatol. 58 (5): 787–93. doi:10.1016/j.jaad.2007.08.049. PMID 18194824. http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(07)02402-4. 
^ Adebamowo CA, Spiegelman D, Berkey CS, et al (2006). "Milk consumption and acne in adolescent girls". Dermatol. Online J. 12 (4): 1. PMID 17083856. 
^ Arbesman H (December 2005). "Dairy and acne--the iodine connection". J. Am. Acad. Dermatol. 53 (6): 1102. doi:10.1016/j.jaad.2005.05.046. PMID 16310091. http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(05)02097-9. 
^ a b c d Keri JE, NijhawanRI (2008). "Diet and acne". Expert Rev Dermatol 3 (4): 437–440. doi:10.1586/17469872.3.4.437. http://www.medscape.com/viewarticle/579326_1. 
^ Fulton JE, Plewig G, Kligman AM (December 1969). "Effect of chocolate on acne vulgaris". JAMA 210 (11): 2071–4. doi:10.1001/jama.210.11.2071. PMID 4243053. 
^ Anderson PC (March 1971). "Foods as the cause of acne". Am Fam Physician 3 (3): 102–3. PMID 4251510. 
^ Deplewski D, Rosenfield RL (August 2000). "Role of hormones in pilosebaceous unit development". Endocr. Rev. 21 (4): 363–92. doi:10.1210/er.21.4.363. PMID 10950157. http://edrv.endojournals.org/cgi/pmidlookup?view=long&pmid=10950157. 
^ DiGiovanni J, Bol DK, Wilker E, et al (March 2000). "Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion". Cancer Res. 60 (6): 1561–70. PMID 10749124. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=10749124. 
^ Smith R, Mann N, Mäkeläinen H, Roper J, Braue A, Varigos G (June 2008). "A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial". Mol Nutr Food Res 52 (6): 718–26. doi:10.1002/mnfr.200700307. PMID 18496812. 
^ Selva DM, Hogeveen KN, Innis SM, Hammond GL (December 2007). "Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene". J. Clin. Invest. 117 (12): 3979–87. doi:10.1172/JCI32249. PMID 17992261. 
^ Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA (August 2007). "The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial". J. Am. Acad. Dermatol. 57 (2): 247–56. doi:10.1016/j.jaad.2007.01.046. PMID 17448569. http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(07)00414-8. 
^ Aizawa H, Niimura M (April 1995). "Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne". J. Dermatol. 22 (4): 249–52. PMID 7608381. 
^ Cappel M, Mauger D, Thiboutot D (March 2005). "Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women". Arch Dermatol 141 (3): 333–8. doi:10.1001/archderm.141.3.333. PMID 15781674. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=15781674. 
^ Aizawa H, Niimura M (August 1996). "Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne". J. Dermatol. 23 (8): 526–9. PMID 8854583. 
^ Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J (December 2002). "Acne vulgaris: a disease of Western civilization". Arch Dermatol 138 (12): 1584–90. doi:10.1001/archderm.138.12.1584. PMID 12472346. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=12472346. 
^ Freyre EA, Rebaza RM, Sami DA, Lozada CP (June 1998). "The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity". J Adolesc Health 22 (6): 480–4. doi:10.1016/S1054-139X(97)00277-2. PMID 9627819. http://linkinghub.elsevier.com/retrieve/pii/S1054-139X(97)00277-2. 
^ Fleischer AB, Feldman SR, Bradham DD (January 1994). "Office-based physician services provided by dermatologists in the United States in 1990". J. Invest. Dermatol. 102 (1): 93–7. doi:10.1111/1523-1747.ep12371739. PMID 8288916. 
^ Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J (2002). "Acne vulgaris: a disease of Western civilization". Arch Dermatol 138 (12): 1584–90. doi:10.1001/archderm.138.12.1584. PMID 12472346. http://archderm.ama-assn.org/cgi/content/abstract/138/12/1584. 
^ Smith R, Mann N, Makelainen H, Braue A, Varigos G (2004). "The effect of short-term altered macronutrient status on acne vulgaris and biochemical markers of insulin sensitivity". Asia Pac J Clin Nutr 13 (Suppl): S67. PMID 15294556. 
^ Anderson, Laurence. 2006. Looking Good, the Australian guide to skin care, cosmetic medicine and cosmetic surgery. AMPCo. Sydney. ISBN 0-85557-044-X.
^ Naweko San-Joyz (2007-04-11). "How Does Vitamin A Prevent Acne Outbreaks?". American Chronical. http://www.americanchronicle.com/articles/viewArticle.asp?articleID=24129. Retrieved on 2007-09-17. 
^ El-Akawi Z, Abdel-Latif N, Abdul-Razzak K (2006). "Does the plasma level of vitamins A and E affect acne condition?". Clin. Exp. Dermatol. 31 (3): 430–4. doi:10.1111/j.1365-2230.2006.02106.x. PMID 16681594. 
^ Comparative evaluation of retinoic acid, benzoyl peroxide and erythromycin lotion in acne vulgarils
^ Bernadine Healy (2005-05-09). "Pledging for Accutane". US News Best Health. http://www.usnews.com/usnews/opinion/articles/050905/5healy.htm. 
^ Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T (2002). "Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation". J Dermatol Sci 30 (2): 129–35. doi:10.1016/S0923-1811(02)00068-3. PMID 12413768. 
^ Kjeldstad B (1984). "Photoinactivation of Propionibacterium acnes by near-ultraviolet light". Z Naturforsch [C] 39 (3-4): 300–2. PMID 6730638. 
^ Ashkenazi H, Malik Z, Harth Y, Nitzan Y (2003). "Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light". FEMS Immunol Med Microbiol 35 (1): 17–24. doi:10.1111/j.1574-695X.2003.tb00644.x. PMID 12589953. 
^ "New Light Therapy for Acne" U.S. Food and Drug Administration, FDA Consumer magazine, November-December 2002 Notice
^ Papageorgiou P, Katsambas A, Chu A (2000). "Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris.". Br J Dermatol 142 (5): 973–8. doi:10.1046/j.1365-2133.2000.03481.x. PMID 10809858. 
^ [1]
^ BBC NEWS | Health | Doubts over acne laser treatment
^ Manage Account - Modern Medicine
^ Enforcement Report for January 14, 2004
^ a b Mantle D, Gok MA, Lennard TW (2001). "Adverse and beneficial effects of plant extracts on skin and skin disorders". Adverse drug reactions and toxicological reviews 20 (2): 89–103. PMID 11482001. 
^ Jain A, Basal E (2003). "Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs". Phytomedicine 10 (1): 34–8. doi:10.1078/094471103321648638. PMID 12622461. 
^ http://journals.tubitak.gov.tr/medical/issues/sag-00-30-5/sag-30-5-14-97076.pdf
^ Grow Your Own Drugs - BBC2 James Wong
^ S. Bruce1, C. Conrad, R. D. Peterson, R. Conrad, L. S. Arambide, J. Thompson, and W. Klemp. "Significant Efficacy and Safety of Low Level Intermittent Heat in Patients with Mild to Moderate Acne" (PDF). http://www.myzenoeurope.com/doc/zenowhite.pdf. Retrieved on 2008-03-09. 
^ Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK (June 1995). "Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris". Int. J. Dermatol. 34 (6): 434–7. doi:10.1111/j.1365-4362.1995.tb04449.x. PMID 7657446. 
^ Procter & Gamble. "Niacinamide Research" (PDF). http://www.pgdermatology.com/images/learning_library/anti_aging/PG-Niancinamide-FINAL-090105.pdf. 
^ Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH (2002). "Tea tree oil reduces histamine-induced skin inflammation". Br. J. Dermatol. 147 (6): 1212–7. doi:10.1046/j.1365-2133.2002.05034.x. PMID 12452873. 
^ Khalil Z, Pearce AL, Satkunanathan N, Storer E, Finlay-Jones JJ, Hart PH (2004). "Regulation of wheal and flare by tea tree oil: complementary human and rodent studies". J. Invest. Dermatol. 123 (4): 683–90. doi:10.1111/j.0022-202X.2004.23407.x. PMID 15373773. http://www.nature.com/jid/journal/v123/n4/full/5602507a.html. 
^ Tehrani R, Dharmalingam M (01 Nov 2004). "Management of premenstrual acne with Cox-2 inhibitors: A placebo controlled study". Indian J Dermatol Venereol Leprol [serial online] 70 (6): 345–348. PMID 17642660. http://www.ijdvl.com/text.asp?2004/70/6/345/13475. Retrieved on 2007-06-23. 
^ Dreno B, Amblard P, Agache P, Sirot S, Litoux P (1989). "Low doses of zinc gluconate for inflammatory acne". Acta Derm Venereol 69 (6): 541–3. PMID 2575335. 
^ Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, Bodokh I, Chivot M, Daniel F, Humbert P, Meynadier J, Poli F (2001). "Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris". Dermatology 203 (2): 135–40. doi:10.1159/000051728. PMID 11586012. 
^ Leung, Lit-Hung (December 1998). “Pantothenic Acid in the Treatment of Acne Vulgaris ‘A Medical Hypothesis’” (http://www.pantothenic-acid.com/acne_vulgaris.html), originally printed in Journal of Orthomolecular Medicine 12(2).
^ Cosgrove, Joanna (2008). "Good-For-You Candy." Nutraceuticals World. http://www.nutraceuticalsworld.com/articles/2008/07/online-exclusive-goodforyou-candy.
^ "Tretinoin (retinoic acid) in acne". The Medical letter on drugs and therapeutics 15 (1): 3. 1973. PMID 4265099. 
^ Jones H, Blanc D, Cunliffe WJ (1980). "13-cis retinoic acid and acne". Lancet 2 (8203): 1048–9. doi:10.1016/S0140-6736(80)92273-4. PMID 6107678. 
^ Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D (2007). "Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective". British journal of clinical pharmacology 63 (2): 196–205. doi:10.1111/j.1365-2125.2006.02837.x. PMID 17214828. 
^ Holmes SC, Bankowska U, Mackie RM (1998). "The prescription of isotretinoin to women: is every precaution taken?". Br. J. Dermatol. 138 (3): 450–5. doi:10.1046/j.1365-2133.1998.02123.x. PMID 9580798. 
^ "Hitting the Shelves: Chocolate … to Treat Acne? -- January 2009." Prepared Foods. http://www.preparedfoods.com/Articles/Product_of_the_Week/BNP_GUID_9-5-2006_A_10000000000000507000.
^ Kim J (2008). "Acne vaccines: therapeutic option for the treatment of acne vulgaris?". J Invest Dermatol 128 (10): 2353–4. doi:10.1038/jid.2008.221. PMID 18787542. 
^ Farrar MD, Howson KM, Bojar RA, West D, Towler JC, Parry J, Pelton K, Holland KT (2007). "Genome sequence and analysis of a Propionibacterium acnes bacteriophage" (PDF). J Bacteriol 189 (11): 4161–7. doi:10.1128/JB.00106-07. PMID 17400737. http://jb.asm.org/cgi/reprint/189/11/4161.pdf. 
^ Leeds, Cook's and Pillsbury scales obtained from here
^ Cohen AF, Tiemstra JD (2002). "Diagnosis and treatment of rosacea". J Am Board Fam Pract 15 (3): 214–7. PMID 12038728. http://www.jabfm.org/cgi/pmidlookup?view=long&pmid=12038728. 
^ Diseaes of Ear, Nose and Throat; 4th Edition; PL Dingra
^ rosacea at Dorland's Medical Dictionary
^ "Glossary - Dermatology - Online Medical Encyclopedia - University of Rochester Medical Center". http://www.urmc.rochester.edu/encyclopedia/content.cfm?pageid=P01903#R. Retrieved on 2009-02-21. 
^ "All About Rosacea". National Rosacea Society. http://www.rosacea.org/patients/allaboutrosacea.php. Retrieved on 2008-11-10. 
^ Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F (2004). "Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea" (PDF reprint). J Am Acad Dermatol 50 (6): 907–12. doi:10.1016/j.jaad.2004.01.048. PMID 15153893. http://www.rosacea.org/grading/gradingsystem.pdf. 
^ Marks, James G; Miller, Jeffery (2006). Lookingbill and Marks' Principles of Dermatology (4th ed.). Elsevier Inc. ISBN 1-4160-3185-5.
^ Jansen T, Plewig G (1998). "Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities". Facial Plast Surg 14 (4): 241–53. PMID 11816064. 
^ Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F (2002). "Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea" (PDF reprint). J Am Acad Dermatol 46: 584–7. doi:10.1067/mjd.2002.120625. PMID 15153893. http://www.rosacea.org/class/classystem.pdf.  - this earlier classification noted terms of Granulomatous Rosacea, Rosacea fulminans and Perioral dermatitis as probably not meeting the accepted definitions for Rosacea. Such terms not mentioned in the later 2004 classification.
^ Helm K, Menz J, Gibson L, Dicken C (1991). "A clinical and histopathologic study of granulomatous rosacea". J Am Acad Dermatol 25 (6 Pt 1): 1038–43. PMID 1839796. 
^ Jansen T, Plewig G, Kligman A (1994). "Diagnosis and treatment of rosacea fulminans". Dermatology 188 (4): 251–4. PMID 8193395. 
^ Helm T, Schechter J (2006). "Biopsy may help identify early pyoderma faciale (rosacea fulminans)". Cutis 77 (4): 225–7. PMID 16706239. 
^ Nguyen V, Eichenfield L (2006). "Periorificial dermatitis in children and adolescents". J Am Acad Dermatol 55 (5): 781–5. doi:10.1016/j.jaad.2006.05.031. PMID 17052482. 
^ Hölzle E, Jansen T, Plewig G (1995). "[Morbihan disease--chronic persistent erythema and edema of the face]". Hautarzt 46 (11): 796–8. doi:10.1007/s001050050341. PMID 8641887. 
^ Landow K (December 2002). "Unraveling the mystery of rosacea -- Keys to getting the red out". Postgraduate Medicine 112 (6). http://www.postgradmed.com/issues/2002/12_02/landow.htm. 
^ Panconesi, E. (1984). "Psychosomatic dermatology". Clin Dermatol 2: 94–179. doi:10.1016/0738-081X(84)90050-6. PMID 6242532. 
^ Yamasaki K, Di Nardo A, Bardan A, et al (August 2007). "Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea". Nat. Med. 13 (8): 975–80. doi:10.1038/nm1616. PMID 17676051. http://dx.doi.org/10.1038/nm1616. 
^ See the August 5, 2007 issue of Nature Medicine for details.
^ Kendall SN (May 2004). "Remission of rosacea induced by reduction of gut transit time". Clin Exp dermatol. 29 (3): 297–9. doi:10.1111/j.1365-2230.2004.01461.x. PMID 15115515. 
^ Parodi A,Paolino S,Greco A,Drago F,Mansi C,Rebora A,Parodi AU,Savarino V (May 2008). "Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication". Clin Gastroenterol Hepatol.. doi:10.1016/j.cgh.2008.02.054. PMID 18456568. 
^ Erbagcaronci Z, Özgöztascedili O (June 1998). "The significance of Demodex folliculorum density in rosacea". Int J Dermatol. 37 (6): 421–5. doi:10.1046/j.1365-4362.1998.00218.x. PMID 9646125. 
^ a b Baima B, Sticherling M (2002). "Demodicidosis revisited". Acta Derm Venereol 82 (1): 3–6. doi:10.1080/000155502753600795. PMID 12013194. 
^ Aaron F. Cohen, MD, and Jeffrey D. Tiemstra, MD (May-June 2002). "Diagnosis and treatment of rosacea". J Am Board Fam Pract. 15 (3): 214–7. PMID 12038728. 
^ Dahl, Colin (2008). A Practical Understanding of Rosacea - part one.. Australian Sciences. http://www.ausci.com/rosacea.htm. 
^ Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, Parker F, Wolf JE Jr, Aly R, Bayles C, Reusser B, Weidner M, Coleman E, Patrignelli R, Tuley MR, Baker MO, Herndon JH Jr, Czernielewski JM (June 1998). "Topical

metronidazole maintains remissions of rosacea". Arch Dermatol 134 (6): 679–83. doi:10.1001/archderm.134.6.679. PMID 9645635. 
^ Hoting E, Paul E, Plewig G (December 1986). "Treatment of rosacea with isotretinoin". Int J Dermatol 25 (10): 660–3. doi:10.1111/j.1365-4362.1986.tb04533.x. PMID 2948928. 
^ Cunliffe WJ, Dodman B, Binner JG (January 1977). "Clonidine and facial flushing in rosacea". Br Med J 1 (6053): 105. PMID 137764. 
^ Berardesca E, Cameli N, Cavallotti C, Levy JL, Piérard GE, de Paoli Ambrosi G (2008). "Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation". J Cosmet Dermatol 7 (1): 8–14. doi:10.1111/j.1473-2165.2008.00355.x. PMID 18254805. http://www.blackwell-synergy.com/doi/full/10.1111/j.1473-2165.2008.00355.x. 
^ Marla C Angermeier (1999). "Treatment of facial vascular lesions with intense pulsed light". J Cutan Laser Ther. 1 (2): 95–100. doi:10.1080/14628839950516922. PMID 11357295. 
^ Rigel, Darrell S.; Robert A. Weiss, Henry W. Lim, Jeffrey S. Dover (2004). Photoaging. Informa Health Care. pp. 174. ISBN 0824754506. 
^ "PHOTO REJUVENATION". http://www.topdocs.com/display_procedure.php?id=photorejuvenation. Retrieved on 2008-08-14. 
^ "Research a cosmetic surgery procedure". http://www.cosmeticsurgery.com/research/cosmetic-surgery/Photo-Rejuvenation/. Retrieved on 2008-08-14. 
^ a b Jane E. Brody (March 16, 2004). "Sometimes Rosy Cheeks Are Just Rosy Cheeks". New York Times. http://query.nytimes.com/gst/fullpage.html?sec=health&res=9400E5DB1631F935A25750C0A9629C8B63. 
^ Burnham, Virginia (2003). The Two-Edged Sword: A Study of the Paranoid Personality in Action. Sunstone Press. pp. 61. http://books.google.com/books?id=zMoN2XhwNXEC&pg=PA61&dq=rosacea+morgan&as_brr=3&sig=ACfU3U3NYI-02ai4iJZHWen9tW0P05ModQ. 
^ Rosie O'Donnell - ELLE
^ I’ve got thighs and buttocks — I’m never going to be a size zero - Times Online
^ Subscription Center - News Archive
^ Q&A | OMM | The Observer
^ Lisa Faulkner: My unslightly rosacea - Celebrity gossip on Now Magazine
^ http://www.abc.net.au/news/stories/2003/12/06/1004714.htm
http://en.wikipedia.org/wiki/Milia

·  ^ Mowad CM, McGinley KJ, Foglia A, Leyden JJ (1995). "The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria". J. Am. Acad. Dermatol. 33 (5 Pt 1): 729–33. doi:10.1016/0190-9622(95)91809-4. PMID 7593770. 

·  ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ Haas N, Martens F, Henz BM (2004). "Miliaria crystallina in an intensive care setting". Clin. Exp. Dermatol. 29 (1): 32–4. doi:10.1111/j.1365-2230.2004.01444.x. PMID 14723716. 

·  ^ Niparko, John Kim; Klag, Michael J.; Lawrence, Robert M.; Romaine-Davis, Ada (1999). Johns Hopkins family health book. London: HarperCollins. p. 1308. ISBN 0-06-270149-5.

·  ^ a b c d "HS-USA :: What is Hidradenitis Suppurativa?". http://www.hs-usa.org/hidradenitis_suppurativa.htm. Retrieved on 2007-07-08. 

·  ^ Gao M, Wang PG, Cui Y, et al (2006). "Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3". J. Invest. Dermatol. 126 (6): 1302–6. doi:10.1038/sj.jid.5700272. PMID 16543891. http://www.nature.com/jid/journal/v126/n6/abs/5700272a.html. 

·  ^ "HS-USA :: Prevalence of Hidradenitis Suppurativa". http://hs-usa.org/pub/articles/prevalence.htm. Retrieved on 2007-07-08. 

·  ^ Scheinfeld N (2006). "Hidradenitis should not be renamed acne inversa". Dermatol. Online J. 12 (7): 6. PMID 17459292. 

·  ^ Verneuil AS: Etudes sur les tumor de la peau. Arch Gen Med 1854; 94: 693.

·  ^ a b DermNet acne/hidradenitis-suppurativa

·  ^ ClinicalTrials.gov NCT00329823 Etanercept in Hidradenitis Suppurativa

·  ^ "HSF - What is Hidradenitis Suppurativa? What is HS?". http://www.hs-foundation.org/abouths/what.htm. Retrieved on 2007-07-08. 

·  ^ Talmant JC, Bruant-Rodier C, Nunziata AC, Rodier JF, Wilk A (2006). "[Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review]" (in French). Ann Chir Plast Esthet 51 (1): 82–6. doi:10.1016/j.anplas.2005.11.002. PMID 16488526. 

·  ^ Short KA, Kalu G, Mortimer PS, Higgins EM (2005). "Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa". Clin. Exp. Dermatol. 30 (5): 481–3. doi:10.1111/j.1365-2230.2005.01875.x. PMID 16045671. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2230.2005.01875.x. 

·  ^ "abscesses.org - About Hidradenitis Suppurativa". http://abscesses.org/hidradenitisSuppurativa/content/view/22/33/. Retrieved on 2007-07-08. 

·  ^ Cusack C, Buckley C (2006). "Etanercept: effective in the management of hidradenitis suppurativa". Br. J. Dermatol. 154 (4): 726–9. doi:10.1111/j.1365-2133.2005.07067.x. PMID 16536817. 

·  ^ Scheinfeld N (2006). "Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab". J. Am. Acad. Dermatol. 55 (1): 163–4. doi:10.1016/j.jaad.2006.01.024. PMID 16781316.

·  ^ "Series 1 - The Boy Whose Skin Fell Off". Channel 4. 2004. http://www.channel4.com/programmes/the-boy-whose-skin-fell-off/episode-guide/series-1/episode-1. Retrieved on 2009-02-28. 

·  ^ Mary E. O'Brien, M.D.. "Caroline". The Columbia Observer. http://www.columbia.edu/cu/observer/issues/2004Fall/nonfic/Caroline.html. Retrieved on 2008-07-22. 

·  ^ Roddy Isles, Head of Press (2005-05-12). "Dundee Scientists on road to cure for "Butterfly Children" condition". University of Dundee. http://www.dundee.ac.uk/pressreleases/prmay05/butterfly.html. Retrieved on 2008-07-22. 

·  ^ Suellen Hinde, Health reporter (2006-11-26). "Little girl's life of pain". HeraldSun.com.au. http://www.news.com.au/heraldsun/story/0,21985,20819799-2862,00.html. Retrieved on 2008-07-22. 

·  ^ By Robyn Gobert, Past President of DEBRA Australia Inc. (May 2002). "Times change - A family's story about living with EB". e-bility.com. http://www.e-bility.com/articles/eb_intro.php. Retrieved on 2008-07-22. 

·  ^ Gena Brumitt Gruschovnik, DEBRA International Executive Committee. "DEBRA Chile website". http://www.debrachile.cl/. 

·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.

·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

·  ^ M Peter Marinkovich, MD, Associate Professor, Department of Dermatology and Program in Epithelial Biology, Stanford University Medical Center; Jean Paul Ortonne, MD, Chair, Department of Dermatology, Professor, Hospital L'Archet, Nice University, France; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Van Perry, MD, Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas Health Science Center; Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System (December 3, 2007). "Epidermolysis Bullosa". Bullous Diseases. emedicine.com. http://www.emedicine.com/DERM/topic124.htm. Retrieved on 2008-07-22. 

·  ^ Ellen Pfendner, Jouni Uitto and Jo-David Fine (2000-11-07). "Epidermolysis Bullosa Carrier Frequencies in the US Population". Journal of Investigative Dermatology. nature.com. http://www.nature.com/jid/journal/v116/n3/full/5601019a.html. Retrieved on 2008-07-22. 

·  ^ Josephine Marcotty (2008-07-03). "Long-shot stem-cell treatment gives two brothers a future". Star Tribune. http://www.startribune.com/lifestyle/health/19471139.html. Retrieved on 2008-07-22.

^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Pettigrew R, Kuo HC, Scriven P, et al (December 2000). "A pregnancy following PGD for X-linked dominant [correction of X-linked autosomal dominant incontinentia pigmenti (Bloch-Sulzberger syndrome): case report]". Hum. Reprod. 15 (12): 2650–2. PMID 11098039. http://humrep.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11098039. 
^ "Incontinentia pigmenti. DermNet NZ". http://dermnetnz.org/systemic/incontinentia-pigmenti.html. 
^ Smahi A, Courtois G, Vabres P, et al (2000). "Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium". Nature 405 (6785): 466–72. doi:10.1038/35013114. PMID 10839543. 
^ synd/1762 at Who Named It?
^ B. Bloch. Eigentümliche, bisher nicht beschriebene Pigmentaffektion (incontinentia pigmenti). Schweizerische medizinische Wochenschrift, Basel, 1926, 56: 404-405.
^ M. B. Sulzberger. Über eine bisher nicht beschriebene kongenitale Pigmentanomalie (incontinentia pigmenti). Archiv für Dermatologie und Syphilis, Berlin, 1927, 154: 19-32.
·  ^ a b Dissanayake, C. B.; Chandrajith, Rohana; Tobschall, H. J. (1999). "The iodine cycle in the tropical environment — implications on iodine deficiency disorders". International Journal of Environmental Studies 56 (3): 357–372. doi:10.1080/00207239908711210. 

·  ^ a b N. Bell, L. Hsu, D. J. Jacob, M. G. Schultz, D. R. Blake, J. H. Butler, D. B. King, J. M. Lobert, and E. Maier-Reimer (2002). "Methyl iodide: Atmospheric budget and use as a tracer of marine convection in global models". Journal of GeophysicalResearch 107 (D17): 4340. doi:10.1029/2001JD001151. 

·  ^ a b Jessica Elzea Kogel, Nikhil C. Trivedi, James M. Barker, Stanley T. Krukowski (2006). Industrial Minerals & Rocks: Commodities, Markets, and Uses. SME. pp. 541–552. ISBN 9780873352338. http://www.google.com/books?id=zNicdkuulE4C. 

·  ^ Tatsuo Maekawa, Shun-Ichiro Igari and Nobuyuki Kaneko (2006). "Chemical and isotopic compositions of brines from dissolved-in-water type natural gas fields in Chiba, Japan". Geochemical Journal 40: 475–484. doi:10.2343/geochemj.40.475. 

·  ^ Bernard Courtois (1813) "Découverte d'une substance nouvelle dans le Vareck," Annales de chimie, vol. 88, pages 304-310. In French, seaweed that had been washed onto the shore was called "varec", "varech", or "vareck", whence the English word "wrack". Later, "varec" also referred to the ashes of such seaweed: the ashes were used as a source of iodine and salts of sodium and potassium.

·  ^ Patricia A. Swain (2005) "Bernard Courtois (1777-1838) famed for discovering iodine (1811), and his life in Paris from 1798," Bulletin for the History of Chemistry, vol. 30, no. 2, pages 103-111. Available on-line at: http://www.scs.uiuc.edu/~mainzv/HIST/awards/OPA%20Papers/2007-Swain.pdf .

·  ^ J. Gay-Lussac (1813) "Sur un nouvel acide formé avec la substance décourverte par M. Courtois," Annales de chimie, vol. 88, pages 311-318.

·  ^ J. Gay-Lussac (1813) "Sur la combination de l'iode avec d'oxigène," Annales de chimie, vol. 88, pages 319-321.

·  ^ J. Gay-Lussac (1814) "Mémoire sur l'iode," Annales de chimie, vol. 91, pages 5-160.

·  ^ H. Davy (1813) "Sur la nouvelle substance découverte par M. Courtois, dans le sel de Vareck," Annales de chimie, vol. 88, pages 322-329.

·  ^ H. Davy (1814) "Some experiments and observations on a new substance which becomes a violet-colored gas by heat," Philosophical Transactions of the Royal Society of London, Part 1, pages 74-93.

·  ^ Block, Seymour Stanton (2001). Disinfection, sterilization, and preservation. Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 159. ISBN 0-683-30740-1. 

·  ^ R. Toreki. "Peroxide". The MSDS HyperGlossary. http://www.ilpi.com/msdS/ref/peroxide.html. 

·  ^ King, C. S.; Hartman, W. W. (1943). "Methyl Iodide". Org. Synth.; Coll. Vol. 2: 399. 

·  ^ 21 USC Sec. 872 01/22/02

·  ^ Chemical Supplier Convicted of Diversion of Iodine

·  ^ a b c Advanced Inorganic Chemistry by Cotton and Wilkinson, 2nd ed.

·  ^ Merck Index of Chemicals and Drugs, 9th ed.

·  ^ General Chemistry (volume 2) by N.L. Glinka, Mir Publishing 1981

·  ^ a b General Chemistry by Linus Pauling, 1947 ed.

·  ^ a b c d e f g Patrick L (June 2008). "Iodine: deficiency and therapeutic considerations". Altern Med Rev 13 (2): 116–27. PMID 18590348. http://www.thorne.com/altmedrev/.fulltext/13/2/116.pdf. 

·  ^ a b National Research Council. (2000). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, pp. 258-259. National Acadamies Press. Free full-text available online.

·  ^ International Council for the Control of Iodine Deficiency Disorders Sources of iodine

·  ^ a b MedlinePlus Medical Encyclopedia: Iodine in diet

·  ^ Wu T, Liu GJ, Li P, Clar C (2002). "Iodised salt for preventing iodine deficiency disorders". Cochrane Database Syst Rev (3): CD003204. doi:10.1002/14651858.CD003204. PMID 12137681. 

·  ^ "Micronutrients - Iodine, Iron and Vitamin A". UNICEF. http://www.unicef.org/nutrition/index_iodine.html. 

·  ^ Frequently Asked Questions on Potassium Iodide (KI)

·  ^ Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies

·  ^ a b Stoddard II, F. R.; Brooks, A. D.; Eskin, B. A.; Johannes, G. J. (2008). "Iodine Alters Gene Expression in the MCF7 Breast Cancer Cell Line: Evidence for an Anti-Estrogen Effect of Iodine". International Journal of Medical Science 5: 189–196. PMID 18645607. http://www.medsci.org/v05p0189.htm. 

·  ^ Eskin, B. A.; Grotkowski, C. E.; Connolly, C. P.; Ghent W. R.; (1995). "Different tissue responses for iodine and iodide in rat thyroid and mammary glands". Bioligal Trace Elements Research 49: 9–19. doi:10.1007/BF02788999. PMID 14965610. 

·  ^ Venturi, S. (2001). "Is there a role for iodine in breast diseases?". The Breast 10 (5): 379–382. doi:10.1054/brst.2000.0267. PMID 7577324. 

·  ^ "Safety data for iodomethane". Oxford University. http://msds.chem.ox.ac.uk/IO/iodomethane.html. 

·  ^ Gribble, G. W. (1996). "Naturally occurring organohalogen compounds - A comprehensive survey". Progress in the Chemistry of Organic Natural Products 68: 1–423.

^ Walker et al. (27 April 1979) Thyroxine increases nerve growth factor concentration in adult mouse brain. Science. Vol. 204, No. 4391. pp. 427 - 429.
^ MeSH Dextrothyroxine
^ C10AX01
·  ^ Faculty of Medicine & Dentistry (2006). "Course-Based Physical Examination - Endocrinology -- Endocrinology Objectives (Thyroid Exam)". Undergraduate Medical Education. University of Alberta. http://www.med.ualberta.ca/education/ugme/clinicaled12/clinskills_endocrinology.cfm?yr=1. Retrieved on 2007-01-28. 

·  ^ Geffner, DL, Hershman, JM.ß-adrenergic blockade for the treatment of hyperthyroidism. Am J Med 1992; 93:61.

·  ^ Berglund J, Christensen SB, Dymling JF, Hallengren B (1991). "The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970-1974". J. Intern. Med. 229 (5): 435–42. PMID 1710255. 

·  ^ Esfahani AF, Kakhki VR, Fallahi B, et al (2005). "Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs". Hellenic journal of nuclear medicine 8 (3): 158–61. PMID 16390021. 

·  ^ Markovic V, Eterovic D (2007). "Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease". J. Clin. Endocrinol. Metab. 92 (9): 3547–52. doi:10.1210/jc.2007-0879. PMID 17609305. 

·  ^ http://www.thyroid-info.com/articles/cat-hyper.htm

·  ^ Susan Little (2006). "Feline Hyperthyroidism" (PDF). Winn Feline Foundation. http://www.winnfelinehealth.org/Pages/Feline_Hyperthyroidism_Web.pdf. Retrieved on 2007-01-28.

·  ^ New Zealand Dermatological Society (2006-01-14). "Chickenpox (varicella)". http://www.dermnetnz.org/viral/varicella.html. Retrieved on 2006-08-18. 

·  ^ "General questions about the disease". Varicella Disease (Chickenpox). CDCP. 2001-12-02. http://www.cdc.gov/nip/diseases/varicella/faqs-gen-disease.htm. Retrieved on 2006-08-18. 

·  ^ Heather Brannon (2005-12-25). "Chicken Pox - Varicella Virus Infection". http://dermatology.about.com/cs/chickenpox/a/chickenpox.htm. Retrieved on 2006-08-18. 

·  ^ http://dermatology.about.com/cs/pregnancy/a/chickenpreg.htm

·  ^ http://www.marchofdimes.com/professionals/14332_1185.asp

·  ^ a b c Royal College of Obstetricians and Gynaecologists (September 2007). "Chickenpox in Pregnancy" (PDF). http://www.rcog.org.uk/resources/Public/pdf/greentop13_chickenpox0907.pdf. Retrieved on 2008-04-12. 

·  ^ McPherson & Pincus: Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed., 2007, Chapter 54.

·  ^ Chaves SS, Gargiullo P, Zhang JX, et al. (2007). "Loss of vaccine-induced immunity to varicella over time". N Engl J Med 356 (11): 1121–9. doi:10.1056/NEJMoa064040. PMID 17360990. 

·  ^ NHS Direct: Why isn’t the chickenpox vaccine available in the UK?

·  ^ UK Health Protection Agency (Prevention section)

·  ^ Tebruegge M, Kuruvilla M, Margarson I (2006). "Does the use of calamine or antihistamine provide symptomatic relief from pruritus in children with varicella zoster infection?". Arch. Dis. Child. 91 (12): 1035–6. doi:10.1136/adc.2006.105114. PMID 17119083. http://adc.bmj.com/cgi/content/extract/91/12/1035. 

·  ^ "Chicken Pox - A guide to Management". http://www.naturalparenting.com.au/flex/childrens-health/7788/chicken-pox-a-guide-to-management-from-incubation-to-recuperation.cfm. Retrieved on 31/03/09. 

·  ^ "BestBets: Should acyclovir be prescribed for immunocompetent children presenting with chickenpox?". http://www.bestbets.org/bets/bet.php?id=781. 

·  ^ Somekh E, Dalal I, Shohat T, Ginsberg GM, Romano O (2002). "The burden of uncomplicated cases of chickenpox in Israel". J. Infect. 45 (1): 54–7. PMID 12217733. 

·  ^ US Centers for Disease Control and Prevention. "Varicella Treatment Questions & Answers". CDC Guidelines. CDC. http://www.cdc.gov/vaccines/vpd-vac/varicella/dis-faqs-gen-treatment.htm. Retrieved on 2007-08-23. 

·  ^ "Definition of Chickenpox". MedicineNet.com. http://www.medterms.com/script/main/art.asp?articlekey=2702. Retrieved on 2006-08-18. 

·  ^ "Is Necrotizing Fasciitis a complication of Chickenpox of Cutaneous Vasculitis?". atmedstu.com. http://www.atmedstu.com/exam%20plus/Is%20Necrotizing%20Fasciitis%20a%20complication%20of%20Chickenpox%20or%20of%20Cutaneous%20Vasculitis.php. Retrieved on 2008-01-18. 

·  ^ a b Chicken Pox Complications

·  ^ a b "Epidemiology of Varicella Zoster Virus Infection, Epidemiology of VZV Infection, Epidemiology of Chicken Pox, Epidemiology of Shingles". http://virology-online.com/viruses/VZV3.htm. Retrieved on 2008-04-22. 

·  ^ Harminder S. Dua, Ahmad Muneer Otri, Arun D. Singh (2008), "Abu Bakr Razi", British Journal of Ophthalmology (BMJ Group) 92: 1324

http://en.wikipedia.org/wiki/Burns

·  ^ Ekzema, Henry George Liddell, Robert Scott, A Greek-English Lexicon, at Perseus

·  ^ MeSH Eczema

·  ^ eczema at Dorland's Medical Dictionary

·  ^ Johansson SG, Hourihane JO, Bousquet J, et al (2001). "A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force". Allergy 56 (9): 813–24. doi:10.1034/j.1398-9995.2001.t01-1-00001.x. PMID 11551246. 

·  ^ Hoare C, Li Wan Po A, Williams H (2000). "Systematic review of treatments for atopic eczema". Health technology assessment (Winchester, England) 4 (37): 1–191. PMID 11134919. 

·  ^ Atherton DJ (2003). "Topical corticosteroids in atopic dermatitis". BMJ 327 (7421): 942–3. doi:10.1136/bmj.327.7421.942. PMID 14576221. http://www.bmj.com/cgi/content/full/327/7421/942. 

·  ^ Lee NP, Arriola ER (1999). "Topical corticosteroids: back to basics" ("Scanned & PDF"). West. J. Med. 171 (5-6): 351–3. PMID 10639873. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=10639873. 

·  ^ "neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate (Neomycin sulfate and Polymyxin B Sulfate, Bacitracin zinc and Hydrocortisone Acetate) ointment -- Warnings". U.S. Food and Drug Administration. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1932#nlm34071-1. 

·  ^ Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ (1999). "The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group". Br. J. Dermatol. 140 (6): 1114–21. PMID 10354080. 

·  ^ Bewley,A. (2008). "Expert Consensus: Time for a Change in the Way We Advise Our Patients to Use Topical Corticosteroids" ([dead link] – Scholar search). British Journal of Dermatology 158 (5): 917–920. doi:10.1111/j.1365-2133.2008.08479.x. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2008.08479.x.  Also at Medscape

·  ^ "FDA Issues Public Health Advisory Informing Health Care Providers of Safety Concerns Associated with the Use of Two Eczema Drugs, Elidel and Protopic". FDA. March 10, 2005. http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01343.html. Retrieved on 2007-10-16. 

·  ^ N H Cox and Catherine H Smith (December 2002). "Advice to dermatologists re topical tacrolimus" (DOC). Therapy Guidelines Committee. British Association of Dermatologists. http://www.bad.org.uk/healthcare/guidelines/Advice_re_topical_tacrolimus.doc. 

·  ^ "Pimecrolimus cream for atopic dermatitis". Drug and Therapeutics Bulletin 41: 33–6. May 2003. doi:10.1136/dtb.2003.41533 (inactive 2008-06-25). PMID 12789846. http://dtb.highwire.org/cgi/content/abstract/41/5/33. Retrieved on 2007-10-16. 

·  ^ Martins GA, Arruda L (June 2004). "Systemic treatment of psoriasis - Part I: methotrexate and acitretin translation" ([dead link] – Scholar search). An. Bras. Dermatol 79 (3): 263–278. doi:10.1590/S0365-05962004000300002. http://www.anaisdedermatologia.org.br/artigo_en.php?artigo_id=159. 

·  ^ "Atopic dermatitis (eczema) - Prevention at Mayoclinic's website". http://www.mayoclinic.com/health/eczema/DS00986/DSECTION=8. Retrieved on 2008-05-07. 

·  ^ "Daily Skin Care Essential to Control Atopic Dermatitis article at American Academy of Dermatology's EczemaNet website". http://www.skincarephysicians.com/eczemanet/daily_care.html. Retrieved on 2009-03-24. 

·  ^ "Bathing and Moisturizing at National Eczema Association's EASE website". http://www.easeeczema.org/erc/bathing_and_mosturizing.htm. Retrieved on 2008-05-07. 

·  ^ "Treating Eczema at The Eczema Society of Canada's website". http://70.47.127.244/eczemahelp/treatment.htm. Retrieved on 2008-05-07. 

·  ^ Coderch L, López O, de la Maza A, Parra JL (2003). "Ceramides and skin function.". American Journal of Clinical Dermatology 4 (2): pp. 107-29. http://www.ncbi.nlm.nih.gov/pubmed/12553851. 

·  ^ Bouwstra JA, Ponec M (2006). "The skin barrier in healthy and diseased state". Biochim Biophys Acta 1758 (12): pp. 2080-95. http://www.ncbi.nlm.nih.gov/pubmed/16945325. 

·  ^ Choi MJ, Maibach HI (2005). "Role of ceramides in barrier function of healthy and diseased skin". American Journal of Clinical Dermatology 6 (4): pp. 215-23. http://www.ncbi.nlm.nih.gov/pubmed/16060709. 

·  ^ "New Skin-healing Chemicals". Science Daily. August 30, 2007. http://www.sciencedaily.com/releases/2007/08/070827184713.htm. Retrieved on 2007-10-06. 

·  ^ Corazza M, Virgili A (2005). "Allergic contact dermatitis from ophthalmic products: can pre-treatment with sodium lauryl sulfate increase patch test sensitivity?". Contact Derm. 52 (5): 239–41. doi:10.1111/j.0105-1873.2005.00606.x. PMID 15898995. 

·  ^ Murphy LA, White IR, Rastogi SC (2004). "Is hypoallergenic a credible term?". Clin. Exp. Dermatol. 29 (3): 325–7. doi:10.1111/j.1365-2230.2004.01521.x. PMID 15115531. 

·  ^ Carswell F, Thompson S (1986). "Does natural sensitisation in eczema occur through the skin?". Lancet 2 (8497): 13–5. doi:10.1016/S0140-6736(86)92560-2. PMID 2873316. 

·  ^ Henszel Ł, Kuźna-Grygiel W (2006). "[House dust mites in the etiology of allergic diseases]" (in Polish). Ann Acad Med Stetin 52 (2): 123–7. PMID 17633128. 

·  ^ Atopic Dermatitis at eMedicine

·  ^ Mihrshahi S, Marks G, Vanlaar C, Tovey E, Peat J (2002). "Predictors of high house dust mite allergen concentrations in residential homes in Sydney". Allergy 57 (2): 137–42. doi:10.1034/j.1398-9995.2002.5720999.x. PMID 11929416. 

·  ^ Causer SM, Lewis RD, Batek JM, Ong KH (2004). "Influence of wear, pile height, and cleaning method on removal of mite allergen from carpet". J Occup Environ Hyg 1 (4): 237–42. doi:10.1080/15459620490432169. PMID 15204862. 

·  ^ Wassenaar DP (1988). "Effectiveness of vacuum cleaning and wet cleaning in reducing house-dust mites, fungi and mite allergen in a cotton carpet: a case study". Exp. Appl. Acarol. 4 (1): 53–62. doi:10.1007/BF01213841. PMID 3378462. 

·  ^ Beck HI, Bjerring P, Harving H (1989). "Atopic dermatitis and the indoor climate. The effect from preventive measures". Acta Derm. Venereol. 69 (2): 162–5. PMID 2564236. 

·  ^ Polderman MC, Wintzen M, le Cessie S, Pavel S (2005). "UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center". Photodermatology, photoimmunology & photomedicine 21 (2): 93–6. doi:10.1111/j.1600-0781.2005.00150.x. PMID 15752127. 

·  ^ Stöppler MC (31 May 2007). "Psoriasis PUVA Treatment Can Increase Melanoma Risk". MedicineNet. http://www.medicinenet.com/script/main/art.asp?articlekey=548. Retrieved on 2007-10-17. 

·  ^ Stern RS (2001). "The risk of melanoma in association with long-term exposure to PUVA". J. Am. Acad. Dermatol. 44 (5): 755–61. doi:10.1067/mjd.2001.114576. PMID 11312420. 

·  ^ Kanny G (2005). "[Atopic dermatitis in children and food allergy: combination or causality? Should avoidance diets be initiated?]" (in French). Annales de dermatologie et de vénéréologie 132 Spec No 1: 1S90–103. PMID 15984300. 

·  ^ "Food Allergies Commonly Misdiagnosed, Especially Among Eczema Patients". March 16, 2009. http://www.nationaljewish.org/about/mediacenter/pressreleases/2009/food-allergies-commonly-misdiagnosed.aspx. Retrieved on 2009-03-20. 

·  ^ "Omega-3 can soothe eczema". Dermatology Times. March 27, 2008. http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Omega-3-can-soothe-eczema/ArticleStandard/Article/detail/505982?contextCategoryId=44290. Retrieved on 2008-04-23. 

·  ^ http://www.acupuncturetoday.com/archives2005/mar/03glick.html

·  ^ http://news.bbc.co.uk/2/hi/health/7291783.stm

·  ^ http://www.medicine.ox.ac.uk/bandolier/booth/alternat/AT021.html

·  ^ http://www.acupuncture.ca.gov/

·  ^ http://www.bad.org.uk/patients/disease/atopic/salt.asp

·  ^ "Sulfur". University of Maryland Medical Center. 4/1/2002. http://www.umm.edu/altmed/articles/000328.htm. Retrieved on 2007-10-15. 

·  ^ Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML (2008). "Probiotics for treating eczema". Cochrane Database Syst Rev (4): CD006135. doi:10.1002/14651858.CD006135.pub2. PMID 18843705. 

·  ^ EldredDC, Tuchin PJ (1999). "Treatment of acute atopic eczema by chiropractic care: a case study". Australas Chiropr Osteopathy 8 (3): 96–101. PMID 17987197. 

·  ^ Ricci G, Patrizi A, Bellini F, Medri M (2006). "Use of textiles in atopic dermatitis: care of atopic dermatitis" (PDF). Curr Probl Dermatol 33: 127–43. doi:10.1159/000093940. PMID 16766885. http://content.karger.com/ProdukteDB/Katalogteile/isbn3_8055/_81/_21/Biofunctional_Textiles_03.pdf. 

·  ^ Bridgett C (2000). "Psychodermatology and Atopic Skin Disease in London 1989-1999 - Helping Patients to Help Themselves". Dermatology and Psychosomatics 1 (4). doi:10.1159/000057975) (inactive 2008-06-25). 

·  ^ Bridgett C (2004). "Psychocutaneous medicine". Journal of cosmetic dermatology 3 (2): 116. doi:10.1111/j.1473-2130.2004.00047.x. PMID 17147570. 

·  ^ Walley AJ, Chavanas S, Moffatt MF, et al (2001). "Gene polymorphism in Netherton and common atopic disease". Nat. Genet. 29 (2): 175–8. doi:10.1038/ng728. PMID 11544479. 

·  ^ Palmer, C.N. et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 38(4), 441-6. PMID 16550169

·  ^ "'Blood chemicals link' to eczema -- Scientists have identified two blood chemicals linked to itchy eczema, offering new treatment possibilities.". BBC News. 26 August 2007. http://news.bbc.co.uk/2/hi/health/6962450.stm. Retrieved on 2007-10-16. 

·  ^ http://news.bbc.co.uk/1/hi/health/7955312.stm

·  ^ Kaiser J (2007). "Smallpox vaccine. A tame virus runs amok". Science 316 (5830): 1418–9. doi:10.1126/science.316.5830.1418. PMID 17556562.

·  ^ Dickerson FB, Boronow JJ, Stallings C, et al (March 2004). "Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder". Biol. Psychiatry 55 (6): 588–93. doi:10.1016/j.biopsych.2003.10.008. PMID 15013827. 

·  ^ Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (January 1997). "Herpes simplex virus type 1 in brain and risk of Alzheimer's disease". Lancet 349 (9047): 241–4. doi:10.1016/S0140-6736(96)10149-5. PMID 9014911. 

·  ^ a b c d e f g Gupta R, Warren T, Wald A (December 2007). "Genital herpes". Lancet 370 (9605): 2127–37. doi:10.1016/S0140-6736(07)61908-4. PMID 18156035. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)61908-4. 

·  ^ Brown ZA, Selke S, Zeh J, et al (August 1997). "The acquisition of herpes simplex virus during pregnancy". N Engl J Med. 337 (8): 509–15. doi:10.1056/NEJM199708213370801. PMID 9262493. http://content.nejm.org/cgi/content/full/337/8/509. 

·  ^ Fleming, Thomas R. (2008). "Linear erosive Herpes Simplex Virus infection in immunocompromised patients: the “Knife-Cut Sign”". Clin Infect Dis 47: 1440–1441. doi:10.1086/591390. 

·  ^ Takasu T, Furuta Y, Sato KC, Fukuda S, Inuyama Y, Nagashima K (1992). "Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia

by the polymerase chain reaction". Acta Otolaryngol. 112 (6): 1004–11. doi:10.3109/00016489209137502. PMID 1336296. 

·  ^ Sugita T, Murakami S, Yanagihara N, Fujiwara Y, Hirata Y, Kurata T (1995). "Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis". Ann. Otol. Rhinol. Laryngol. 104 (7): 574–81. PMID 7598372. 

·  ^ Lazarini PR, Vianna MF, Alcantara MP, Scalia RA, Caiaffa Filho HH (2006). "Herpes simplex virus in the saliva of peripheral Bell's palsy patients" (in Portuguese). Rev Bras Otorrinolaringol (Engl Ed) 72 (1): 7–11. PMID 16917546. 

·  ^ Linder T, Bossart W, Bodmer D (2005). "Bell's palsy and Herpes simplex virus: fact or mystery?". Otol. Neurotol. 26 (1): 109–13. doi:10.1097/00129492-200501000-00020. PMID 15699730. 

·  ^ Kanerva M, Mannonen L, Piiparinen H, Peltomaa M, Vaheri A, Pitkäranta A (2007). "Search for Herpesviruses in cerebrospinal fluid of facial palsy patients by PCR". Acta Otolaryngol. 127 (7): 775–9. doi:10.1080/00016480601011444. PMID 17573575. 

·  ^ Stjernquist-Desatnik A, Skoog E, Aurelius E (2006). "Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique". Ann. Otol. Rhinol. Laryngol. 115 (4): 306–11. PMID 16676828. 

·  ^ Tiemstra JD, Khatkhate N (2007). "Bell's palsy: diagnosis and management". Am Fam Physician 76 (7): 997–1002. PMID 17956069. 

·  ^ Middleton PJ, Peteric M, Kozak M, Rewcastle NB, McLachlan DR. (1980). "Herpes simplex viral genome and senile and presenile dementias of Alzheimer and Pick.". Lancet 315: 1038. doi:10.1016/S0140-6736(80)91490-7. 

·  ^ Dobson CB, Itzhaki RF (1999). "Herpes simplex virus type 1 and Alzheimer's disease". Neurobiol. Aging 20 (4): 457–65. doi:10.1016/S0197-4580(99)00055-X. PMID 10604441. http://linkinghub.elsevier.com/retrieve/pii/S0197-4580(99)00055-X. 

·  ^ Pyles RB (November 2001). "The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors". Herpes 8 (3): 64–8. PMID 11867022. http://www.ihmf.com/journal/download/83pyles(64)vol864.pdf. 

·  ^ Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (January 1997). "Herpes simplex virus type 1 in brain and risk of Alzheimer's disease". Lancet 349 (9047): 241–4. doi:10.1016/S0140-6736(96)10149-5. PMID 9014911. 

·  ^ Wozniak MA, Mee AP, Itzhaki RF (January 2009). "Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques". J Pathol. 217 (1): 131–8. doi:10.1002/path.2449. PMID 18973185. http://www3.interscience.wiley.com/journal/121411445/abstract. 

·  ^ Stumpf MP, Laidlaw Z, Jansen VA (2002). "Herpes viruses hedge their bets". Proc. Natl. Acad. Sci. U.S.A. 99 (23): 15234–7. doi:10.1073/pnas.232546899. PMID 12409612. http://www.pnas.org/content/99/23/15234. 

·  ^ Sainz B, Loutsch JM, Marquart ME, Hill JM (2001). "Stress-associated immunomodulation and herpes simplex virus infections". Med. Hypotheses 56 (3): 348–56. doi:10.1054/mehy.2000.1219. PMID 11359358. 

·  ^ http://www.sciencenews.org/view/generic/id/42223/title/How_herpes_re-rears_its_ugly_head_

·  ^ Myśliwska J, Trzonkowski P, Bryl E, Lukaszuk K, Myśliwski A (2000). "Lower interleukin-2 and higher serum tumor necrosis factor-a levels are associated with perimenstrual, recurrent, facial Herpes simplex infection in young women". Eur. Cytokine Netw. 11 (3): 397–406. PMID 11022124. 

·  ^ Segal AL, Katcher AH, Brightman VJ, Miller MF (1974). "Recurrent herpes labialis, recurrent aphthous ulcers, and the menstrual cycle". J. Dent. Res. 53 (4): 797–803. PMID 4526372. 

·  ^ Chambers A, Perry M (2008). "Salivary mediated autoinoculation of herpes simplex virus on the face in the absence of "cold sores," after trauma". J. Oral Maxillofac. Surg. 66 (1): 136–8. doi:10.1016/j.joms.2006.07.019. PMID 18083428. 

·  ^ Perna JJ, Mannix ML, Rooney JF, Notkins AL, Straus SE (1987). "Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model". J. Am. Acad. Dermatol. 17 (3): 473–8. doi:10.1016/S0190-9622(87)70232-1. PMID 2821086. 

·  ^ Rooney JF, Straus SE, Mannix ML, et al (1992). "UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir". J. Infect. Dis. 166 (3): 500–6. PMID 1323616. 

·  ^ Oakley C, Epstein JB, Sherlock CH (1997). "Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 (3): 272–8. doi:10.1016/S1079-2104(97)90342-5. PMID 9377190. 

·  ^ Ichihashi M, Nagai H, Matsunaga K (2004). "Sunlight is an important causative factor of recurrent herpes simplex". Cutis 74 (5 Suppl): 14–8. PMID 15603217. 

·  ^ Martinez V, Caumes E, Chosidow O (2008). "Treatment to prevent recurrent genital herpes". Curr Opin Infect Dis 21 (1): 42–48. doi:10.1097/QCO.0b013e3282f3d9d3. PMID 18192785. 

·  ^ "AHMF: Preventing Sexual Transmission of Genital herpes". http://www.ahmf.com.au/health_professionals/guidelines/preventing_gh_transmission.htm. Retrieved on 2008-02-24. 

·  ^ a b c d Leone P (2005). "Reducing the risk of transmitting genital herpes: advances in understanding and therapy". Curr Med Res Opin 21 (10): 1577–82. doi:10.1185/030079905X61901. PMID 16238897. 

·  ^ Kim H, Meier A, Huang M, Kuntz S, Selke S, Celum C, Corey L, Wald A (2006). "Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.". J Infect Dis 194 (4): 420–7. doi:10.1086/505879. PMID 16845624. 

·  ^ a b Mertz, G.J. (1993). "Epidemiology of genital herpes infections.". Infect Dis Clin North Am 7 (4): 825–39. PMID 8106731. 

·  ^ a b c Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, Tyring S, Douglas JM Jr, Corey L. (2001). "Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women". JAMA 285 (24): 3100–3106. doi:10.1001/jama.285.24.3100. PMID 11427138. http://jama.ama-assn.org/cgi/content/full/285/24/3100. 

·  ^ a b Casper C, Wald A. (2002). "Condom use and the prevention of genital herpes acquisition," (PDF). Herpes 9 (1): 10–14. PMID 11916494. http://www.ihmf.org/journal/download/91casper(10)vol910.pdf. 

·  ^ de Visser RO, Smith AM, Rissel CE, Richters J, Grulich AE. (2003). "Sex in Australia: safer sex and condom use among a representative sample of adults". Aust. N. Z. J. Public Health. 27 (2): 223–229. doi:10.1111/j.1467-842X.2003.tb00812.x. PMID 14696715. 

·  ^ Seppa, Nathan (2005-01-05). "One-Two Punch: Vaccine fights herpes with antibodies, T cells" (in English). Science News. pp. 5. http://www.sciencenews.org/articles/20050101/fob6.asp. Retrieved on 2007-03-29. 

·  ^ Carla K. Johnson (August 23, 2006). "Percentage of people with herpes drops". Associated Press. http://www.newsobserver.com/150/story/477928.html. 

·  ^ a b Kulhanjian JA, Soroush V, Au DS, et al (02 April 1992). "Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy". N. Engl. J. Med. 326 (14): 916–20. PMID 1311799. http://content.nejm.org/cgi/content/abstract/326/14/916. 

·  ^ Corey L, Wald A, Patel R, et al (January 2004). "Once-daily valacyclovir to reduce the risk of transmission of genital herpes". N Engl J Med. 350 (1): 11–20. doi:10.1056/NEJMoa035144. PMID 14702423. http://content.nejm.org/cgi/reprint/350/1/11.pdf. 

·  ^ Wald A, Langenberg AG, Krantz E, et al (November 2005). "The relationship between condom use and herpes simplex virus acquisition". Ann Intern Med. 143 (10): 707–13. PMID 16287791. http://www.annals.org/cgi/reprint/143/10/707. 

·  ^ Template:Ref journal

·  ^ Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L (2003). "Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant". JAMA 289: 203–209. 

·  ^ Brown ZA, Benedetti J, Ashley R et al. (1991). "Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor". N Engl J Med 324: 1247. 

·  ^ Whitley RJ, Kimberlin DW, Roizman B (1998). "Herpes simplex viruses". Clin Infect Dis 26 (3): 541–53. doi:10.1086/514600. PMID 9524821. http://www.journals.uchicago.edu/doi/pdf/10.1086/514600. 

·  ^ Brown ZA, Benedetti J, Ashley R, et al (May 1991). "Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor". N. Engl. J. Med. 324 (18): 1247–52. PMID 1849612. 

·  ^ Sobngwi‐Tambekou J, Taljaard D, Lissouba P, et al.. "Effect of HSV‐2 Serostatus on Acquisition of HIV by Young Men: Results of a Longitudinal Study in Orange Farm, South Africa". J Infect Dis 199: 958–964. doi:10.1086/597208. 

·  ^ Koelle DM, Corey L (2008). "Herpes Simplex: Insights on Pathogenesis and Possible Vaccines". Annu Rev Med 59: 381–395. doi:10.1146/annurev.med.59.061606.095540. PMID 18186706. 

·  ^ a b c d e f g h i Fatahzadeh M, Schwartz RA (2007). "Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management". J. Am. Acad. Dermatol. 57 (5): 737–63; quiz 764–6. doi:10.1016/j.jaad.2007.06.027. PMID 17939933. 

·  ^ Handsfield HH (2000). "Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?". Curr Infect Dis Rep 2 (1): 25–30. doi:10.1007/s11908-000-0084-y. PMID 11095834. 

·  ^ a b c d e f g h i j k l m Smith JS, Robinson NJ (2002). "Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review". J. Infect. Dis. 186 Suppl 1: S3–28. doi:10.1086/343739. PMID 12353183. http://www.journals.uchicago.edu/doi/full/10.1086/343739. 

·  ^ a b c d e f g h i j Patnaik P, Herrero R, Morrow RA, et al (2007). "Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study". Sex Transm Dis 34 (12): 1019–24. PMID 18080353. http://www.stdjournal.com/pt/re/std/abstract.00007435-200712000-00016.htm. 

·  ^ a b c Shin HS, Park JJ, Chu C, et al (2007). "Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part". J. Korean Med. Sci. 22 (6): 957–62. doi:10.3346/jkms.2007.22.6.957. PMID 18162706. 

·  ^ a b c d e Pebody RG, Andrews N, Brown D, et al (2004). "The seroepidemiology of herpes simplex virus type 1 and 2 in Europe". Sex Transm Infect 80 (3): 185–91. doi:10.1136/sti.2003.005850. PMID 15170000. http://sti.bmj.com/cgi/content/abstract/80/3/185. 

·  ^ Mertz GJ, Rosenthal SL, Stanberry LR (October 2003). "Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes?". Sex Transm Dis 30 (10): 801–2. doi:10.1097/01.OLQ.0000093080.55201.D1. PMID 14520182. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0148-5717&volume=30&issue=10&spage=801. 

·  ^ Roberts CM, Pfister JR, Spear SJ (2003). "Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students" (PDF). Sex Transm Dis 30 (10): 797–800. doi:10.1097/01.OLQ.0000092387.58746.C7. PMID 14520181. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200310000-00012.pdf. 

·  ^ Malkin JE (2004). "Epidemiology of genital herpes simplex virus infection in developed countries" (PDF). Herpes 11 Suppl 1: 2A–23A. PMID 15115626. http://www.ihmf.org/journal/download/11Malkin(2A)sup12A.pdf. 

·  ^ "Herpes simplex" (in English) (HTML). University of Maryland Medical Center. http://www.umm.edu/patiented/articles/who_gets_herpes_simplex_virus_000052_4.htm. Retrieved on 2007-09-03. 

·  ^ "LEARN ABOUT HERPES > Fast Facts" (in English) (HTML). ASHA Herpes Resource Center. http://www.ashastd.org/herpes/herpes_learn.cfm. Retrieved on 2007-09-03. 

·  ^ "STD Facts - Genital Herpes" (in English) (HTML). Centers for Disease Control and Prevention. http://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Retrieved on 2007-09-03. 

·  ^ "Herpes" (in English) (HTML). Stanford University Sexual Health Peer Resource Center. http://www.stanford.edu/group/SHPRC/ch4_her.html. Retrieved on 2007-09-03. 

·  ^ a b Howard M, Sellors JW, Jang D, et al (January 2003). "Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada". J Clin Microbiol. 41 (1): 84–9. doi:10.1128/JCM.41.1.84-89.2003. PMID 12517830. PMC: 149555. http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=12517830. 

·  ^ Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML (July 2001). "Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years". Sex Transm Dis 28 (7): 424–8. doi:10.1097/00007435-200107000-00011. PMID 11460028. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200107000-00011.htm. 

·  ^ Singh AE, Romanowski B, Wong T, et al (February 2005). "Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics". Sex Transm Dis 32 (2): 95–100. doi:10.1097/01.olq.0000151415.78210.85. PMID 15668615. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200502000-00006.htm. 

·  ^ Forward KR, Lee SH (March 2003). "Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia". Can J Infect Dis 14 (2): 94–6. PMID 18159431. 

·  ^ a b c Weiss H (2004). "Epidemiology of herpes simplex virus type 2 infection in the developing world". Herpes 11 Suppl 1: 24A–35A. PMID 15115627. 

·  ^ Loutfy SA, Alam El-Din HM, Ibrahim MF, Hafez MM (2006). "Seroprevalence of herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt Kundi". Saudi Med J 27 (8): 1139–45. PMID 16883441. 

·  ^ Meguenni S, Djenaoui T, Bendib A, et al (1989). "Herpes simplex virus infections in Algiers" (in French). Arch Inst Pasteur Alger 57: 61–72. PMID 2562258. 

·  ^ Smith JS, Herrero R, Muñoz N, et al (2001). "Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines". Sex Transm Dis 28 (4): 187–94. doi:10.1097/00007435-200104000-00001. PMID 11318248. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200104000-00001.htm. 

·  ^ Kaur R, Gupta N, Baveja UK (2005). "Seroprevalence of HSV1 and HSV2 infections in family planning clinic attenders". J Commun Dis 37 (4): 307–9. PMID 17278662. 

·  ^ a b Dolar N, Serdaroglu S, Yilmaz G, Ergin S (2006). "Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey". J Eur Acad Dermatol Venereol 20 (10): 1232–6. doi:10.1111/j.1468-3083.2006.01766.x. PMID 17062037. 

·  ^ Abuharfeil N, Meqdam MM (2000). "Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan". New Microbiol. 23 (3): 235–9. PMID 10939038. 

·  ^ Davidovici BB, Grotto I, Balicer RD, Robinson NJ, Cohen D (November 2006). "Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002" (PDF). Sex Transm Dis 33 (11): 641–5. doi:10.1097/01.olq.0000216068.01028.38. PMID 16614586. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200611000-00001.pdf. 

·  ^ a b Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D (2006). "Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel". J. Infect. 52 (5): 367–73. doi:10.1016/j.jinf.2005.08.005. PMID 16213591. 

·  ^ Dan M, Sadan O., Glezerman M, Raveh D, Samra Z (2003). "Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel" (PDF). Sex Transm Dis 30(11): 835–8. PMID 14603091. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200311000-00007.pdf. 

·  ^ Feldman PA, Steinberg J, Madeb R, et al (September 2003). "Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel" (PDF). Isr. Med. Assoc. J. 5 (9): 626–8. PMID 14509150. http://www.ima.org.il/imaj/ar03sep-5.pdf. 

·  ^ Samra Z, Scherf E, Dan M (2003). "Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel". Sex Transm Dis 30 (10): 794–6. doi:10.1097/01.OLQ.0000079517.04451.79. PMID 14520180. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200310000-00011.htm. 

·  ^ Ibrahim AI, Kouwatli KM, Obeid MT (2000). "Frequency of herpes simplex virus in Syria based on type-specific serological assay". Saudi Med J 21 (4): 355–60. PMID 11533818. 

·  ^ a b c Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A (2006). "Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey". Sex Transm Infect 82 (2): 164–8. doi:10.1136/sti.2005.016899. PMID 16581748. http://sti.bmj.com/cgi/content/abstract/82/2/164. 

·  ^ a b Haddow LJ, Dave B, Mindel A, et al (2006). "Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003". Sex Transm Infect 82 (3): 255–9. doi:10.1136/sti.2005.018176. PMID 16731681. http://sti.bmj.com/cgi/content/abstract/82/3/255. 

·  ^ Lyttle PH (1994). "Surveillance report: disease trends at New Zealand sexually transmitted disease clinics 1977-1993". Genitourin Med 70 (5): 329–35. PMID 8001945. 

·  ^ "Local anesthetic creams". BMJ 297 (6661): 1468. 1988. PMID 3147021. 

·  ^ Kaminester LH, Pariser RJ, Pariser DM, et al (1999). "A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis". J. Am. Acad. Derm 41 (6): 996–1001. doi:10.1016/S0190-9622(99)70260-4. PMID 10570387. 

·  ^ a b Chow AW, Roland A, Fiala M, et al (March 1973). "Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients". Antimicrob. Agents Chemother. 3 (3): 412–7. PMID 4790599. PMC: 444424. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=4790599. 

·  ^ Kaufman HE, Howard GM (August 1962). "Therapy of experimental herpes simplex keratitis". Invest Ophthalmol 1: 561–4. PMID 14454441. http://www.iovs.org/cgi/pmidlookup?view=long&pmid=14454441. 

·  ^ Ch'ien LT, Whitley RJ, Alford CA, Galasso GJ (June 1976). "Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study". J. Infect. Dis. 133 Suppl: A184–91. PMID 180198. 

·  ^ McKelvey EM, Kwaan HC (November 1969). "Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia". Blood 34 (5): 706–11. PMID 5352659. http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=5352659. 

·  ^ Fiala M, Chow A, Guze LB (April 1972). "Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains". Antimicrob. Agents Chemother. 1 (4): 354–7. PMID 4364937. PMC: 444221. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=4364937. 

·  ^ Allen LB, Hintz OJ, Wolf SM, et al (June 1976). "Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice". J. Infect. Dis. 133 Suppl: A178–83. PMID 6598. 

·  ^ Juel-Jensen BE (March 1970). "Varicella and cytosine arabinoside". Lancet 1 (7646): 572. doi:10.1016/S0140-6736(70)90815-9. PMID 4190397. 

·  ^ Nahmias AJ, Kibrick S (May 1964). "Inhibitory effect of heparin on herpes simplex virus". J. Bacteriol. 87 (5): 1060–6. PMID 4289440. PMC: 277146. http://jb.asm.org/cgi/pmidlookup?view=long&pmid=4289440. 

·  ^ Allen LB, Sidwell RW (September 1972). "Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine". Antimicrob. Agents Chemother. 2 (3): 229–33. PMID 4790562. PMC: 444296. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=4790562. 

·  ^ Allen LB, Wolf SM, Hintz CJ, Huffman JH, Sidwell RW (March 1977). "Effect of ribavirin on Type 2 Herpesvirus hominis (HVH/2) in vitro and in vivo". Ann. N. Y. Acad. Sci. 284: 247–53. doi:10.1111/j.1749-6632.1977.tb21957.x. PMID 212976. 

·  ^ Allen LB, Cochran KW (November 1972). "Target-organ treatment of neurotropic virus disease with interferon inducers". Infect. Immun. 6 (5): 819–23. PMID 4404669. PMC: 422616. http://iai.asm.org/cgi/pmidlookup?view=long&pmid=4404669. 

·  ^ Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK (August 1972). "Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide". Science (journal) 177 (50): 705–6. PMID 4340949. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=4340949. 

·  ^ Babiuk LA, Meldrum B, Gupta VS, Rouse BT (December 1975). "Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside". Antimicrob. Agents Chemother. 8 (6): 643–50. PMID 1239978. PMC: 429441. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=1239978. 

·  ^ O'Meara A, Deasy PF, Hillary IB, Bridgen WD (December 1979). "Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemia". Lancet 2 (8153): 1196. doi:10.1016/S0140-6736(79)92428-0. PMID 91931. 

·  ^ Whitley R, Arvin A, Prober C, et al (February 1991). "A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group". N. Engl. J. Med. 324 (7): 444–9. PMID 1988829. http://content.nejm.org/cgi/content/abstract/324/7/444. 

·  ^ a b c Kimberlin DW, Lin CY, Jacobs RF, et al (August 2001). "Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections". Pediatrics 108 (2): 230–8. doi:10.1542/peds.108.2.230. PMID 11483782. http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=11483782. 

·  ^ a b De Clercq E, Field HJ (2006). "Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy". Br. J. Pharmacol. 147 (1): 1–11. doi:10.1038/sj.bjp.0706446. PMID 16284630. 

·  ^ Leung DT, Sacks SL. (2003). "Current treatment options to prevent perinatal transmission of herpes simplex virus". Expert Opin. Pharmacother. 4 (10): 1809–1819. doi:10.1517/14656566.4.10.1809. PMID 14521490. 

·  ^ The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment"[1]"

·  ^ Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study"[2]"

·  ^ Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy"[3]"

·  ^ Observation May Indicate A Possible Clinical Effect On Latency"[4]"

·  ^ Thackray AM, Field HJ. (1996). "Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency". J. Infect. Dis. 173 (2): 291–299. PMID 8568288. 

·  ^ Worrall G (06 Jul 1996). "Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak". BMJ 313 (7048): 46. PMID 8664786. http://www.bmj.com/cgi/content/full/313/7048/46/a. 

·  ^ Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R (1997). "Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group". JAMA 277 (17): 1374–9. doi:10.1001/jama.277.17.1374. PMID 9134943. http://jama.ama-assn.org/cgi/content/abstract/277/17/1374. 

·  ^ "Drug Name: ABREVA (docosanol) - approval". centerwatch.com. July 2000. http://www.centerwatch.com/patient/drugs/dru627.html. Retrieved on 2007-10-17. 

·  ^ "California Court Upholds Settlement Of Class Action Over Cold Sore Medicationl". BNA Inc.. July 2000. http://subscript.bna.com/SAMPLES/plp.nsf/85256269004a991e8525611300214487/29d5bb623a50fd25852572ad0074f772?OpenDocument. Retrieved on 2007-10-17. 

·  ^ Bishop, C.D. (1995). "Anti-viral Activity of the Essential Oil of Melaleuca alternifolia". Journal of Essential Oil Research: 641–644. 

·  ^ De Bony F, Tod M, Bidault R, On NT, Posner J, Rolan P. (2002). "Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir". Antimicrob. Agents Chemother. 46 (2): 458–463. doi:10.1128/AAC.46.2.458-463.2002. PMID 11796358. 

·  ^ Karadi I, Karpati S, Romics L. (1998). "Aspirin in the management of recurrent herpes simplex virus infection". Ann. Intern. Med. 128 (8): 696–697. PMID 9537952. 

·  ^ Gebhardt BM, Varnell ED, Kaufman HE. (2004). "Acetylsalicylic acid reduces viral shedding induced by thermal stress". Curr. Eye Res. 29 (2-3): 119–125. doi:10.1080/02713680490504588. PMID 15512958. 

·  ^ a b c d e "Herpevac Trial for Women". http://www.niaid.nih.gov/dmid/stds/herpevac/. Retrieved on 2008-02-25. 

·  ^ "Molecular Therapy - Abstract of article: 801. RNA Gene Therapy Targeting Herpes Simplex Virus". http://www.nature.com/mt/journal/v13/n1s/abs/mt2006942a.html. 

·  ^ Perfect MM, Bourne N, Ebel C, Rosenthal SL (2005). "Use of complementary and alternative medicine for the treatment of genital herpes". Herpes 12 (2): 38–41. PMID 16209859. 

·  ^ McCune MA, Perry HO, Muller SA, O'Fallon WM. (2005). "Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride". Cutis. 34 (4): 366–373. PMID 6435961. 

·  ^ Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A. (1987). "Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis". Dermatologica. 175 (4): 183–190. PMID 3115841. 

·  ^ Griffith RS, Norins AL, Kagan C. (1978). "A multicentered study of lysine therapy in Herpes simplex infection". Dermatologica. 156 (5): 257–267. PMID 640102. 

·  ^ Vogler BK and Ernst E.. "Aloe vera: a systematic review of its clinical effectiveness.". British Journal of General Practice 49: 823–828. http://www.jr2.ox.ac.uk/bandolier/booth/alternat/AT125.html. 

·  ^ Allahverdiyev A, Duran N, Ozguven M, Koltas S. (2004). "Antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type-2.". Phytomedicine. 11 (7-8): 657–661. doi:10.1016/j.phymed.2003.07.014. PMID 15636181. 

·  ^ a b Koytchev R, Alken RG, Dundarov S (1999). "Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis". Phytomedicine 6 (4): 225–30. PMID 10589440. 

·  ^ Zacharopoulos VR, Phillips DM. (1997). "Vaginal formulations of carrageenan protect mice from herpes simplex virus infection". Clin. Diagn. Lab. Immunol. 4 (4): 465–468. PMID 9220165. 

·  ^ Carlucci MJ, Scolaro LA, Damonte EB. (1999). "Inhibitory action of natural carrageenans on Herpes simplex virus infection of mouse astrocytes". Chemotherapy 45 (6): 429–436. doi:10.1159/000007236. PMID 10567773. 

·  ^ Binns SE, Hudson J, Merali S, Arnason JT (2002). "Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I)". Planta Med. 68 (9): 780–3. doi:10.1055/s-2002-34397. PMID 12357386. 

·  ^ Vonau B, Chard S, Mandalia S, Wilkinson D, Barton SE (2001). "Does the extract of the plant Echinacea purpurea influence the clinical course of recurrent genital herpes?". Int J STD AIDS 12 (3): 154–8. doi:10.1258/0956462011916947. PMID 11231867. 

·  ^ Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL. (1999). "Resveratrol inhibition of herpes simplex virus replication". Antiviral Res. 43 (3): 145–155. doi:10.1016/S0166-3542(99)00042-X. PMID 10551373. 

·  ^ Docherty JJ, Smith JS, Fu MM, Stoner T, Booth T. (2004). "Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice". Antiviral Res. 61 (1): 19–26. doi:10.1016/j.antiviral.2003.07.001. PMID 14670590. 

·  ^ Weber ND, Andersen DO, North JA, Murray BK, Lawson LD, Hughes BG (1992). "In vitro virucidal effects of Allium sativum (garlic) extract and compounds". Planta Med. 58 (5): 417–23. doi:10.1055/s-2006-961504. PMID 1470664. 

·  ^ Chiu LC, Zhub W, Oo VE (2004). "A polysaccharide fraction from medicinal herb Prunella vulgaris downregulates the expression of herpes simplex virus antigen in Vero cells". Journal of Ethnopharmacology 93 (1): 63–68. doi:10.1016/j.jep.2004.03.024. 

·  ^ Andersen JH, Jenssen H, Gutteberg TJ. (2003). "Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir". Antiviral Res. 58 (3): 209–215. doi:10.1016/S0166-3542(02)00214-0. PMID 12767468. 

·  ^ Gaby AR (2006). "Natural remedies for Herpes simplex". Altern Med Rev 11 (2): 93–101. PMID 16813459. 

·  ^ Yazici AC, Baz K, Ikizoglu G (2006). "Recurrent herpes labialis during isotretinoin therapy: is there a role for photosensitivity?". J Eur Acad Dermatol Venereol 20 (1): 93–5. doi:10.1111/j.1468-3083.2005.01358.x. PMID 16405618. 

·  ^ Snipes W, Person S, Keith A, Cupp J (April 1975). "Butylated hydroxytoluene inactivated lipid-containing viruses". Science 188 (4183): 64–6. doi:10.1126/science.163494. PMID 163494. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=163494. 

·  ^ Richards JT, Katz ME, Kern ER (October 1985). "Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs". Antiviral Res. 5 (5): 281–90. doi:10.1016/0166-3542(85)90042-7. PMID 2998276. http://linkinghub.elsevier.com/retrieve/pii/0166-3542(85)90042-7. 

·  ^ Vezina C, Steben M. (2001). "Genital Herpes: Psychosexual Impacts and Counselling" (PDF). The Canadian Journal of CME (June): 125–34. http://www.stacommunications.com/journals/cme/images/cmepdf/june01/hsv.pdf. 

·  ^ "HWerks.com Herpes Dating, HPV Dating, Information, Events and Support Community". http://www.HWerks.com. 

·  ^ "NationalHClub.com Local and National Herpes Events". http://www.NationalHClub.com. 

·  ^ "A to Z Herpes Support Groups". http://www.herpesaz.com/html/groups.html. 

·  ^ "Herpes Support Groups". http://www.herpes-coldsores.com/support/herpes.htm. 

·  ^ "Herpes Viruses Association". http://www.herpes.org.uk. 

·  ^ "Herpes & Cold Sore Support Forum". http://www.herpes-coldsores.com/messageforum. 

·  ^ "Herpes Dating H-Date.com - genital herpes dating/HPV picture". http://www.h-date.com. 

·  ^ "Herpes Dating, HPV Dating, and Support on Antopia's MPwH.net". http://www.mpwh.net/. 

·  ^ Green J, Ferrier S, Kocsis A, Shadrick J, Ukoumunne OC, Murphy S, Hetherton J. (2003). "Determinants of disclosure of genital herpes to partners.". Sex. Transm. Infect. 79 (1): 42–44. doi:10.1136/sti.79.1.42. PMID 12576613. http://sti.bmj.com/cgi/content/full/79/1/42.

·  ^ a b c d e Johnson, RW & Dworkin, RH (2003). "Clinical review: Treatment of herpes zoster and postherpetic neuralgia". BMJ 326 (7392): 748. doi:10.1136/bmj.326.7392.748. PMID 12676845. http://www.bmj.com/cgi/content/full/326/7392/748. 

·  ^ a b Kennedy PG (2002). "Varicella-zoster virus latency in human ganglia". Rev. Med. Virol. 12 (5): 327–34. doi:10.1002/rmv.362. PMID 12211045. 

·  ^ Peterslund NA (1991). "Herpesvirus infection: an overview of the clinical manifestations". Scand J Infect Dis Suppl 80: 15–20. PMID 1666443. 

·  ^ a b Gilden DH, Cohrs RJ, Mahalingam R (2003). "Clinical and molecular pathogenesis of varicella virus infection". Viral Immunol 16 (3): 243–58. doi:10.1089/088282403322396073. PMID 14583142. 

·  ^ a b c d e f Dworkin RH, Johnson RW, Breuer J et al. (2007). "Recommendations for the management of herpes zoster". Clin. Infect. Dis 44 Suppl 1: S1–26. doi:10.1086/510206. PMID 17143845. http://www.journals.uchicago.edu/doi/full/10.1086/510206. 

·  ^ a b Donahue JG, Choo PW, Manson JE, Platt R (1995). "The incidence of herpes zoster". Arch. Intern. Med 155 (15): 1605–9. doi:10.1001/archinte.155.15.1605. PMID 7618983. 

·  ^ a b Araújo LQ, Macintyre CR, Vujacich C (2007). "Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America" (PDF). Herpes 14 (Suppl 2): 40A–4A. PMID 17939895. http://www.ihmf.org/journal/download/5%20-%20Herpes%2014.2%20suppl%20Araujo.pdf. 

·  ^ a b Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, Levin MJ, Macintyre CR (2008). "The prevention and management of herpes zoster". Med. J. Aust. 188 (3): 171–6. PMID 18241179. 

mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman";} ·  ^ Zamula E (2001). "Shingles: An Unwelcome Encore". FDA Consum 35 (3): 21–5. PMID 11458545. http://www.fda.gov/fdac/features/2001/301_pox.html. Retrieved on 2007-12-15.  Revised June 2005.

·  ^ a b c d e Stankus SJ, Dlugopolski M, Packer D (2000). "Management of herpes zoster (shingles) and postherpetic neuralgia". Am Fam Physician 61 (8): 2437–44, 2447–8. PMID 10794584. http://www.aafp.org/afp/20000415/2437.html. 

·  ^ Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH (2004). "Acute pain in herpes zoster and its impact on health-related quality of life". Clin. Infect. Dis 39 (3): 342–8. doi:10.1086/421942. PMID 15307000. http://www.journals.uchicago.edu/doi/full/10.1086/421942. 

·  ^ Furuta Y, Ohtani F, Mesuda Y, Fukuda S, Inuyama Y (2000). "Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy". Neurology 55 (5): 708–10. PMID 10980741. 

·  ^ Shaikh S, Ta CN (2002). "Evaluation and management of herpes zoster ophthalmicus". Am Fam Physician 66 (9): 1723–1730. PMID 12449270. http://www.aafp.org/afp/20021101/1723.html. 

·  ^ Oranje AP, Folkers E (1988). "The Tzanck smear: old, but still of inestimable value". Pediatr Dermatol 5 (2): 127–9. doi:10.1111/j.1525-1470.1988.tb01154.x. PMID 2842739. 

·  ^ Chan J, Bergstrom RT, Lanza DC, Oas JG (2004). "Lateral sinus thrombosis associated with zoster sine herpete". Am J Otolaryngol 25 (5): 357–60. doi:10.1016/j.amjoto.2004.03.007. PMID 15334402. 

·  ^ Arvin AM (1996). "Varicella-zoster virus" (PDF). Clin. Microbiol. Rev 9 (3): 361–81. PMID 8809466. http://cmr.asm.org/cgi/reprint/9/3/361.pdf. 

·  ^ Beards G, Graham C, Pillay D (1998). "Investigation of vesicular rashes for HSV and VZV by PCR". J. Med. Virol 54 (3): 155–7. doi:10.1002/(SICI)1096-9071(199803)54:3<155::AID-JMV1>3.0.CO;2-4. PMID 9515761. 

·  ^ Stránská R, Schuurman R, de Vos M, van Loon AM. (2003). "Routine use of a highly automated and internally controlled real-time PCR assay for the diagnosis of herpes simplex and varicella-zoster virus infections". J Clin Virol. 30 (1): 39–44. doi:10.1016/j.jcv.2003.08.006. PMID 15072752. 

·  ^ a b Steiner I, Kennedy PG, Pachner AR (2007). "The neurotropic herpes viruses: herpes simplex and varicella-zoster". Lancet Neurol 6 (11): 1015–28. doi:10.1016/S1474-4422(07)70267-3. PMID 17945155. 

·  ^ a b Weinberg JM (2007). "Herpes zoster: epidemiology, natural history, and common complications". J Am Acad Dermatol 57 (6 Suppl): S130–5. doi:10.1016/j.jaad.2007.08.046. PMID 18021864. 

·  ^ Kennedy PG (2002). "Key issues in varicella-zoster virus latency". J. Neurovirol 8 Suppl 2: 80–4. doi:10.1080/13550280290101058. PMID 12491156. 

·  ^ Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PG (2003). "Herpes simplex virus-1 and varicella-zoster virus latency in ganglia" (PDF). J. Neurovirol 9 (2): 194–204. doi:10.1080/713831492. PMID 12707850. http://www.jneurovirol.com/o_pdf/9(2)/194-204.pdf. 

·  ^ a b c Thomas SL, Hall AJ (2004). "What does epidemiology tell us about risk factors for herpes zoster?". Lancet Infect Dis 4 (1): 26–33. doi:10.1016/S1473-3099(03)00857-0. PMID 14720565. 

·  ^ Schmader K (2007). "Herpes zoster and postherpetic neuralgia in older adults". Clin. Geriatr. Med. 23 (3): 615–32, vii–viii. doi:10.1016/j.cger.2007.03.003. PMID 17631237. http://linkinghub.elsevier.com/retrieve/pii/S0749-0690(07)00021-3. 

·  ^ Schmader K (1999). "Herpes zoster in the elderly: issues related to geriatrics". Clin. Infect. Dis 28 (4): 736–9. doi:10.1086/515205. PMID 10825029. 

·  ^ Paryani SG, Arvin AM (1986). "Intrauterine infection with varicella-zoster virus after maternal varicella". N. Engl. J. Med. 314 (24): 1542–6. PMID 3012334. 

·  ^ Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994). "Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases". Lancet 343 (8912): 1548–51. doi:10.1016/S0140-6736(94)92943-2. PMID 7802767. 

·  ^ Sørensen HT, Olsen JH, Jepsen P, Johnsen SP, Schønheyder HC, Mellemkjaer L (2004). "The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study". Br. J. Cancer 91 (7): 1275–9. doi:10.1038/sj.bjc.6602120. PMID 15328522. 

·  ^ Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO (1982). "Risk of cancer after herpes zoster: a population-based study". N. Engl. J. Med. 307 (7): 393–7. PMID 6979711. 

·  ^ a b c Tyring SK (2007). "Management of herpes zoster and postherpetic neuralgia". J Am Acad Dermatol 57 (6 Suppl): S136–42. doi:10.1016/j.jaad.2007.09.016. PMID 18021865. 

·  ^ Breuer J, Whitley R (2007). "Varicella zoster virus: natural history and current therapies of varicella and herpes zoster" (PDF). Herpes 14 (Suppl 2): 25–9. PMID 17939892. http://www.ihmf.org/journal/download/2%20-%20Herpes%2014.2%20suppl%20Breuer.pdf. 

·  ^ Baron R (2004). "Post-herpetic neuralgia case study: optimizing pain control". Eur. J. Neurol 11 Suppl 1: 3–11. doi:10.1111/j.1471-0552.2004.00794.x. PMID 15061819. 

·  ^ a b Whitley RJ, Weiss H, Gnann JW, Tyring S, Mertz GJ, Pappas PG, Schleupner CJ, Hayden F, Wolf J, Soong SJ (1996). "Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group". Ann. Intern. Med. 125 (5): 376–83. PMID 8702088. 

·  ^ Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T (2000). "Comparison of the Efficacy and Safety of Valaciclovir and Acyclovir for the Treatment of Herpes zoster Ophthalmicus". Ophthalmology 107 Number 8: 1507–11. doi:10.1016/S0161-6420(00)00222-0. PMID 10919899. 

·  ^ Osterberg L, Blaschke T (2005). "Adherence to medication". N Engl J Med 353 (5): 487–97. doi:10.1056/NEJMra050100. PMID 16079372. 

·  ^ Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al. (2005). "A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults". N Engl J Med 253 (22): 2271–84. doi:10.1056/NEJMoa051016. PMID 15930418. 

·  ^ Pellissier JM, Brisson M, Levin MJ (2007). "Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults". Vaccine 25 (49): 8326–37. doi:10.1016/j.vaccine.2007.09.066. PMID 17980938. 

·  ^ Advisory Committee on Immunization Practices (20 Nov 2007). "Recommended adult immunization schedule: United States, October 2007–September 2008". Ann Intern Med 147 (10): 725–9. PMID 17947396. http://www.annals.org/cgi/content/full/147/10/725. 

·  ^ Brisson M, Gay N, Edmunds W, Andrews N (2002). "Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox". Vaccine 20 (19–20): 2500–7. doi:10.1016/S0264-410X(02)00180-9. PMID 12057605. 

·  ^ NHS Direct (2008-02-07). "Why isn’t the chickenpox vaccine available in the UK?". http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=1032. Retrieved on 2008-03-22. 

·  ^ Health Protection Agency (2006-05-11). "Chickenpox / Varicella — General Information". http://www.hpa.org.uk/infections/topics_az/chickenpox/gen_info.htm. Retrieved on 2008-03-22. 

·  ^ Thomas SL, Wheeler JG, Hall AJ (2006). "Micronutrient intake and the risk of herpes zoster: a case-control study". Int J Epidemiol 35 (2): 307–14. doi:10.1093/ije/dyi270. PMID 16330478. http://ije.oxfordjournals.org/cgi/content/full/35/2/307. 

·  ^ Apisarnthanarak A, Kitphati R, Tawatsupha P, Thongphubeth K, Apisarnthanarak P, Mundy LM (2007). "Outbreak of varicella-zoster virus infection among Thai healthcare workers". Infect Control Hosp Epidemiol 28 (4): 430–4. doi:10.1086/512639. PMID 17385149. 

·  ^ Abendroth A, Arvin AM (2001). "Immune evasion as a pathogenic mechanism of varicella zoster virus". Semin. Immunol. 13 (1): 27–39. doi:10.1006/smim.2001.0293. PMID 11289797. 

·  ^ Strangfeld A, Listing J; Herzer P; et al. (2009). "Risk of herpes zoster in patients with rheumatoid arthritis treated With anti–TNF-α agents". J Am Med Assoc 301 (7): 737–744. doi:10.1001/jama.2009.146. PMID 19224750. 

·  ^ a b Weller TH (1997). "Varicella-herpes zoster virus". in Evans AS, Kaslow RA. Viral Infections of Humans: Epidemiology and Control. Plenum Press. pp. 865–92. ISBN 978-0306448553. 

·  ^ Wharton M (1996). "The epidemiology of varicella-zoster virus infections". Infect Dis Clin North Am 10 (3): 571–81. doi:10.1016/S0891-5520(05)70313-5. PMID 8856352. 

·  ^ Insinga RP (2005). "The incidence of herpes zoster in a United States administrative database". J Gen Intern Med 20 (6): 748–753. doi:10.1111/j.1525-1497.2005.0150.x. PMID 16050886. 

·  ^ Marin M, Güris D, Chaves SS, Schmid S, Seward JF (2007). "Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep 56 (RR-4): 1–40. PMID 17585291. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm. 

·  ^ Volpi A (2007). "Severe complications of herpes zoster" (PDF). Herpes 14 (Suppl 2): 35A–9A. PMID 17939894. http://www.ihmf.org/journal/download/4%20-%20Herpes%2014.2%20suppl%20Volpi.pdf. 

·  ^ Coplan P, Black S, Rojas C (2001). "Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease". Pediatr Infect Dis J 20 (7): 641–5. doi:10.1097/00006454-200107000-00002. PMID 11465834. 

·  ^ Weaver BA (01 Mar 2007). "The burden of herpes zoster and postherpetic neuralgia in the United States". J Am Osteopath Assoc 107 (3 Suppl): S2–7. PMID 17488884. http://www.jaoa.org/cgi/content/full/107/suppl_1/S2. 

·  ^ Hicks LD, Cook-Norris RH, Mendoza N, Madkan V, Arora A, TyringSK (May 2008). "Family history as a risk factor for herpes zoster: a case-control study". Arch Dermatol 144 (5): 603–8. doi:10.1001/archderm.144.5.603. PMID 18490586. 

·  ^ Weller TH (2000). "Chapter 1. Historical perspective". in Arvin AM, Gershon AA. Varicella-Zoster Virus: Virology and Clinical Management. CambridgeUniversity Press. ISBN 0521660246. 

·  ^ Oaklander AL (October 1999). "The pathology of shingles: Head and Campbell's 1900 monograph". Arch. Neurol. 56 (10): 1292–4. PMID 10520948. 

·  ^ Weller TH (1953). "Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster". Proc. Soc. Exp. Biol. Med. 83 (2): 340–6. PMID 13064265. 

·  ^ Holt LE, McIntosh R (1936). Holt's Diseases of Infancy and Childhood. D Appleton Century Company. pp. 931–3. 

·  ^ Hope-Simpson RE (1965). "The nature of herpes zoster; a long-term study and a new hypothesis". Proc R Soc Med 58: 9–20. PMID 14267505.

^ Impetigo - school sores - Better Health Channel
^ a b Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 843 ISBN 978-1-4160-2973-1
^ Stulberg DL, Penrod MA, Blatny RA (2002). "Common bacterial skin infections. In Japanese, this is known as Tobihi.". American family physician 66 (1): 119–24. PMID 12126026. http://www.aafp.org/afp/20020701/119.html. 
^ http://www.bmj.com/cgi/content/full/329/7472/979
·  ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.

·  ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.

·  ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.

·  ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.

·  ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.

·  ^ http://www.cdc.gov/scabies

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Arlian, L. Biology, Host Relations and Epidemiology of Sarcoptes Scabiei. Ann. Rev. Entomol 1989; 34:139-61. 5 Feb. 2009 <http://arjournals.annualreviews.org/doi/pdf/10.1146/annurev.en.34.010189.001035?cookieSet=1>

·  ^ Scheinfeld NS (2004). "Controlling scabies in institutional settings: a review of medications, treatment models, and implementation". Amer J Clin Dermatol 5 (1): 31–7. doi:10.2165/00128071-200405010-00005. PMID 14979741. 

·  ^ Permethrin Factsheet (PDF)

·  ^ http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202170.html

·  ^ FDA Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Lice

·  ^ "Lindane Post Marketing Safety Review" (PDF). U.S. Food and Drug Administration (FDA). 2003. http://www.fda.gov/cder/drug/infopage/lindane/lindaneaeredacted.pdf. 

·  ^ a b c http://www.fda.gov/cder/foi/label/2003/006309lotionlbl.pdf.

·  ^ Commission for Environmental Cooperation. North American Regional Action Plan (NARAP) on lindane and other hexachlorocyclohexane (HCH) isomers. November 30, 2006.

·  ^ U.S. EPA. Assessment of lindane and other hexachlorocyclohexane isomers. February 8, 2006

·  ^ Medication Guide Lindane Lotion USP, 1%. Updated March 28, 2003.

·  ^ Lin AN, Reimer RJ, Carter DM (1988). "Sulfur revisited". J Am Acad Dermatol 18: 553–58. doi:10.1016/S0190-9622(88)70079-1. 

·  ^ Pruksachatkunakorn C, Damrongsak M, Sinthupuan S (2002). "Sulfur for Scabies Outbreaks in Orphanages". Pediatric Dermatology 19 (5): 448–53. doi:10.1046/j.1525-1470.2002.00205.x. http://www3.interscience.wiley.com/journal/118919953/abstract. Retrieved on 2008-08-01. 

·  ^ Heinrich M, et al. (2005). "Plants as Medicines". in Prance G, Nesbitt M. The Cultural History of Plants. London: Routledge. pp. 228. ISBN 0415927463. 

·  ^ Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ (May 2004). "Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol". Arch Dermatol 140 (5): 563–6. doi:10.1001/archderm.140.5.563. PMID 15148100. 

·  ^ Apgar B (January 15, 2000). "Efficacy and Safety of Therapy for Human Scabies Infestation". American Family Physician. http://www.aafp.org/afp/20000115/tips/15.html. 
Chouela EN, Abeldaño AM, Pellerano G, et al (June 1999). "Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies". Arch Dermatol 135 (6): 651–5. doi:10.1001/archderm.135.6.651. PMID 10376691. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=10376691. 
Strong M, Johnstone PW (2007). "Interventions for treating scabies". Cochrane Database Syst Rev (3): CD000320. doi:10.1002/14651858.CD000320.pub2. PMID 17636630. 

·  ^ Borsboom GJ, Boatin BA, Nagelkerke NJ, et al (March 2003). "Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa". Filaria J 2 (1): 8. doi:10.1186/1475-2883-2-8. PMID 12769825. PMC: 156613. http://www.filariajournal.com/content/2/1/8. 

·  ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.

·  ^ Green, M. Epidemiology of Scabies. Epidemiological Reviews 1989; 11:126-150. 5 Feb. 2009 <http://epirev.oxfordjournals.org/cgi/reprint/11/1/126>.

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge’s Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.

·  ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.

·  ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Chakrabarti A (1985). "Some epidemiological aspects of animal scabies in human population". Int J Zoonoses 12 (1): 39–52. PMID 4055268. 

·  ^ Ulmer A, Schanz S, Röcken M, Fierlbeck G (2007). "A papulovesicular rash in a farmer and his wife". Clin Infect Dis 45 (3): 395–96. doi:10.1086/519434. PMID 17599314.

^ Understanding Horse Nutrition.Com on buckwheat
http://en.wikipedia.org/wiki/Photosensitivity

^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology (10th ed.). Saunders. ISBN 0721629210.
^ "eMedicine - Dyshidrotic Eczema : Article by Camila K Janniger". http://www.emedicine.com/ped/topic1867.htm. Retrieved on 2007-07-10. 
^ BIRT AR (March 1964). "Drugs for eczema of children". Can Med Assoc J 90 (11): 693–4. PMID 14127384. 
^ Stalder JF, Fleury M, Sourisse M, et al (1992). "Comparative effects of two topical antiseptics (chlorhexidine vs KMn04) on bacterial skin flora in atopic dermatitis". Acta Derm Venereol Suppl (Stockh) 176: 132–4. PMID 1476027. 
^ Baron S, Moss C (February 2003). "Caustic burn caused by potassium permanganate". Arch. Dis. Child. 88 (2): 96. PMID 12538301. PMC: 12538301. http://adc.bmj.com/cgi/pmidlookup?view=long&pmid=12538301. 
Arch Dermatol. 2004;140:1453-1459 Vol. 140 No. 12, December 2004 Archives
Oral Alitretinoin (9-cis-Retinoic Acid) Therapy for Chronic Hand Dermatitis in Patients Refractory to Standard Therapy Results of a Randomized, Double-blind, Placebo-Controlled, Multicenter Trial
Thomas Ruzicka, MD; Frederik Grønhøj Larsen, MD, PhD; Dorota Galewicz, MD; Attila Horváth, MD; Peter Jan Coenraads, MD; Kristian Thestrup-Pedersen, MD; Jean Paul Ortonne, MD; Christos C. Zouboulis, MD; Martin Harsch, PhD; Thomas C. Brown, PhD; Maurice Zultak, MD Arch Dermatol. 2004;140:1453-1459.
·  ^ Singal A, Bhattacharya SN, Baruah MC (2002). "Dermatitis herpetiformis and rheumatoid arthritis". Indian J Dermatol Venereol Leprol 68 (4): 229–30. PMID 17656946. http://www.ijdvl.com/article.asp?issn=0378-6323;year=2002;volume=68;issue=4;spage=229;epage=230;aulast=Singal. 

·  ^ dermatitis herpetiformis at Dorland's Medical Dictionary

·  ^ Marietta EV, Camilleri MJ, Castro LA, Krause PK, Pittelkow MR, Murray JA (February 2008). "Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue". J. Invest. Dermatol. 128 (2): 332–5. doi:10.1038/sj.jid.5701041. PMID 17762854. http://dx.doi.org/10.1038/sj.jid.5701041. 

·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

·  ^ Van L, Browning JC, Krishnan RS, Kenner-Bell BM, Hsu S (2008). "Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence". Dermatol. Online J. 14 (1): 21. PMID 18319038. http://dermatology.cdlib.org/141/correspondence/dh/van.html. 

·  ^ Jelinek JE (1979). "Jean-Paul Marat. The differential diagnosis of his skin disease". Am J Dermatopathol 1 (3): 251–2. PMID 396805.
·  ^ erythema multiforme at Dorland's Medical Dictionary

·  ^ Lamoreux MR, Sternbach MR, Hsu WT (December 2006). "Erythema multiforme". Am Fam Physician 74 (11): 1883–8. PMID 17168345. http://www.aafp.org/afp/20061201/1883.html. 

·  ^ YeungAK, Goldman RD (November 2005). "Use of steroids for erythema multiforme in children". Can Fam Physician 51: 1481–3. PMID 16353829. PMC: 1479482. http://www.cfp.ca/cgi/pmidlookup?view=long&pmid=16353829.
^ Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J (2008). "Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study". BMJ 337: a180. PMID 18614511. PMC: 2483869. http://bmj.com/cgi/pmidlookup?view=long&pmid=18614511.
·  ^ a b c d e f g Garra, GP (2007). "Toxic Epidermal Necrolysis". Emedicine.com. Retrieved on December 13, 2007.

·  ^ Carrozzo M, Togliatto M, Gandolfo S (1999). "Erythema multiforme. A heterogeneous pathologic phenotype". Minerva Stomatol 48 (5): 217–26. PMID 10434539. 

·  ^ Farthing P, Bagan J, Scully C (2005). "Mucosal disease series. Number IV. Erythema multiforme". Oral Dis 11 (5): 261–7. doi:10.1111/j.1601-0825.2005.01141.x. PMID 16120111. 

·  ^ Pereira FA, Mudgil AV, Rosmarin DM (2007). "Toxic Epidermal Necrolysis". J Am Acad Dermatol 56 (2): 181–200. doi:10.1016/j.jaad.2006.04.048. PMID 17224365. 

·  ^ Quinn AM et al (2005). "Uncovering histological criteria with prognostic significance in toxic epidermal necrolysis". Arch Dermatol 141 (6): 683–7. doi:10.1001/archderm.141.6.683. PMID 15967913.
·  ^ Yeh, S.W; Ahmed, Babar; Sami, Naveed; Ahmed, A. Razzaque. "Blistering disorderes: diagnosis and treatment." Dermatologic therapy. 2003;16(3):214-23. PMID 14510878.

·  ^ International Pemphigus & Pemphigoid Foundation: What is Pemphigus?

·  ^ Beutner, E. H.; Jordon, R.E. (November 1964). "Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining". Proc. Soc. Exp. Biol. Med. 117: pp. 505-510. 

·  ^ "Dermatology Foundation: BEUTNER, JORDAN SHARE 2000 DERMATOLOGY FOUNDATION DISCOVERY AWARD". http://www.dermfnd.org/press01/beutner.html. 

·  ^ Jordon, Robert E.; Sams, Jr., W. Mitchell; Diaz, Gustavo; Beutner, Ernst H. (1971). "NEGATIVE COMPLEMENT IMMUNOFLUORESCENCE IN PEMPHIGUS". Journal of Investigative Dermatology: pp. 407–410. http://www.nature.com/jid/journal/v57/n6/abs/5617954a.html. 

·  ^ Hailey Hailey Disease Society

·  ^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.

·  ^ British Association of Dermtologists, Steroid sparing (or adjuvant) drugs

·  ^ Ahmed AR, Spigelman Z, Cavacini LA, Posner MR (2006). "Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin". N. Engl. J. Med. 355 (17): 1772–9. doi:10.1056/NEJMoa062930. PMID 17065638. 

·  ^ Joly P, Mouquet H, Roujeau JC, et al (2007). "A single cycle of rituximab for the treatment of severe pemphigus". N. Engl. J. Med. 357 (6): 545–52. doi:10.1056/NEJMoa067752. PMID 17687130.
·  ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.

·  ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.

·  ^ “Scabies.” 15 February 2008. DermNet NZ. New Zealand Dermatological Society Incorporated. 12 Feb. 2009 < http://www.dermnetnz.org/arthropods/pdf/scabies-dermnetnz.pdf>.

·  ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.

·  ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.

·  ^ http://www.cdc.gov/scabies

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Arlian, L. Biology, Host Relations and Epidemiology of Sarcoptes Scabiei. Ann. Rev. Entomol 1989; 34:139-61. 5 Feb. 2009 <http://arjournals.annualreviews.org/doi/pdf/10.1146/annurev.en.34.010189.001035?cookieSet=1>

·  ^ Scheinfeld NS (2004). "Controlling scabies in institutional settings: a review of medications, treatment models, and implementation". Amer J Clin Dermatol 5 (1): 31–7. doi:10.2165/00128071-200405010-00005. PMID 14979741. 

·  ^ Permethrin Factsheet (PDF)

·  ^ http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202170.html

·  ^ FDA Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Lice

·  ^ "Lindane Post Marketing Safety Review" (PDF). U.S. Food and Drug Administration (FDA). 2003. http://www.fda.gov/cder/drug/infopage/lindane/lindaneaeredacted.pdf. 

·  ^ a b c http://www.fda.gov/cder/foi/label/2003/006309lotionlbl.pdf.

·  ^ Commission for Environmental Cooperation. North American Regional Action Plan (NARAP) on lindane and other hexachlorocyclohexane (HCH) isomers. November 30, 2006.

·  ^ U.S. EPA. Assessment of lindane and other hexachlorocyclohexane isomers. February 8, 2006

·  ^ Medication Guide Lindane Lotion USP, 1%. Updated March 28, 2003.

·  ^ Lin AN, Reimer RJ, Carter DM (1988). "Sulfur revisited". J Am Acad Dermatol 18: 553–58. doi:10.1016/S0190-9622(88)70079-1. 

·  ^ Pruksachatkunakorn C, Damrongsak M, Sinthupuan S (2002). "Sulfur for Scabies Outbreaks in Orphanages". Pediatric Dermatology 19 (5): 448–53. doi:10.1046/j.1525-1470.2002.00205.x. http://www3.interscience.wiley.com/journal/118919953/abstract. Retrieved on 2008-08-01. 

·  ^ Heinrich M, et al. (2005). "Plants as Medicines". in Prance G, Nesbitt M. The Cultural History of Plants. London: Routledge. pp. 228. ISBN 0415927463. 

·  ^ Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ (May 2004). "Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol". Arch Dermatol 140 (5): 563–6. doi:10.1001/archderm.140.5.563. PMID 15148100. 

·  ^ Apgar B (January 15, 2000). "Efficacy and Safety of Therapy for Human Scabies Infestation". American Family Physician. http://www.aafp.org/afp/20000115/tips/15.html. 
Chouela EN, Abeldaño AM, Pellerano G, et al (June 1999). "Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies". Arch Dermatol 135 (6): 651–5. doi:10.1001/archderm.135.6.651. PMID 10376691. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=10376691. 
Strong M, Johnstone PW (2007). "Interventions for treating scabies". Cochrane Database Syst Rev (3): CD000320. doi:10.1002/14651858.CD000320.pub2. PMID 17636630. 

·  ^ Borsboom GJ, Boatin BA, Nagelkerke NJ, et al (March 2003). "Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa". Filaria J 2 (1): 8. doi:10.1186/1475-2883-2-8. PMID 12769825. PMC: 156613. http://www.filariajournal.com/content/2/1/8. 

·  ^ "Scabies." 5 Dec. 2008. Laboratory Identification of Parasites of Public Health Concern. DPDx. CDC, Atlanta. 5 Feb. 2009 <http://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm>.

·  ^ Green, M. Epidemiology of Scabies. Epidemiological Reviews 1989; 11:126-150. 5 Feb. 2009 <http://epirev.oxfordjournals.org/cgi/reprint/11/1/126>.

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge’s Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.

·  ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.

·  ^ Roncalli, RA. The History of Scabies in Veterinary and Human Medicine from Biblical to Modern Times. Veterinary Parasitology 1987; 25: 193-198.

·  ^ Markell EK, John DT, Krotoski WA. Markell and Voge's Medical Parasitology, 9th ed. Philadelphia: W.B. Saunders, 2006.

·  ^ Chakrabarti A (1985). "Some epidemiological aspects of animal scabies in human population". Int J Zoonoses 12 (1): 39–52. PMID 4055268. 

·  ^ Ulmer A, Schanz S, Röcken M, Fierlbeck G (2007). "A papulovesicular rash in a farmer and his wife". Clin Infect Dis 45 (3): 395–96. doi:10.1086/519434. PMID 17599314.
·  ^ Wang, K; Pugh, Ew; Griffen, S; Doheny, Kf; Mostafa, Wz; Al-Aboosi, Mm; El-Shanti, H; Gitschier, J (April 2001). "Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3". American journal of human genetics 68 (4): 1055–60. doi:10.1086/319514. PMID 11254458. 

·  ^ Küry, S; Dréno, B; Bézieau, S; Giraudet, S; Kharfi, M; Kamoun, R; Moisan, Jp (July 2002). "Identification of SLC39A4, a gene involved in acrodermatitis enteropathica". Nature genetics 31 (3): 239–40. doi:10.1038/ng913. PMID 12068297. 

·  ^ Michalczyk, A; Varigos, G; Catto-Smith, A; Blomeley, Rc; Ackland, Ml (August 2003). "Analysis of zinc transporter, hZnT4 ( Slc30A4), gene expression in a mammary gland disorder leading to reduced zinc secretion into milk". Human genetics 113 (3): 202–10. doi:10.1007/s00439-003-0952-2. PMID 12743795.
^ http://www.merck.com/mmhe/sec13/ch162/ch162e.html Acromegaly and Gigantism
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Baseball's Steroid Era
^ "Andre the Giant: Bio". WWE.com. http://www.wwe.com/superstars/halloffame/andrethegiant/bio/. Retrieved on 2007-10-16. 
^ "André the Giant official website.". http://www.andrethegiant.com/. Retrieved on 2007-07-08. 
^ [1]
^ http://www.barrybrown.info/unsungheroes/rondohatton.html
^ BBC News report on Punch and Acromegaly

^ Login IS, Login J (July 2008). "Governor Pio Pico, the monster of California...no more: lessons in neuroendocrinology". Pituitary. doi:10.1007/s11102-008-0127-1. PMID 18597174.  Open Access; http://www.springerlink.com/content/u7645787h2435373/fulltext.pdf
^ Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008). "Pituitary tumor apoplexy: a review". J Intensive Care Med 23 (2): 75–90. doi:10.1177/0885066607312992. PMID 18372348. 
Endocrine and Metabolic Diseases Information Service
·  ^ Kumar, Abbas, Fausto. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier-Saunders; New York, 2005.

·  ^ Cushing HW. (1932). "The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism).". Bull Johns Hopkins Hosp 50: 137–95. 

·  ^ Yudofsky, Stuart C.; Robert E. Hales (2007). The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences (5th ed.). American Psychiatric Pub, Inc.. ISBN 1585622397. 

·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.

·  ^ Raff H, Findling JW (2003). "A physiologic approach to diagnosis of the Cushing syndrome". Ann. Intern. Med. 138 (12): 980–91. PMID 12809455. http://www.annals.org/cgi/pmidlookup?view=long&pmid=12809455. 

·  ^ Nelson DH, Meakin JW, Thorn GW (1960). "ACTH-producing pituitary tumors following adrenalectomy for Cushing syndrome". Ann. Intern. Med. 52: 560–9. PMID 14426442. 

·  ^ Ezzat S, Asa SL, Couldwell WT, et al (2004). "The prevalence of pituitary adenomas: a systematic review". Cancer 101 (3): 613–9. doi:10.1002/cncr.20412. PMID 15274075.
·  ^ Scheinfeld NS (2006). "Ulcerative paraneoplastic dermatomyositis secondary to metastatic breast cancer". Skinmed 5 (2): 94–6. doi:10.1111/j.1540-9740.2006.03637.x. PMID 16603844. http://www.lejacq.com/articleDetail.cfm?pid=SKINmed_5;2:94. 

·  ^ "Polymyositis and Dermatomyositis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Edition". http://www.merck.com/mmhe/sec05/ch068/ch068e.html. 

·  ^ Page 151 in: Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). Robbins Basic Pathology. Philadelphia: Saunders. ISBN 1-4160-2973-7.  8th edition.

·  ^ Ghirardello, A; Zampieri S, Tarricone E et al. (May 2006). "Clinical implications of autoantibody screening in patients with autoimmune myositis". Autoimmunity 39 (3): 217–221. doi:10.1080/08916930600622645. PMID 16769655. 

·  ^ Benveniste, O; Squier W, Boyer O et al. (November 2004). "Pathogenesis of primary inflammatory myopathies". Presse Médicale 33 (20): 1444–1450. doi:10.1016/S0755-4982(04)98952-X. PMID 15611679. 

·  ^ Nirmalananthan, N; Holton JL, Hanna MG (November 2004). "Is it really myositis? A consideration of the differential diagnosis". Current Opinion in Rheumatology 16 (6): 684–691. doi:10.1097/01.bor.0000143441.27065.bc. PMID 15577605. 

·  ^ Scheinfeld N (2006). "A review of rituximab in cutaneous medicine". Dermatol. Online J. 12 (1): 3. PMID 16638371. http://dermatology.cdlib.org/121/reviews/rituxab/scheinfeld.html.
·  ^ polymyositis at Dorland's Medical Dictionary

·  ^ "Polymyositis and Dermatomyositis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Edition". http://www.merck.com/mmhe/sec05/ch068/ch068e.html.
·  ^ "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. http://www.diabetesbluecircle.org. 

·  ^ L M Tierney, S J McPhee, M A Papadakis (2002). Current medical Diagnosis & Treatment. International edition. New York: Lange Medical Books/McGraw-Hill. pp. 1203–1215. ISBN 0-07-137688-7. 

·  ^ a b c Rother, KI (2007). "Diabetes Treatment — Bridging the Divide". N Engl J Med 356 (15): 1499–1501. doi:10.1056/NEJMp078030. PMID 17429082. http://content.nejm.org/cgi/content/full/356/15/1499. 

·  ^ a b c World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications" (PDF). http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf. 

·  ^ Mailloux, Lionel (2007-02-13). "UpToDate Dialysis in diabetic nephropathy". UpToDate. http://patients.uptodate.com/topic.asp?file=dialysis/15147. Retrieved on 2007-12-07. 

·  ^ "Other "types" of diabetes". American Diabetes Association. August 25, 2005. http://www.diabetes.org/other-types.jsp. 

·  ^ "Diseases: Johns Hopkins Autoimmune Disease Research Center". http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&DiseaseID=23. Retrieved on 2007-09-23. 

·  ^ "FDA Approves First Ever Inhaled Insulin Combination Product for Treatment of Diabetes". http://www.fda.gov/bbs/topics/news/2006/NEW01304.html. Retrieved on 2007-09-09. 

·  ^ "MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility". http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182. Retrieved on 2008-10-23. 

·  ^ Baillie, K (2008-07-05). "ClinicLog article on current diabetes trials.". ClinicLog.com. http://www.cliniclog.com/type_1_diabetes_trials.php. Retrieved on 2008-07-23. 

·  ^ Eberhart, MS; Ogden C, Engelgau M, Cadwell B, Hedley AA, Saydah SH (19 November 2004). "Prevalence of Overweight and Obesity Among Adults with Diagnosed Diabetes --- United States, 1988--1994 and 1999--2002". Morbidity and Mortality Weekly Report (Centers for Disease Control and Prevention) 53 (45): 1066–1068. http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm. Retrieved on 2007-03-11. 

·  ^ Arlan Rosenbloom, Janet H Silverstein (2003). Type 2 Diabetes in Children and Adolescents: A Clinician's Guide to Diagnosis, Epidemiology, Pathogenesis, Prevention, and Treatment. American Diabetes Association,U.S.. pp. 1. ISBN 978-1580401555. 

·  ^ Lang, Iain A.; Tamara S. Galloway, Alan Scarlett, William E. Henley, Michael Depledge, Robert B. Wallace, and David Melzer (2008). "Association of Urinary Bisphenol A Concentration with Medical Disorders and Laboratory Abnormalities in Adults". Journal of the American Medical Association 300 (1): 1303–1310. doi:10.1001/jama.300.11.1303. 

·  ^ "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group". Lancet 352 (9131): 854–65. 1998. doi:10.1016/S0140-6736(98)07037-8. PMID 9742977. 

·  ^ Lawrence JM, Contreras R, Chen W, Sacks DA (May 2008). "Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005". Diabetes Care 31 (5): 899–904. doi:10.2337/dc07-2345. PMID 18223030. 

·  ^ Lyssenko, V. (2008). "Clinical risk factors, DNA variants, and the development of type 2 diabetes". N Engl J Med 359 (21): 2220–2232. doi:10.1056/NEJMoa0801869. http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC. 

·  ^ Walley AJ, Blakemore AI, Froguel P (2006). "Genetics of obesity and the prediction of risk for health". Hum. Mol. Genet. 15 Spec No 2: R124–30. doi:10.1093/hmg/ddl215. PMID 16987875. 

·  ^ "Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young". National Diabetes Information Clearinghouse (NDIC) (National Institute of Diabetes and Digestive and Kidney Diseases, NIH). http://www.diabetes.niddk.nih.gov/dm/pubs/mody/. Retrieved on 2008-08-04. 

·  ^ Barrett TG (2001). "Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes". Best Pract. Res. Clin. Endocrinol. Metab. 15 (3): 325–43. doi:10.1053/beem.2001.0149. PMID 11554774. 

·  ^ Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H. "Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose". Summary of Evidence Report/Technology Assessment, No. 128. Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/epcsums/impglusum.htm. Retrieved on 2008-07-20. 

·  ^ Sniderman, AD; Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A (2007). "Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis". International journal of epidemiology 36 (1): 220–225. doi:10.1093/ije/dyl245. PMID 17510078. 

·  ^ Genuth S (Jan-Feb 2006). "Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes". Endocr Pract 12 (Suppl 1): 34–41. ISSN 1530-891X. PMID 16627378. 

·  ^ Lee CM, Huxley RR, Lam TH, Martiniuk AL, Ueshema H, Pan WH, Welborn T, Woodward M; Asia Pacific Cohort Studies Collaboration (2007). "Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions". Asia Pac J Clin Nutr 16 (1): 187–92. PMID 17215197. 

·  ^ Seidell JC (2000). "Obesity, insulin resistance and diabetes--a worldwide epidemic". Br. J. Nutr. 83 Suppl 1: S5–8. PMID 10889785. 

·  ^ Daneman D (2006). "Type 1 diabetes". Lancet 367 (9513): 847–58. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579. 

·  ^ Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J (1984). "Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis". Lancet 2 (8411): 1083–6. doi:10.1016/S0140-6736(84)91517-4. PMID 6150150. 

·  ^ Naim Shehadeh, Raanan Shamir, Moshe Berant, Amos Etzioni (2001). "Insulin in human milk and the prevention of type 1 diabetes". Pediatric Diabetes 2 (4): 175–177. doi:10.1034/j.1399-5448.2001.20406.x. http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi. 

·  ^ Virtanen S, Knip M (2003). "Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age". Am J Clin Nutr 78 (6): 1053–67. PMID 14668264. 

·  ^ Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (2001). "Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study". Lancet 358: 1500. doi:10.1016/S0140-6736(01)06580-1. PMID 11705562. 

·  ^ Elliott RB, Pilcher CC, Fergusson DM, Stewart AW (Sep-Oct 1996). "A population based strategy to prevent insulin-dependent diabetes using nicotinamide". J. Pediatr. Endocrinol. Metab. 9 (5): 501–9. PMID 8961125. 

·  ^ Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J (2006). "Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study". Lancet 368 (9548): 1673–9. doi:10.1016/S0140-6736(06)69701-8. PMID 17098085. 

·  ^ a b Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D (2002). "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin". N Engl J Med 346 (6): 393–403. doi:10.1056/NEJMoa012512. PMID 11832527. 

·  ^ Bantle JP, Wylie-Rosett J, Albright AL, et al (2006). "Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association". Diabetes Care 29 (9): 2140–57. doi:10.2337/dc06-9914. PMID 16936169. http://care.diabetesjournals.org/cgi/content/full/29/9/2140. 

·  ^ Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R (2006). "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial". Lancet 368 (9541): 1096–105. doi:10.1016/S0140-6736(06)69420-8. PMID 16997664. 

·  ^ Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators (2006). "Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial". J Hypertens 24 (7): 1405–1412. doi:10.1097/01.hjh.0000234122.55895.5b. PMID 16794491. 

·  ^ Wasko MC, Hubert HB, Lingala VB, et al (2007). "Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis". JAMA 298 (2): 187–93. doi:10.1001/jama.298.2.187. PMID 17622600. 

·  ^ Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB (2005). "Duration of lactation and incidence of type 2 diabetes". JAMA 294 (20): 2601–10. doi:10.1001/jama.294.20.2601. PMID 16304074. 

·  ^ Adler, A.I.; Stratton, I. M.; Neil, H.A.; et al (2000). "Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study". BMJ 321 (7258): 412–419. doi:10.1136/bmj.321.7258.412. PMID 10938049. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&rendertype=abstract. 

·  ^ a b c Vinik AI, Fishwick DT, Pittenger G (2004). "Advances in diabetes for the millennium: toward a cure for diabetes". MedGenMed : Medscape general medicine 6 (3 Suppl): 12. PMID 15647717. 

·  ^ Stratta RJ, Alloway RR. (1998). "Pancreas transplantation for diabetes mellitus: a guide to recipient selection and optimum immunosuppression". BioDrugs. 10 (5): 347–357. doi:10.2165/00063030-199810050-00002. PMID 18020607. 

·  ^ Shapiro AM, Ricordi C, Hering BJ, et al (2006). "International trial of the Edmonton protocol for islet transplantation". N. Engl. J. Med. 355 (13): 1318–30. doi:10.1056/NEJMoa061267. PMID 17005949. 

·  ^ Voltarelli, JC; Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simoes BP, Foss MC, Squiers E, Burt RK. (2007). "Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus". JAMA 297 (14): 1568–76. doi:10.1001/jama.297.14.1568. PMID 17426276. http://jama.ama-assn.org/cgi/content/full/297/14/1568. 

·  ^ Rubino, F; Gagner M (2002). "Potential of surgery for curing type 2 diabetes mellitus". Ann. Surg. 236 (5): 554–9. doi:10.1097/00000658-200211000-00003. PMID 12409659. 

·  ^ Adams, TD; Gress RE, Smith SC, et al (2007). "Long-term mortality after gastric bypass surgery". N. Engl. J. Med. 357 (8): 753–61. doi:10.1056/NEJMoa066603. PMID 17715409. 

·  ^ Cohen, RV; Schiavon CA, Pinheiro JS, Correa JL, Rubino F (2007). "Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases". Surg Obes Relat Dis. 3 (2): 195–7. doi:10.1016/j.soard.2007.01.009. PMID 17386401. 

·  ^ Vasonconcelos, Alberto (2007-09-01). "Could type 2 diabetes be reversed using surgery?". New Scientist (2619): 11–13. http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html. Retrieved on 2007-09-26. 

·  ^ Nathan, D.M.; Cleary P.A., Backlund J.Y., et al (2005). "Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes". N. Engl. J. Med. 353 (25): 2643–53. doi:10.1056/NEJMoa052187. PMID 16371630. 

·  ^ The Diabetes Control and Complications Trial Research Group (15 Apr 1995). "The effect of intensive diabetes therapy on the development and progression of neuropathy". Annals of Internal Medicine 122 (8): 561–568. ISSN 0003-4819. PMID 7887548. http://www.annals.org/cgi/content/abstract/122/8/561. 

·  ^ a b Harris MI, Flegal KM, Cowie CC, et al (1998). "Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994". Diabetes Care 21 (4): 518–24. doi:10.2337/diacare.21.4.518. PMID 9571335. 

·  ^ Annette M. Chang and Jeffrey B. Halter (2003). "Aging and insulin secretion". AJP - Endocrinology and Metabolism. http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck. Retrieved on 2007-05-14. 

·  ^ "Diabetes and Aging". Diabetes Dateline. National Institute of Diabetes and Digestive and Kidney Diseases. 2002. http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm. Retrieved on 2007-05-14. 

·  ^ Weiss J, Sumpio B (2006). "Review of prevalence and outcome of vascular disease in patients with diabetes mellitus". Eur J Vasc Endovasc Surg 31 (2): 143–50. doi:10.1016/j.ejvs.2005.08.015. PMID 16203161. 

·  ^ Aristides Veves, Rayaz A. Malik (2007). Diabetic Neuropathy: Clinical Management (Clinical Diabetes), Second Edition. New York: Humana Press. pp. 188–198. ISBN 1-58-829626-1. 

·  ^ Gispen WH, Biessels GJ (November 2000). "Cognition and synaptic plasticity in diabetes mellitus". Trends Neurosci. 23 (11): 542–9. doi:10.1016/S0166-2236(00)01656-8. PMID 11074263. 

·  ^ a b c d Wild S, Roglic G, Green A, Sicree R, King H (May 2004). "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030". Diabetes Care 27 (5): 1047–53. doi:10.2337/diacare.27.5.1047. PMID 15111519. http://care.diabetesjournals.org/cgi/content/full/27/5/1047. 

·  ^ hhttp://www.cdc.gov/Features/diabetesfactsheet/

·  ^ "CDC's Diabetes Program - News and Information - Press Releases - October 26 2000". http://www.cdc.gov/Diabetes/news/docs/010126.htm. Retrieved on 2008-06-23. 

·  ^ Narayan K, Boyle J, Thompson T, Sorensen S, Williamson D (2003). "Lifetime risk for diabetes mellitus in the United States". JAMA 290 (14): 1884–90. doi:10.1001/jama.290.14.1884. PMID 14532317. 

·  ^ American Diabetes Association (2005). "Total Prevalence of Diabetes & Pre-diabetes". http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Retrieved on 2006-03-17. 

·  ^ "Seniors and Diabetes". Elderly And Diabetes - Diabetes and Seniors. LifeMed Media. 2006. http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/. Retrieved on 2007-05-14. 

·  ^ Australian Institute for Health and Welfare. "Diabetes, an overview". http://www.aihw.gov.au/indigenous/health/diabetes.cfm. Retrieved on 2008-06-23. 

·  ^ Dobson, M. (1776). "Nature of the urine in diabetes". Medical Observations and Inquiries 5: 298–310. 

·  ^ Medvei (1993). History of Clinical Endocrinology. 23-34

·  ^ a b Dwivedi, Girish & Dwivedi, Shridhar (2007). History of Medicine: Sushruta – the Clinician – Teacher par Excellence. National Informatics Centre (Government of India).

·  ^ Nabipour, I. (2003), "Clinical Endocrinology in the Islamic Civilization in Iran", International Journal of Endocrinology and Metabolism 1: 43–45 [44–5] 

·  ^ a b c Patlak M (2002). "New weapons to combat an ancient disease: treating diabetes". Faseb J 16 (14): 1853. doi:10.1096/fj.02-0974bkt. PMID 12468446. http://www.fasebj.org/cgi/content/full/16/14/1853e. 

·  ^ Von Mehring J, Minkowski O. (1890). "Diabetes mellitus nach pankreasexstirpation". Arch Exp Pathol Pharmakol 26: 371–387. doi:10.1007/BF01831214. 

·  ^ Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (01 Jan 1922). "Pancreatic extracts in the treatment of diabetes mellitus". Canad Med Assoc J 12 (10): 141–146. PMID 1933711. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=1933711. 

·  ^ Himsworth (1936). "Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types". Lancet i: 127–130. doi:10.1016/S0140-6736(01)36134-2. 

·  ^ Department of Health (Malta), 1897–1972:Annual Reports.

·  ^ Yalow RS, Berson SA (1960). "Immunoassay of endogenous plasma insulin in man". J. Clin. Invest. 39: 1157–75. doi:10.1172/JCI104130. PMID 13846364. 

·  ^ The Diabetes Control And Complications Trial Research Group, (1993). "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group". N Engl J Med 329 (14): 977–86. doi:10.1056/NEJM199309303291401. PMID 8366922. 

·  ^ Theodore H. Tulchinsky, Elena A. Varavikova (2008). The New Public Health, Second Edition. New York: Academic Press. p. 200. ISBN 0-12-370890-7. 

·  ^ Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. (1993). "Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee.". Diabet Med. 10 (4): 303–4. PMID 8508624. 

·  ^ Dubois, HFW and Bankauskaite, V (2005). "Type 2 diabetes programmes in Europe" (PDF). Euro Observer 7 (2): 5–6. http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf. 

·  ^ Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA (2007). "Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce". J. Occup. Environ. Med. 49 (6): 672–9. doi:10.1097/JOM.0b013e318065b83a. PMID 17563611.
^ Frederickson DS, Lee RS. A system for phenotyping hyperlipidemia. Circulation 1965;31:321-7. PMID 14262568.
^ Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106; page 3240
^ Thompson GR. Management of dyslipidaemia. Heart 2004;90:949-55. PMID 15253984.
·  ^ a b Jack DeRuiter (2002) (PDF). Thyroid Pathology. pp. 30. http://www.auburn.edu/~deruija/endp_thyroidpathol.pdf. 

·  ^ Brooks W (01/06/2008). "Hypothyroidism in Dogs". The Pet Health Library. VetinaryPartner.com. http://www.veterinarypartner.com/Content.plx?P=A&A=461. Retrieved on 2008-02-28. 

·  ^ Simon H (2006-04-19). "Hypothyroidism". University of Maryland Medical Center. http://www.umm.edu/patiented/articles/what_causes_hypothyroidism_000038_2.htm. Retrieved on 2008-02-28. 

·  ^ Department of Pathology (June 13, 2005). "Pituitary Gland -- Diseases/Syndromes". Virginia Commonwealth University (VCU). http://www.pathology.vcu.edu/education/endocrine/endocrine/pituitary/diseases.html. Retrieved on 2008-02-28. 

·  ^ a b American Thyroid Association (ATA) (2003) (PDF). Hypothyroidism Booklet. pp. 6. http://www.thyroid.org/patients/brochures/Hypothyroidism%20_web_booklet.pdf#search=%22hypothyroidism%22. 

·  ^ Heinrich TW, Grahm G (2003). Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited. 5. pp. 260–266. PMID 15213796. 

·  ^ MedlinePlus Encyclopedia Hypothyroidism — primary — see list of Symptoms

·  ^ "Hypothyroidism — In-Depth Report." The New York Times. Copyright 2008

·  ^ "Hypothyroidism" (PDF). American Association of Clinical Endocrinologists. http://www.aace.com/pub/thyroidbrochures/pdfs/Hypothyroidism.pdf. 

·  ^ Yeum CH, Kim SW, Kim NH, Choi KC, Lee J (July 2002). "Increased expression of aquaporin water channels in hypothyroid rat kidney". Pharmacol. Res. 46 (1): 85–8. doi:10.1016/S1043-6618(02)00036-1. PMID 12208125. 

·  ^ Thyroid and Weight. The American Thyroid Association

·  ^ Hofeldt FD, Dippe S, Forsham PH (1972). "Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administration" (PDF). Am. J. Clin. Nutr. 25 (11): 1193–201. PMID 5086042. http://www.ajcn.org/cgi/reprint/25/11/1193.pdf. 

·  ^ a b Baisier W. Hertoghe J. Eeckhaut W. Thyroid insufficiency. Is TSH the only diagnostic tool? J Nutr Environ ed. 2000;10:105–113. "Thyroid insufficiency. Is TSH the only diagnostic tool?"

·  ^ a b American Association of Clinical Endocrinologists (November/December 2002). "Medical Guidelines For Clinical Practice For The Evaluation And Treatment Of Hyperthyroidism And Hypothyroidism" (PDF). Endocrine Practice 8 (6): 457–469. http://www.aace.com/pub/pdf/guidelines/hypo_hyper.pdf. 

·  ^ a b Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ (February 1999). "Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism". N. Engl. J. Med. 340 (6): 424–9. doi:10.1056/NEJM199902113400603. PMID 9971866. http://content.nejm.org/cgi/content/full/340/6/424. 

·  ^ a b Baisier, W.V.; Hertoghe, J.; Eeckhaut, W. (September 2001). "Thyroid Insufficiency. Is Thyroxine the Only Valuable Drug?". Journal of Nutritional and Environmental Medicine 11 (3): 159–66. doi:10.1080/13590840120083376.  — Abstract

·  ^ Robertas Bunevicius, Arthur J. Prange Jr. (June 2000). "Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism". The International Journal of Neuropsychopharmacology 3 (2): 167–174. doi:10.1017/S1461145700001826. http://journals.cambridge.org/action/displayAbstract?aid=52289. 

·  ^ Siegmund W, Spieker K, Weike AI, et al (June 2004). "Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism". Clin. Endocrinol. (Oxf) 60 (6): 750–7. doi:10.1111/j.1365-2265.2004.02050.x. PMID 15163340. 

·  ^ Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A (2007). "Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis". Psychosomatics 48 (5): 379–84. doi:10.1176/appi.psy.48.5.379. PMID 17878495. 

·  ^ Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM (April 2007). "Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy". Exp. Clin. Endocrinol. Diabetes 115 (4): 261–7. doi:10.1055/s-2007-973071. PMID 17479444. 

·  ^ "Subclinical Thyroid Disease". Guidelines & Position Statements. The American Association of Clinical Endocrinologists. July 11, 2007. http://www.aace.com/pub/positionstatements/subclinical.php. Retrieved on 2008-06-08. 

·  ^ Villar H, Saconato H, Valente O, Atallah A (2007). "Thyroid hormone replacement for subclinical hypothyroidism". Cochrane database of systematic reviews (Online) (3): CD003419. doi:10.1002/14651858.CD003419.pub2. PMID 17636722. 

·  ^ Biondi B, Palmieri EA, Lombardi G, Fazio S (December 2002). "Effects of subclinical thyroid dysfunction on the heart". Ann. Intern. Med. 137 (11): 904–14. PMID 12458990. 

·  ^ Ochs N, Auer R, BauerDC, et al (June 2008). "Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality". Ann. Intern. Med. 148 (11): 832–45. PMID 18490668. http://www.annals.org/cgi/content/full/148/11/832. 

·  ^ Alan Gaby (2004). ""Sub-laboratory" Hypothyroidism and the Empirical use of Armour Thyroid" (PDF). Alternative Medicine Review 9 (2): 157–179. http://www.thorne.com/media/hypothyroidism9-2.pdf.
·  ^ a b Ciliberto H, et al. (May 2005). "Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial". BMJ 330: 1109. doi:10.1136/bmj.38427.404259.8F. http://www.bmj.com/cgi/content/full/330/7500/1109. 

·  ^ Williams CD (1935). "Kwashiorkor: a nutritional disease of children associated with a maize diet". Lancet 226: 1151–2. doi:10.1016/S0140-6736(00)94666-X. 

·  ^ "Jamaica Gleaner : Pieces of the Past: A Pioneer, A Survivor: Dr. Cicely Williams". http://www.jamaica-gleaner.com/pages/history/story0037.htm. Retrieved on 2007-09-18. 

·  ^ "Merriam Webster Dictionary". http://www.merriam-webster.com/dictionary/kwashiorkor. Retrieved on 2009-04-05. 

·  ^ Pretorius PJ, de Villiers LS (1962). "Antibody response in children with protein malnultrition". Am. J. Clin. Nutr. 10 (5): 379–82. http://www.ajcn.org/cgi/reprint/10/5/379.pdf. 

·  ^ Krawinkel M (2003). "Kwashiorkor is still not fully understood". Bull. World Health Organ. 81 (12): 910–1. PMID 14997244. http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862003001200010&lng=en&nrm=iso&tlng=en.
·  ^ a b Pitche P (2005). "Pellagra". Sante 15 (3): 205–8. PMID 16207585. 

·  ^ a b Bapurao S, Krishnaswamy K (1978). "Vitamin B6 nutritional status of pellagrins and their leucine tolerance". Am J Clin Nutr 31 (5): 819–24. PMID 206127. 

·  ^ "Definition of Pellagra". MedicineNet.com. http://www.medterms.com/script/main/art.asp?articlekey=4821. Retrieved on 2007-06-18. 

·  ^ Bollet A (1992). "Politics and pellagra: the epidemic of pellagra in the U.S. in the early twentieth century". Yale J Biol Med 65 (3): 211–21. PMID 1285449. 

·  ^ Swan, Patricia (2005). "Goldberger's War: The Life and Work of a Public Health Crusader (review)". Bulletin of the History of Medicine (The JohnsHopkinsUniversity Press) 79 (1): 146-147. http://muse.jhu.edu/journals/bulletin_of_the_history_of_medicine/v079/79.1swan.html. 

·  ^ Miller DF (1978). "Pellagra deaths in the United States". Am. J. Clin. Nutr. 31 (4): 558–9. PMID 637029. 

·  ^ Brenton, Barrett (2000). "Pellagra, Sex and Gender: Biocultural Perspectives on Differential Diets and Healths". Nutritional Anthropology 23 (1): 20–24. doi:10.1525/nua.2000.23.1.20. 

·  ^ Carpenter, Kenneth (1981). Pellagra. Stoudsburg, PA: Hutchinson Ross. 

·  ^ Gillman, Joseph; Gillman, Theodore (1951). Perspectives in Human Malnutrition: A Contribution to the Biology of Disease from a Clinical and Pathological Study of Chronic Malnutrion and Pellagra in the African. New York, New York: Grune and Stratton. 

·  ^ Jagielska G, Tomaszewicz-Libudzic EC, Brzozowska A (2007). "Pellagra: a rare complication of anorexia nervosa". Eur Child Adolesc Psychiatry 16 (7): 417–20. doi:10.1007/s00787-007-0613-4. PMID 17712518. 

·  ^ Hegyi J, Schwartz R, Hegyi V (2004). "Pellagra: dermatitis, dementia, and diarrhoea". Int J Dermatol 43 (1): 1–5. doi:10.1111/j.1365-4632.2004.01959.x. PMID 14693013. 

·  ^ Cleary, MJ, Cleary, JP: Anorexia nervosa: a form of subclinical pellagra, Int Clin Nutr Rev, 9:137-143

·  ^ Haas EM. "Vitamin B3—Niacin". Excepted from: Staying Healthy with Nutrition: The Complete Guide to Diet and Nutritional Medicine. http://www.healthy.net/scr/article.asp?ID=2125. Retrieved on 2007-06-18.
·  ^ a b c Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 403-406 ISBN 978-1-4160-2973-1

·  ^ rheumatic fever at Dorland's Medical Dictionary

·  ^ Medline Plus Medical Encyclopedia: Rheumatic fever

·  ^ Porth, Carol (2007). Essentials of pathophysiology: concepts of altered health states. Hagerstown, MD: Lippincott Williams & Wilkins. ISBN 0-7817-7087-4. 

·  ^ Jones TD (1944). "The diagnosis of rheumatic fever.". JAMA 126: 481–4. 

·  ^ Ferrieri P (2002). "Proceedings of the Jones Criteria workshop". Circulation 106 (19): 2521–3. doi:10.1161/01.CIR.0000037745.65929.FA. PMID 12417554. http://circ.ahajournals.org/cgi/content/full/106/19/2521?ck=nck. 

·  ^ Steven J Parrillo, DO, FACOEP, FACEP. "eMedicine — Rheumatic Fever". http://www.emedicine.com/emerg/topic509.htm. Retrieved on 2007-07-14. 

^ "Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association". JAMA 268 (15): 2069–73. 1992. PMID 1404745. 

·  ^ Saxena, Anita (2000). "Diagnosis of rheumatic fever: Current status of Jones criteria and role of echocardiography". Indian Journal of Pediatrics 67 (4): 283–6. doi:10.1007/BF02758174. PMID 11129913. 

·  ^ Abbas and Lechtman. Basic Immunology: Functions and Disorders of the Immune System. Elsevier Inc. 2004.

·  ^ Faé KC, da Silva DD, Oshiro SE, et al (May 2006). "Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease". J. Immunol. 176 (9): 5662–70. PMID 16622036. http://www.jimmunol.org/cgi/pmidlookup?view=long&pmid=16622036. 

·  ^ a b Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease. St. Louis, Mo: Elsevier Saunders. ISBN 0-7216-0187-1. http://www.robbinspathology.com/. 

·  ^ "Rheumatic Heart Disease/Rheumatic Fever". American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=4709. Retrieved on 2008-02-17.
·  ^ a b c Majithia V, Geraci SA (2007). "Rheumatoid arthritis: diagnosis and management". Am. J. Med. 120 (11): 936–9. doi:10.1016/j.amjmed.2007.04.005. PMID 17976416. 

·  ^ a b Landré-Beauvais AJ (1800). La goutte asthénique primitive (doctoral thesis). Paris.  reproduced in Landré-Beauvais AJ (March 2001). "The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800". Joint Bone Spine 68 (2): 130–43. doi:10.1016/S1297-319X(00)00247-5. PMID 11324929. http://linkinghub.elsevier.com/retrieve/pii/S1297319X00002475. 

·  ^ Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003). "Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years". Ann. Rheum. Dis. 62 (8): 722–7. doi:10.1136/ard.62.8.722. PMID 12860726. 

·  ^ Jijith Krishnan,Document on Rhuematoid arthritis

·  ^ de Groot K (August 2007). "[Renal manifestations in rheumatic diseases]". Internist (Berl) 48 (8): 779–85. doi:10.1007/s00108-007-1887-9. PMID 17571244. 

·  ^ Wolfe F, Mitchell DM, Sibley JT, et al (April 1994). "The mortality of rheumatoid arthritis". Arthritis Rheum. 37 (4): 481–94. doi:10.1002/art.1780370408. PMID 8147925. 

·  ^ Westwood OM, Nelson PN, Hay FC (April 2006). "Rheumatoid factors: what's new?". Rheumatology (Oxford) 45 (4): 379–85. doi:10.1093/rheumatology/kei228. PMID 16418203. http://rheumatology.oxfordjournals.org/cgi/content/full/45/4/379. 

·  ^ a b Nishimura K, Sugiyama D, Kogata Y, et al (June 2007). "Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis" (PDF). Ann. Intern. Med. 146 (11): 797–808. PMID 17548411. http://www.annals.org/cgi/reprint/146/11/797. 

·  ^ Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N, Healey L, Kaplan S, Liang M, Luthra H (1988). "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.". Arthritis Rheum 31 (3): 315–24. doi:10.1002/art.1780310302. PMID 3358796. http://www.rheumatology.org/publications/classification/ra/ra.asp?aud=mem. 

·  ^ a b Berkow R, ed (1992). The Merck Manual (16th ed.). Merck Publishing Group. pp. 1307–08. ISBN 0-91191-016-6. 

·  ^ "SUNY Stony Brook Pathology Department HBP310 Immunology". http://www.path.sunysb.edu/coursemat/hbp310immun.htm. Retrieved on 2008-09-20. 

·  ^ "Hypersensitivity reactions". http://pathmicro.med.sc.edu/ghaffar/hyper00.htm. Retrieved on 2008-09-20. 

·  ^ "Lecture 14: Hypersensitivity". http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html. Retrieved on 2008-09-20. 

·  ^ Edwards JC, Cambridge G, Abrahams VM (June 1999). "Do self-perpetuating B lymphocytes drive human autoimmune disease?". Immunology 97 (2): 188–96. doi:10.1046/j.1365-2567.1999.00772.x. PMID 10447731. 

·  ^ Alvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, et al (September 2005). "Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction". Ann. Rheum. Dis. 64 (9): 1357–9. doi:10.1136/ard.2004.033514. PMID 16100341. http://ard.bmj.com/cgi/content/abstract/64/9/1357. 

·  ^ Ferrell PB, Aitcheson CT, Pearson GR, Tan EM (March 1981). "Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis". J. Clin. Invest. 67 (3): 681–7. doi:10.1172/JCI110083. PMID 6259207. 

·  ^ Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH (November 1979). "Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis". Proc. Natl. Acad. Sci. U.S.A. 76 (11): 5825–8. doi:10.1073/pnas.76.11.5825. PMID 230491. 

·  ^ Balandraud N, Roudier J, Roudier C (July 2004). "Epstein-Barr virus and rheumatoid arthritis". Autoimmun Rev 3 (5): 362–7. doi:10.1016/j.autrev.2004.02.002. PMID 15288002. 

·  ^ Plenge RM, Seielstad M, Padyukov L, et al (September 2007). "TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study". N. Engl. J. Med. 357 (12): 1199–209. doi:10.1056/NEJMoa073491. PMID 17804836. 

·  ^ Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (October 2004). "A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis". Arthritis Rheum. 50 (10): 3085–92. doi:10.1002/art.20553. PMID 15476204. 

·  ^ Boland EW, Headley NE (June 1951). "Results of long-continued cortisone administration in rheumatoid arthritis". Calif Med 74 (6): 416–423. 

·  ^ O'Dell J (2004). "Therapeutic strategies for rheumatoid arthritis.". N Engl J Med 350 (25): 2591–602. doi:10.1056/NEJMra040226. PMID 15201416. 

·  ^ Hasler P (June 2006). "Biological therapies directed against cells in autoimmune disease.". Springer Semin Immunopathol 27 (4): 443–56. doi:10.1007/s00281-006-0013-8. PMID 16738955. 

·  ^ Vital E, Emery P (Sep 15 2005). "Advances in the treatment of early rheumatoid arthritis.". Am Fam Physician 72 (6): 1002, 1004. PMID 16190499. http://www.aafp.org/afp/20050915/editorials.html. 

·  ^ Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T (2004). "Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.". N Engl J Med 350 (25): 2572–81. doi:10.1056/NEJMoa032534. PMID 15201414. 

·  ^ Fresenius HemoCare, Inc., "New Hope for Rheumatoid Arthritis Patients," press release, September 17, 1999.

·  ^ Hart FD (March 1976). "History of the treatment of rheumatoid arthritis". Br Med J 1 (6012): 763–5. PMID 177148. 

·  ^ Franke A, Reiner L, Pratzel HG, Franke T, Resch KL (August 2000). "Long-term efficacy of radon spa therapy in rheumatoid arthritis--a randomized, sham-controlled study and follow-up". Rheumatology (Oxford) 39 (8): 894–902. doi:10.1093/rheumatology/39.8.894. PMID 10952746. http://rheumatology.oxfordjournals.org/cgi/content/full/39/8/894. 

·  ^ S. Wright, M. Ware and G. Guy (2006). "The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis (LTE)". Rheumatology (Oxford) 45: 781. doi:10.1093/rheumatology/kel114. PMID 16621924. http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781. 

·  ^ Lee1 MS, Shin B-C, Ernst E (2008). "Acupuncture for rheumatoid arthritis: a systematic review". Rheumatology 47: 1747–53. doi:10.1093/rheumatology/ken330. PMID 18710899. 

·  ^ Excess mortality in rheumatoid arthritis

·  ^ The second largest contributor of mortality is cerebrovascular disease. Increased risk of heart disease in rheumatoid arthritis patients

·  ^ Cardiac disease in rheumatoid arthritis

·  ^ Alamanos Y, Voulgari PV, Drosos AA (2006). "Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review". Semin. Arthritis Rheum. 36 (3): 182–8. doi:10.1016/j.semarthrit.2006.08.006. PMID 17045630. 

·  ^ http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm Tennessee Origins of Rheumatoid Arthritis

·  ^ http://www.arc.org.uk/newsviews/arctdy/104/bones.htm Bones of Contention

·  ^ Rothschild BM, Rothschild C, Helbling M (2003). "Unified theory of the origins of erosive arthritis: conditioning as a protective/directing mechanism?". J. Rheumatol. 30 (10): 2095–102. PMID 14528501. 

·  ^ Scientist finds surprising links between arthritis and tuberculosis

·  ^ Appelboom T, de Boelpaepe C, Ehrlich GE, Famaey JP (1981). "Rubens and the question of antiquity of rheumatoid arthritis". JAMA 245 (5): 483–6. doi:10.1001/jama.245.5.483. PMID 7005475. 

·  ^ http://japan.medscape.com/viewarticle/538251 Did RA travel from New World to Old? The Rubens connection

·  ^ Dequeker J., Rico H. (1992). "Rheumatoid arthritis-like deformities in an early 16th-century painting of the Flemish-Dutch school". JAMA 268: 249–251. doi:10.1001/jama.268.2.249. PMID 1608144. 

·  ^ GarrodAB (1859). The Nature and Treatment of Gout and Rheumatic Gout. London: Walton and Maberly. 

·  ^ "The Insider: Amgen recruits high-flier to help Enbrel sales take off". Seattle Post-Intelligencer. 2007-11-07. http://seattlepi.nwsource.com/business/113804_theinsider24.shtml. Retrieved on 2003-03-24. 

·  ^ ""Sopranos" Star Aida Turturro Brings Rheumatoid Arthritis Awareness Campaign to Philadelphia". http://findarticles.com/p/articles/mi_pwwi/is_200308/ai_mark654573218. Retrieved on 2007-12-18.
^ a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ a b c d e f Anisur Rahman and David A. Isenberg (February 28, 2008). "Review Article: Systemic Lupus Erythematosus". N Engl J Med 358 (9): 929–939. doi:10.1056/NEJMra071297. PMID 18305268. http://content.nejm.org/cgi/content/full/358/9/929. 
^ "LUPUS FOUNDATION OF AMERICA". http://www.lupus.org/education/stats.html#1. Retrieved on 2007-07-04. 
^ a b Harrison's Internal Medicine, 17th ed. Chapter 313. Systemic Lupus Erythematosus.
^ Discoid Lupus Erythematosus
^ a b c d "Handout on Health: Systemic Lupus Erythematosus". The National Institute of Arthritis and Musculoskeletal and Skin Diseases. National Institutes of Health. August 2003. http://www.niams.nih.gov/Health_Info/Lupus/default.asp. Retrieved on 2007-11-23. 
^ "Lupus, "The Great Imitator"". University Health Care. http://healthcare.utah.edu/healthtools/articles/lupus.html. Retrieved on 2009-02-03. 
^ "Lupus: Symptoms - MayoClinic.com". http://www.mayoclinic.com/health/lupus/DS00115/DSECTION=symptoms. Retrieved on 2008-07-14. 
^ a b Joint and Muscle Pain Lupus Foundation of America
^ Hodkinson B, Musenge E, Tikly M (February 2009). "Osteoarticular tuberculosis in patients with systemic lupus erythematosus". QJM. doi:10.1093/qjmed/hcp015. PMID 19246552. http://qjmed.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=19246552. 
^ Hemminki K, Li X, Sundquist J, Sundquist K (February 2009). "Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions". Arthritis Rheum. 60 (3): 661–668. doi:10.1002/art.24328. PMID 19248111. 
^ Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H, et al (February 2009). "Risk factors of vertebral fractures in women with systemic lupus erythematosus". Clin. Rheumatol.. doi:10.1007/s10067-009-1105-3. PMID 19224131. 
^ Syuto T, Shimizu A, Takeuchi Y, et al (February 2009). "Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus". Clin. Rheumatol.. doi:10.1007/s10067-009-1123-1. PMID 19224124. 
^ Yu Asanuma, M.D., Ph.D., Annette Oeser, B.S., Ayumi K. Shintani, Ph.D., M.P.H., Elizabeth Turner, M.D., Nancy Olsen, M.D., Sergio Fazio, M.D., Ph.D., MacRae F. Linton, M.D., Paolo Raggi, M.D., and C. Michael Stein, M.D. (2003). "Premature coronary-artery atherosclerosis in systemic lupus erythematosus". New England Journal of Medicine 349 (Dec. 18): 2407–2414. doi:10.1056/NEJMoa035611. PMID 14681506 Abstract (full text requires registration). 
^ Bevra Hannahs Hahn, M.D. (2003). "Systemic lupus erythematosus and accelerated atherosclerosis". New England Journal of Medicine 349 (Dec. 18): 2379–2380. doi:10.1056/NEJMp038168. PMID 14681501 Extract (full text requires registration). http://content.nejm.org/cgi/content/full/349/25/2379. 
^ Mary J. Roman, M.D., Beth-Ann Shanker, A.B., Adrienne Davis, A.B., Michael D. Lockshin, M.D., Lisa Sammaritano, M.D., Ronit Simantov, M.D., Mary K. Crow, M.D., Joseph E. Schwartz, Ph.D., Stephen A. Paget, M.D., Richard B. Devereux, M.D., and Jane E. Salmon, M.D. (2003). "Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus". New England Journal of Medicine 349 (Dec. 18): 2399–2406. doi:10.1056/NEJMoa035471. PMID 14681505 Abstract (full text requires registration). 
^ "General Pathology Images for Immunopathology". http://erl.pathology.iupui.edu/C603/GENE607.HTM. Retrieved on 2007-07-24. 
^ "The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes". Arthritis Rheum. 42 (4): 599–608. April 1999. doi:10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F. PMID 10211873. 
^ a b c Honczarenko K, Budzianowska A, Ostanek L (2008). "Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome". Neurol. Neurochir. Pol. 42 (6): 513–517. PMID 19235104. http://www.neurology.termedia.pl/showarticle.php?id=11794. 
^ Omdal R (2002). "Some controversies of neuropsychiatric systemic lupus erythematosus". Scand. J. Rheumatol. 31 (4): 192–7. doi:10.1080/030097402320318369. PMID 12369649. 
^ Xue Z, Wang X, Liu F, et al (February 2009). "Intracranial hypertension syndrome in systemic lupus erythematosus: Clinical analysis and review of the literature". J. Huazhong Univ. Sci. Technol. Med. Sci. 29 (1): 107–11. doi:10.1007/s11596-009-0123-3 (inactive 2009-03-23). PMID 19224175. 
^ D'Cruz DP (April 2006). "Systemic lupus erythematosus". BMJ 332 (7546): 890–4. doi:10.1136/bmj.332.7546.890. PMID 16613963. 
^ Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB (September 2005). "Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support". J. Rheumatol. 32 (9): 1699–705. PMID 16142863. http://www.jrheum.com/subscribers/05/09/1699.html. 
^ Medeiros PB, Febrônio MV, Bonfá E, Borba EF, Takiuti AD, Silva CA (January 2009). "Menstrual and hormonal alterations in juvenile systemic lupus erythematosus". Lupus 18 (1): 38–43. doi:10.1177/0961203308094652. PMID 19074167. http://lup.sagepub.com/cgi/pmidlookup?view=long&pmid=19074167. 
^ Abdallah M, B'Chir Hamzaoui S, Bouslama K, et al (October 2005). "[Acute pancreatitis associated with hemophagocytic syndrome in systemic lupus erythematous: a case report]" (in French). Gastroenterol. Clin. Biol. 29 (10): 1054–6. PMID 16435516. 
^ Yoshida S, Takeuchi T, Itami Y, et al (February 2009). "[Hemophagocytic syndrome as primary manifestation in a patient with systemic lupus erythematosus after parturition]" (in Japanese) ([dead link] – Scholar search). Nihon Rinsho Meneki Gakkai Kaishi 32 (1): 66–70. PMID 19252381. http://joi.jlc.jst.go.jp/JST.JSTAGE/jsci/32.66?from=PubMed. 
^ Carr EJ, Clatworthy MR, Lowe CE, et al (March 2009). "Contrasting genetic association of IL2RA with SLE and ANCA - associated vasculitis". BMC Med. Genet. 10 (1): 22. doi:10.1186/1471-2350-10-22. PMID 19265545. 
^ Zielonka TM, Demkow U, Zycinska K, et al (December 2008). "Angiogenic activity of sera from patients with systemic autoimmune diseases in relation to clinical, radiological, and functional pulmonary status". J. Physiol. Pharmacol. 59 Suppl 6: 791–800. PMID 19218706. http://www.jpp.krakow.pl/journal/archive/1208_s6/pdf/791_1208_s6_article.pdf. 
^ Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA (March 2009). "Risks of myeloid malignancies in patients with autoimmune conditions". Br. J. Cancer 100 (5): 822–8. doi:10.1038/sj.bjc.6604935. PMID 19259097. 
^ a b D'Cruz DP, Khamashta MA, Hughes GR (February 2007). "Systemic lupus erythematosus". Lancet 369 (9561): 587–96. doi:10.1016/S0140-6736(07)60279-7. PMID 17307106. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)60279-7. Retrieved on 2009-02-01. 
^ Kanta H, Mohan C (March 2009). "Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation". Genes Immun.. doi:10.1038/gene.2009.6. PMID 19262576. 
^ Martens HA, Nolte IM, van der Steege G, et al (March 2009). "An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus". Scand. J. Rheumatol.: 1–7. doi:10.1080/03009740802552469. PMID 19255932. http://www.informaworld.com/openurl?genre=article&doi=10.1080/03009740802552469&magic=pubmed||1B69BA326FFE69C3F0A8F227DF8201D0. 
^ a b c Yang W, Ng P, Zhao M, et al (February 2009). "Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese". Genes Immun.. doi:10.1038/gene.2009.1. PMID 19225526. 
^ Kim K, Sung YK, Kang CP, Choi CB, Kang C, Bae SC (March 2009). "A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis". Genes Immun.. doi:10.1038/gene.2009.5. PMID 19262578. 
^ Rhodes B, Vyse TJ (November 2008). "The genetics of SLE: an update in the light of genome-wide association studies". Rheumatology (Oxford) 47 (11): 1603–11. doi:10.1093/rheumatology/ken247. PMID 18611920. 
^ Burry, J. (1969). "Lipstick and lupus erythematosus". New England Journal of Medicine 281: 620–621. 
^ Wang J, Kay AB, Fletcher J, Formica MK & McAlindon TE (2008). "Is lipstick associated with the development of systemic lupus erythematosus (SLE)?". Clinical Rheumatology 29 (9): 1183–1197. doi:10.1007/s10067-008-0937-6. 
^ Masters, K. (2009). "Lupus And Lipstick: The Industry Responds". The Internet Journal of Dermatology 7 (1). http://www.ispub.com/journal/the_internet_journal_of_dermatology/volume_7_number_1_18/article/lupus_and_lipstick_the_industry_responds.html. 
^ Mary K. Crow (February 28, 2008). "Collaboration, Genetic Associations, and Lupus Erythematosus". N Engl J Med 358 (9): 956–961. doi:10.1056/NEJMe0800096. PMID 18204099. http://content.nejm.org/cgi/content/full/358/9/956. 
^ Geoffrey Hom, Robert R. Graham, Barmak Modrek, et al. (February 28, 2008). "Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX". N Engl J Med 358 (9): 900–909. doi:10.1056/NEJMoa0707865. PMID 18204098. http://content.nejm.org/cgi/content/full/358/9/900. 
^ University of South Carolina School of Medicine lecture notes, Immunology, Hypersensitivity reactions. General discussion of hypersensitivity, not specific to SLE.
^ Gaipl, U S; Kuhn, A; Sheriff, A; Munoz, L E; Franz, S; Voll, R E; Kalden, J R; Herrmann, M (2006). "Clearance of apoptotic cells in human SLE". Current directions in autoimmunity 9: 173–87. PMID : 1639466 Abstract (full text requires registration). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16394661&dopt=Abstract. 
^ Gaipl US, Munoz LE, Grossmayer G, et al (2007). "Clearance deficiency and systemic lupus erythematosus (SLE)". J. Autoimmun. 28 (2-3): 114–21. doi:10.1016/j.jaut.2007.02.005. PMID 17368845. 
^ Poole BD, Schneider RI, Guthridge JM, et al (February 2009). "Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus". Arthritis Rheum. 60 (3): 848–859. doi:10.1002/art.24306. PMID 19248110. 
^ Pan HF, Wu GC, Li WP, Li XP, Ye DQ (February 2009). "High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus". Mol. Biol. Rep.. doi:10.1007/s11033-009-9485-7. PMID 19247800. 
^ Buyon JP, Clancy RM (December 2003). "Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach". Semin. Arthritis Rheum. 33 (3): 140–54. doi:10.1016/j.semarthrit.2003.09.002. PMID 14671725. http://linkinghub.elsevier.com/retrieve/pii/S0049017203001598. 
^ Iizuka N, Okamoto K, Hirohata S, Kato T (February 2009). "[Analysis of autoantigens in patients with systemic lupus erythematosus by using proteomic approach]" (in Japanese) ([dead link] – Scholar search). Nihon Rinsho Meneki Gakkai Kaishi 32 (1): 43–7. PMID 19252377. http://joi.jlc.jst.go.jp/JST.JSTAGE/jsci/32.43?from=PubMed. 
^ NIM encyclopedic article on the LE cell test
^ Rheumatology.org article on the classification of rheumatic diseases
^ Revision of Rheumatology.org's diagnostic criteria
^ a b c d e f g h i j k Edworthy SM, Zatarain E, McShane DJ, Bloch DA (1988). "Analysis of the 1982 ARA lupus criteria data set by recursive partitioning methodology: new insights into the relative merit of individual criteria". J. Rheumatol. 15 (10): 1493–8. PMID 3060613. 
^ UpToDate Patient information article on DNA antibodies
^ Mnemonic for 11 criteria of American College of Rheumatology
^ Asherson RA, Cervera R, de Groot PG, et al (2003). "Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines". Lupus 12 (7): 530–4. doi:10.1191/0961203303lu394oa. PMID 12892393. 
^ Sangle S, D'Cruz DP, Hughes GR (2005). "Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies". Ann. Rheum. Dis. 64 (1): 147–8. doi:10.1136/ard.2004.020743. PMID 15608315. 
^ Hughes GR, Khamashta MA (2003). "Seronegative antiphospholipid syndrome". Ann. Rheum. Dis. 62 (12): 1127. doi:10.1136/ard.2003.006163. PMID 14644846. 
^ Hughes GR (1998). "Is it lupus? The St. Thomas' Hospital "alternative" criteria". Clin. Exp. Rheumatol. 16 (3): 250–2. PMID 9631744. 
^ Mayra. Almost Lost to Lupus. As Told by Her Father, Victor Dengler
^ Cochat P, Fargue S, Mestrallet G, et al (February 2009). "Disease recurrence in paediatric renal transplantation". Pediatr. Nephrol.. doi:10.1007/s00467-009-1137-6. PMID 19247694. 
^ Foocharoen C, Nanagara R, Salang L, Suwannaroj S, Mahakkanukrauh A (February 2009). "Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital". J Med Assoc Thai 92 (2): 167–74. PMID 19253790. 
^ Poor prognostic factors,Sudheer, SLE document
^ [EARLY STEROIDS MAY PREVENT RELAPSES IN LUPUS, P Jarman (Published in Journal Watch (General) July 18, 1995)
^ a b c d e Danchenko N, Satia JA, Anthony MS (2006). "Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden". Lupus 15 (5): 308–18. doi:10.1191/0961203306lu2305xx. PMID 16761508. http://openurl.ingenta.com/content/nlm?genre=article&issn=0961-2033&volume=15&issue=5&spage=308&aulast=Danchenko. 
^ a b "OMHD|AMH|Factsheets|Lupus". http://www.cdc.gov/omhd/AMH/factsheets/lupus.htm. 
^ Rahman A, Isenberg DA (February 2008). "Systemic lupus erythematosus". N. Engl. J. Med. 358 (9): 929–39. doi:10.1056/NEJMra071297. PMID 18305268. 
^ a b c Hochberg MC (October 1991). "The history of lupus erythematosus". Md Med J 40 (10): 871–3. PMID 1943516. 
^ Jeri Jewett-Tennant. Celebrities with Lupus: Michael Jackson. Updated: August 11, 2008.
^ Jeri Jewett-Tennant. Celebrities with Lupus: Seal. Updated: August 11, 2008.
^ A battle with the wolf. Anthony Gardner, Mail on Sunday, October 10, 2008.
^ Former chess coach named to Hall of Fame. Gary Cramer. Penn State Intercom, September 26, 2002.
^ J Dilla/Jay Dee. Retrieved February 2, 2009.
^ 1963: Labour leader Hugh Gaitskell dies. BBC News, On This Day, January 18, 1963.
^ In the Beginning, 1949~1954 - Teddi King. Allaboutjazz.com. Retrieved February 2, 2009.
^ Celebrities with Lupus: Charles Kuralt. Updated: August 11, 2008.
^ Famous Lupus Patient: Ferdinand Marcos. Updated: August 11, 2008.
^ Flannery O'Connor (1925-1964). New Georgia Encyclopedia. Sarah Gordon, Georgia College and State University. Updated 3/21/2008
^ Dennis Mclellan. Michael Wayne, 68; Producer, Guardian of His Father’s Legacy. Los Angeles Times, April 4, 2003.
^ Jeri Jewett-Tennant. Celebrities with Lupus: Ray Walston. Updated: August 11, 2008.
^ Jeri Jewett-Tennant. Celebrities with Lupus: Tim Raines. Updated: August 28, 2008
^ Celebrities with Lupus: Mary Elizabeth McDonough. Updated: October 28, 2008.
^ Biography. Retrieved February 2, 2009.
^ Jeri Jewett-Tennant. Celebrities with Lupus: Mercedes Scelba-Shorte. Updated: August 28, 2008.
^ Hirschhorn N, Greaves IA. Louisa May Alcott, her mysterious illness. Perspectives in Biology and Medicine 2007;50(2):243-259.
^ Angie Davidson interviews top glamour model Sophie Howard Lupus.org.uk, accessed 21 November 2008
^ Jeri Jewett-Tennant. Celebrities with Lupus: Lauren Schuler Donner. Updated: August 28, 2008
^ systemic scleroderma at Dorland's Medical Dictionary
^ systemic sclerosis at Dorland's Medical Dictionary
^ Hinchcliff M, Varga J (October 2008). "Systemic sclerosis/scleroderma: a treatable multisystem disease". Am Fam Physician 78 (8): 961–8. PMID 18953973. 
^ a b c d Klippel, John H.. Primer On the Rheumatic Diseases 11ED. Atlanta, GA: Arthritis Foundation. ISBN 1-912423-16-2. 
^ Valentini G, Black C (2002). "Systemic sclerosis". Best practice & research. Clinical rheumatology 16 (5): 807–16. doi:10.1053/berh.2002.0258. PMID 12473275. 
^ Olsen NJ, King LE, Park JH (1996). "Muscle abnormalities in scleroderma". Rheum. Dis. Clin. North Am. 22 (4): 783–96. doi:10.1016/S0889-857X(05)70301-X. PMID 8923596. 
^ Steen VD (2005). "The lung in systemic sclerosis". Journal of clinical rheumatology 11 (1): 40–6. PMID 16357695. 
^ a b c Sallam H, McNearney TA, Chen JD (2006). "Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)". Aliment. Pharmacol. Ther. 23 (6): 691–712. doi:10.1111/j.1365-2036.2006.02804.x. PMID 16556171. 
^ a b c Rose S, Young MA, Reynolds JC (1998). "Gastrointestinal manifestations of scleroderma". Gastroenterol. Clin. North Am. 27 (3): 563–94. doi:10.1016/S0889-8553(05)70021-2. PMID 9891698. 
^ Hendel L, Hage E, Hendel J, Stentoft P (1992). "Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis". Aliment. Pharmacol. Ther. 6 (5): 565–77. PMID 1420748. 
^ Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002). "Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis". Journal of the Medical Association of Thailand 85 (11): 1204–9. PMID 12546318. 
^ Steen VD, Mayes MD, Merkel PA (2003). "Assessment of kidney involvement". Clin. Exp. Rheumatol. 21 (3 Suppl 29): S29–31. PMID 12889219. 
^ Steen VD (1994). "Renal involvement in systemic sclerosis". Clin. Dermatol. 12 (2): 253–8. doi:10.1016/S0738-081X(94)90329-8. PMID 8076263. 
^ Steen VD (2003). "Scleroderma renal crisis". Rheum. Dis. Clin. North Am. 29 (2): 315–33. doi:10.1016/S0889-857X(03)00016-4. PMID 12841297. 
^ Rhew EY, Barr WG (2004). "Scleroderma renal crisis: new insights and developments". Current rheumatology reports 6 (2): 129–36. doi:10.1007/s11926-004-0057-5. PMID 15016343. 
^ a b Steen VD, Medsger TA (2000). "Long-term outcomes of scleroderma renal crisis". Ann. Intern. Med. 133 (8): 600–3. PMID 11033587. 
^ a b c Jimenez S, Koenig AS. Scleroderma. eMedicine.com. Accessed: May 22, 2006.
^ Penn H, Howie AJ, Kingdon EJ, et al (August 2007). "Scleroderma renal crisis: patient characteristics and long-term outcomes". QJM 100 (8): 485–94. doi:10.1093/qjmed/hcm052. PMID 17601770. http://qjmed.oxfordjournals.org/cgi/content/full/100/8/485. 
^ Pham PT, Pham PC, Danovitch GM, et al (October 2005). "Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature". Am. J. Transplant. 5 (10): 2565–9. doi:10.1111/j.1600-6143.2005.01035.x. PMID 16162209. http://www.blackwell-synergy.com/doi/full/10.1111/j.1600-6143.2005.01035.x. 
^ a b c d e f g Jimenez SA, Derk CT (2004). "Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis". Ann. Intern. Med. 140 (1): 37–50. PMID 14706971. 
^ "Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee". Arthritis Rheum. 23 (5): 581–90. 1980. PMID 7378088.  Available online at "1980 Criteria for the Classification of Systemic Sclerosis". http://www.rheumatology.org/publications/classification/systsclr.asp. Retrieved on 2007-08-05. 
^ Bianchi DW (2000). "Fetomaternal cell trafficking: a new cause of disease?". Am. J. Med. Genet. 91 (1): 22–8. doi:10.1002/(SICI)1096-8628(20000306)91:1<22::AID-AJMG4>3.0.CO;2-3. PMID 10751084. 
^ Galan A, Cowper SE, Bucala R (2006). "Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)". Current opinion in rheumatology 18 (6): 614–7. doi:10.1097/01.bor.0000245725.94887.8d. PMID 17053507. 
^ Boyd AS, Zic JA, Abraham JL (2007). "Gadolinium deposition in nephrogenic fibrosing dermopathy". J. Am. Acad. Dermatol. 56 (1): 27–30. doi:10.1016/j.jaad.2006.10.048. PMID 17109993. 
^ Sharma SK, Handa R, Sood R, et al (2004). "Bleomycin-induced scleroderma". The Journal of the Association of Physicians of India 52: 76–7. PMID 15633728. 
^ Farrant PB, Mortimer PS, Gore M (2004). "Scleroderma and the taxanes. Is there really a link?". Clin. Exp. Dermatol. 29 (4): 360–2. doi:10.1111/j.1365-2230.2004.01519.x. PMID 15245529. 
^ Kettaneh A, Al Moufti O, Tiev KP, et al (2007). "Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies". J. Rheumatol. 34 (1): 97–103. PMID 17117485. 

^ Fonseca C, Lindahl GE, Ponticos M, et al (September 2007). "A polymorphism in the CTGF promoter region associated with systemic sclerosis". N. Engl. J. Med. 357 (12): 1210–20. doi:10.1056/NEJMoa067655. PMID 17881752. http://content.nejm.org/cgi/content/full/357/12/1210. 
^ Oliver GF, Winkelmann RK (1989). "The current treatment of scleroderma". Drugs 37 (1): 87–96. PMID 2651089. 
^ a b c d e Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005). "New therapeutic strategies for systemic sclerosis--a critical analysis of the literature". Clin. Dev. Immunol. 12 (3): 165–73. PMID 16295521.  Full text at PMC: 2275417
^ Tashkin DP, Elashoff R, Clements PJ, et al (June 2006). "Cyclophosphamide versus placebo in scleroderma lung disease". N. Engl. J. Med. 354 (25): 2655–66. doi:10.1056/NEJMoa055120. PMID 16790698. http://content.nejm.org/cgi/content/full/354/25/2655. 
^ Hoyles RK, Ellis RW, Wellsbury J, et al (December 2006). "A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma". Arthritis Rheum. 54 (12): 3962–70. doi:10.1002/art.22204. PMID 17133610. http://www3.interscience.wiley.com/cgi-bin/fulltext/113490260/HTMLSTART. 
^ Nash RA, McSweeney PA, Crofford LJ, et al (2007). "High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the U.S. multicenter pilot study". Blood 110 (4): 1388–96. doi:10.1182/blood-2007-02-072389. PMID 17452515. 
^ "Juvenile Scleroderma Network". http://www.jsdn.org/. Retrieved on 2008-05-11. 
^ "Scleroderma Foundation". http://www.scleroderma.org/. Retrieved on 2008-05-11. 
^ "Scleroderma Research Foundation". http://www.srfcure.org. Retrieved on 2008-05-11. .
^ For Hope at the Internet Movie Database
^ Jacques Cartier's Second Voyage , 1535 Winter & Scurvy
^ Martini E (2002). "Jacques Cartier witnesses a treatment for scurvy". Vesalius 8 (1): 2–6. PMID 12422875. 
^ a b Lind, James (1753). A Treatise on the Scurvy. London: A. Millar. 
^ Evans PR (December 1983). "Infantile scurvy: the centenary of Barlow's disease". Br Med J (Clin Res Ed) 287 (6408): 1862–3. doi:10.1136/bmj.287.6408.1862. PMID 6423046. 
^ Stone I (1966). "On the genetic etiology of scurvy". Acta Genet Med Gemellol (Roma) 15 (4): 345–50. PMID 5971711. http://www.seanet.com/~alexs/ascorbate/196x/stone-i-acta_genet_med_et_gemell-1966-v15-p345.htm. 
^ a b Bown, Stephen R. "SCURVY: How a Surgeon, a Mariner and a Gentleman Solved the Greatest Medical Mystery of the Age of Sail", Viking 2003
^ Telegraph newspaper, 5th March 2009, http://www.telegraph.co.uk/news/newstopics/howaboutthat/4943570/Cure-for-scurvy-discovered-by-a-woman.html
^ "The Blood of Nelson" by Glenn Barnett - Military History - Oct 2006
^ Fernandez-Armesto, Felipe (2006). Pathfinders: A Global History of Exploration. W.W. Norton & Company. pp. 297. ISBN 0-393-06259-7. 
^ BBC - History - Captain Cook and the Scourge of Scurvy
^ Fernandez-Armesto, Felipe (2006). Pathfinders: A Global History of Exploration. W.W. Norton & Company. pp. 297–298. ISBN 0-393-06259-7. 
^ a b Scott, Robert F."The Voyage of the Discovery", John Murray, London, 1929
^ Shackleton Ernest"South: The Endurance Expedition", Penguin Books, 2008
^ Simpson, J and Weiner, E: "The Oxford English Dictionary", Oxford University Press, 1989
^ Carpenter, Kenneth J. (2004-06-22). "The Nobel Prize and the Discovery of Vitamins". http://www.nobelprize.org. Nobel Foundation. http://nobelprize.org/nobel_prizes/medicine/articles/carpenter/index.html. Retrieved on 2008-01-25. 
^ "The Albert Szent-Gyorgyi Papers Szeged, 1931-1947: Vitamin C, Muscles, and WWII". http://profiles.nlm.nih.gov. U.S. National Library of Medicine. http://profiles.nlm.nih.gov/WG/Views/Exhibit/narrative/szeged.html. Retrieved on 2008-01-25. 
^ Hampl JS, Taylor CA, Johnston CS (2004). "Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994". Am J Public Health 94 (5): 870–5. doi:10.2105/AJPH.94.5.870. PMID 15117714. PMC: 1448351. http://www.ajph.org/cgi/content/full/94/5/870. 
^ WHO (June 4, 2001) (PDF). Area of work: nutrition. Progress report 2000. http://www.who.int//mipfiles/2299/MIP_01_APR_SDE_3.en.pdf. 
^ Davies IJ, Temperley JM (1967). "A case of scurvy in a student". Postgraduate Medical Journal 43 (502): 549–50. doi:10.1136/pgmj.43.502.539. PMID 6074157. 
^ Sthoeger ZM, Sthoeger D (1991). "[Scurvy from self-imposed diet]" (in Hebrew). Harefuah 120 (6): 332–3. PMID 1879769. 
^ Ellis CN, Vanderveen EE, Rasmussen JE (1984). "Scurvy. A case caused by peculiar dietary habits". Arch Dermatol 120 (9): 1212–4. doi:10.1001/archderm.120.9.1212. PMID 6476860. 
^ McKenna KE, Dawson JF (1993). "Scurvy occurring in a teenager". Clin. Exp. Dermatol. 18 (1): 75–7. doi:10.1111/j.1365-2230.1993.tb00976.x. PMID 8440062. 
^ Rivers JM (1987). "Safety of high-level vitamin C ingestion". Ann. N. Y. Acad. Sci. 498: 445–54. doi:10.1111/j.1749-6632.1987.tb23780.x. PMID 3304071. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1749-6632.1987.tb23780.x. 
^ Nutrition information for "Emergen-C" product
^ Nutrition information for "Halls Defense" product
^ acanthosis nigricans at Dorland's Medical Dictionary
^ Schnopp C, Baumstark J (2007). "Oral acanthosis nigricans". N Engl J Med 357 (9): e10. doi:10.1056/NEJMicm062917. PMID 17761587. 
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
^ Armstrong DJ, McCausland EM, Wright GD (February 2007). "Hypertrophic pulmonary osteoarthropathy (HPOA) (Pierre Marie-Bamberger syndrome): two cases presenting as acute inflammatory arthritis. Description and review of the literature". Rheumatol. Int. 27 (4): 399–402. doi:10.1007/s00296-006-0224-2. PMID 17006703. 
^ Deller A, Heuer B, Wiedeck H (December 1998). "Is myositis ossificans following ARDS a complication of prone-dependency or is it osteoarthropathia hypertrophicans (Bamberger-Marie syndrome)?". Intensive Care Med 24 (12): 1345–6. doi:10.1007/s001340050776. PMID 9885895. http://link.springer-ny.com/link/service/journals/00134/bibs/8024012/80241345.htm. 
^ synd/1756 at Who Named It?
^ E. von Bamberger. Veränderungen der Röhrenknochen bei Bronchiektasie. Wiener klinische Wochenschrift, 1889, 2: 226.
^ P. Marie. De l’osteo-arthropathie hypertrophiante pneumique.Rév Med, Paris, 1890, 10: 1-36.
·  ^ Dalberg K, Hellborg H, Wärnberg F (September 2008). "Paget's disease of the nipple in a population based cohort". Breast Cancer Res. Treat. 111 (2): 313–9. doi:10.1007/s10549-007-9783-5. PMID 17952590. http://dx.doi.org/10.1007/s10549-007-9783-5. 

·  ^ "Paget Disease of the Nipple: Q & A - National Cancer Institute". http://www.cancer.gov/cancertopics/factsheet/Sites-Types/paget-breast. Retrieved on 2009-03-23. 

·  ^ Kollmorgen DR, Varanasi JS, Edge SB, Carson WE (August 1998). "Paget's disease of the breast: a 33-year experience". J. Am. Coll. Surg. 187 (2): 171–7. PMID 9704964. http://linkinghub.elsevier.com/retrieve/pii/S1072-7515(98)00143-4.
http://en.wikipedia.org/wiki/Peau_d%27orange
·  ^ a b c Jackson JM and Callen JP. 2006. Emedicine: Pyoderma Gangrenosum. Retrieved on January 23, 2007.

·  ^ Brooklyn T, Dunnill G, Probert C (2006). "Diagnosis and treatment of pyoderma gangrenosum". BMJ 333 (7560): 181–4. doi:10.1136/bmj.333.7560.181. PMID 16858047. 

·  ^ Shankar S, Sterling JC, Rytina E (2003). "Pustular pyoderma gangrenosum". Clin. Exp. Dermatol. 28 (6): 600–3. doi:10.1046/j.1365-2230.2003.01418.x. PMID 14616824. 

·  ^ Langan SM, Powell FC (2005). "Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature". Int. J. Dermatol. 44 (8): 623–9. doi:10.1111/j.1365-4632.2005.02591.x. PMID 16101860. 

·  ^ Seat belt pyoderma gangrenosum: minor pressure as a causative factor. Rashid RM. J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1273-4.

·  ^ Maintenance on GPnotebook site

·  ^ Reichrath J, Bens G, Bonowitz A, Tilgen W (2005). "Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients". J. Am. Acad. Dermatol. 53 (2): 273–83. doi:10.1016/j.jaad.2004.10.006. PMID 16021123.
^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 
^ Blanc, H. W. (1890). "Anthrax: the disease of the Egyptian plagues". New Orleans Med Surg J 18: 1–25. 
^ Jeanne Guillemin. Anthrax. The Investigation of a Deadly Outbreak
^ "Anthrax" by Jeanne Guillemin, University of California Press, 2001, ISBN 0-520-22917-7, pg. 3
^ Cherkasskiy, B. L. (1999). "A national register of historic and contemporary anthrax foci". Journal of Applied Microbiology 87 (2): 192–195. doi:10.1046/j.1365-2672.1999.00868.x. 
^ David V. Cohn (1996-02-11). "Life and Times of Louis Pasteur". School of Dentistry, University of Louisville. http://louisville.edu/library/ekstrom/special/pasteur/cohn.html. Retrieved on 2008-08-13. 
^ Mikesell, P.; Ivins, B. E.; Ristroph, J. D.; Vodkin, M. H.; Dreier, T. M.; Leppla, S. H. (1983), "Plasmids, Pasteur, and Anthrax" (PDF), ASM News 49: 320–322, http://www.asm.org/ASM/files/CCLIBRARYFILES/FILENAME/0000000221/490783p320.pdf 
^ a b "Robert Koch (1843-1910)". About.com. http://german.about.com/library/blerf_koch.htm. Retrieved on 2008-08-13. 
^ "Can Dogs Get Anthrax?" Canine Nation, 30 October 2001. Retrieved 17 February 2007.
^ Dragon, D. C. (1999). "A review of anthrax in Canada and implications for research on the disease in northern bison". Journal of Applied Microbiology 87: 208. doi:10.1046/j.1365-2672.1999.00872.x. 
^ Suffin, S. C.; Carnes, W. H.; Kaufmann, A. F. (September 1978). "Inhalation anthrax in a home craftsman". Human Pathology 9 (5): 594–597. http://www.ncbi.nlm.nih.gov/pubmed/101438. 
^ "Man who breathed in anthrax dies," BBC News, 2 November 2008. Retrieved 2 November 2008.
^ a b Bravata DM, Holty JE, Liu H, McDonald KM, Olshen RA, Owens DK (2006), Systematic review: a century of inhalational anthrax cases from 1900 to 2005, Annals of Internal Medicine; 144(4): 270–80.
^ "Anthrax, Then and Now". MedicineNet.com. http://www.medicinenet.com/script/main/art.asp?articlekey=18812&page=2. Retrieved on 2008-08-13. 
^ a b "Anthrax Q & A: Signs and Symptoms". Emergency Preparedness and Response. Centers for Disease Control and Prevention. 2003. http://www.bt.cdc.gov/agent/anthrax/faq/signs.asp. Retrieved on 2007-04-19. 
^ ANTHRAX, the investigation of a Deadly Outbreak, Jeanne Guillemin, University of California Press, 1999, ISBN 0=520-22917-7, chart of Russian deaths at Sverdlovsk, 1979, pg 27
^ "Anthrax and tea". Society for Applied Microbiology. 2008-03-17. http://www.sfam.org.uk/newsarticle.php?214&2. Retrieved on 2008-08-13. 
^ ANTHRAX, the investigation of a Deadly Outbreak, Jeanne Guillemin, University of California Press, 1999, ISBN 0=520-22917-7, pg 34
^ "Sandia decon formulation, best known as an anthrax killer, takes on household mold". 2007-04-26. http://www.eurekalert.org/pub_releases/2007-04/dnl-sdf042607.php. Retrieved on 2008-08-13. 
^ "Using Bleach to Destroy Anthrax and Other Microbes". Society for Applied Microbiology. http://ehso.com/bleach.htm. Retrieved on 2008-08-13. 
^ The Bulletin Vol. 57 - No. 36 October 17, 2003PDF (332 KiB)[verification needed]
^ Madigan M; Martinko J (editors). (2005). Brock Biology of Microorganisms (11th ed.). Prentice Hall. ISBN 0-13-144329-1. 
^ Decker, Janet. Deadly Diseases and Epidemics, Anthrax. Chelesa House Publishers, 2003. ISBN 0-7910-7302-5 p 27–28.
^ "Anthrax and Anthrax Vaccine - Epidemiology and Prevention of Vaccine-Preventable Diseases", National Immunization Program, Centers for Disease Control and Prevention, January 2006. (PPT format)
^ Bisher, Jamie, "During World War I, Terrorists Schemed to Use Anthrax in the Cause of Finnish Independence," Military History, August 2003, pp. 17-22. Anthrax Sabotage in Finland
^ [1]
^ "Saddam's germ war plot is traced back to one Oxford cow," The Times
^ "UK planned to wipe out Germany with anthrax". Sunday Herald (Glasgow). 2001-10-14. http://www.fpp.co.uk/bookchapters/WSC/Bwar2.html. Retrieved on 2008-08-13. 
^ Southern African News Feature : the plague wars
^ ANTHRAX, the investigation of a Deadly Outbreak, Jeanne Guillemin, University of California Press, 1999, ISBN 0=520-22917-7, names of victims, pg 275-277
^ Guillmin, op. cit.
^ "Plague war: The 1979 anthrax leak". Frontline. PBS. http://www.pbs.org/wgbh/pages/frontline/shows/plague/sverdlovsk/. Retrieved on 2008-08-13. 
^ Michael C. Fishbein. "Anthrax - From Russia with Love". Infectious Diseases: Causes, Types, Prevention, Treatment and Facts. MedicineNet.com. http://www.medicinenet.com/script/main/art.asp?articlekey=18982. Retrieved on 2008-08-13. 
^ a b Alibek, K. Biohazard. New York, New York: Dell Publishing, 1999.
^ a b Meselson, M. et al (1994). "The Sverdlovsk Outbreak of 1979". Science 266(5188) 1202–1208
^ Sternbach, G. (2002). "The History of Anthrax". The Journal of Emergency Medicine 24(4) 463–467.
^ Bohn, Kevin (2008-08-06). "U.S. officials declare researcher is anthrax killer". CNN. http://www.cnn.com/2008/CRIME/08/06/anthrax.case/index.html. Retrieved on 2008-08-07. 
^ "Cepheid, Northrop Grumman Enter Into Agreement for the Purchase of Anthrax Test Cartridges". Security Products. 2007-16-08. http://secprodonline.com/articles/2007/08/16/cepheid-northrop-grumman.aspx. Retrieved on 2009-26-03. 
^ "Latest Facts Update". USPS. 2002-02-12. http://www.usps.com/news/facts/lfu_021202.htm. Retrieved on 2008-08-13. 
^ "High school senior discovers ironing deactivates anthrax," Pittsburgh Tribune-Review, 20 February 2006
^ Nowakowski, John, et al. "Failure of Treatment with Cephalexin for Lyme Disease." Archives of Family Medicine, Vol. 9, June 2000.
^ Vinh DC, Embil JM (September 2007). "Severe skin and soft tissue infections and associated critical illness". Curr Infect Dis Rep 9 (5): 415–21. PMID 17880853. 
^ Douso ML (2009). "Hyperbaric oxygen therapy as adjunctive treatment for postoperative cellulitis involving intrapelvic mesh". J Minim Invasive Gynecol 16 (2): 222–3. doi:10.1016/j.jmig.2008.12.007. PMID 19249714. 
^ Escobar SJ, Slade JB, Hunt TK, Cianci P (2005). "Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate". Undersea Hyperb Med 32 (6): 437–43. PMID 16509286. http://archive.rubicon-foundation.org/4061. Retrieved on 2009-03-07. 
^ Adam EN, Southwood LL (August 2006). "Surgical and traumatic wound infections, cellulitis, and myositis in horses". Vet. Clin. North Am. Equine Pract. 22 (2): 335–61, viii. doi:10.1016/j.cveq.2006.04.003. PMID 16882479. http://journals.elsevierhealth.com/retrieve/pii/S0749-0739(06)00031-9. Retrieved on 2009-03-07. 
^ Fjordbakk CT, Arroyo LG, Hewson J (February 2008). "Retrospective study of the clinical features of limb cellulitis in 63 horses". Vet. Rec. 162 (8): 233–6. PMID 18296664. http://veterinaryrecord.bvapublications.com/cgi/pmidlookup?view=long&pmid=18296664. Retrieved on 2009-03-07. 
Cellulitis Overview (with picture).
King, Christine, BVSc, MACVSc, and Mansmann, Richard, VDM, PhD. "Equine Lameness." Equine Research, Inc. 1997. Pages 548-549.
MFMER. 'Cellulitis'. 3 July 2002. Mayo Foundation for Medical Education and Research. 30 Oct. 2003 [1].
NLM. 'Group A streptococcal infections'. 2002. National Library of Medicine. 30 Oct. 2003 [2].
Pankey, George A. "Approach to rashes and infections of the skin and subcutaneous tissues." Textbook of internal medicine. 2nd ed. 2 vols. Philadelphia: J. B. Lippincott Company, 1992.
·  ^ erysipelas at Dorland's Medical Dictionary

·  ^ See eMedicine link

·  ^ Koster JB, Kullberg BJ, van der Meer JW (2007). "Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies". The Netherlands journal of medicine 65 (3): 89–94. PMID 17387234. 

·  ^ Wollenweber, Brother Leo (2002) "Meet Solanus Casey", St. Anthony Messanger Press, Cincinnati, Ohio Page 107 ISBN 1-56955-281-9

·  ^ Capaldi, Nicholas (2004). John Stuart Mill: a biography. Cambridge, UK: CambridgeUniversity Press. pp. 356. ISBN 0-521-62024-4.
^ MedlinePlus Encyclopedia Hot tub folliculitis
^ boil at Dorland's Medical Dictionary
^ exfoliatin at Dorland's Medical Dictionary
^ tinea at Dorland's Medical Dictionary
^ ringworm at Dorland's Medical Dictionary
http://en.wikipedia.org/wiki/Kerion
·  ^ a b James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ a b Walsh TJ, Dixon DM (1996). "Deep Mycoses". in Baron S et al eds. (via NCBI Bookshelf). Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.4006. 

·  ^ a b c MedlinePlus Encyclopedia Vaginal yeast infection

·  ^ a b c Fidel PL (2002). "Immunity to Candida". Oral Dis. 8: 69–75. doi:10.1034/j.1601-0825.2002.00015.x. PMID 12164664. 

·  ^ a b Pappas PG (2006). "Invasive candidiasis". Infect. Dis. Clin. North Am. 20 (3): 485–506. doi:10.1016/j.idc.2006.07.004. PMID 16984866. 

·  ^ Mulley, A. G.; Goroll, A. H. (2006). Primary Care Medicine: office evaluation and management of the adult patient. Philadelphia: Wolters Kluwer Health. pp. 802–3. ISBN 0-7817-7456-X. http://books.google.com/books?id=aWQhTbwoM9EC&pg=RA1-PA802&lpg=RA1-PA802. Retrieved on 2008-11-23. 

·  ^ Mårdh P A, Novikova N, Stukalova E (October 2003). "Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis". BJOG 110 (10): 934–7. PMID 14550364. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1470-0328&date=2003&volume=110&issue=10&spage=934. 

·  ^ a b Schiefer HG (1997). "Mycoses of the urogenital tract". Mycoses 40 Suppl 2: 33–6. PMID 9476502. 

·  ^ Yamaguchi N, Sonoyama K, Kikuchi H, Nagura T, Aritsuka T, Kawabata J (January 2005). "Gastric colonization of Candida albicans differs in mice fed commercial and purified diets". J. Nutr. 135 (1): 109–15. PMID 15623841. http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=15623841. 

·  ^ Nwokolo N C, Boag F C (May 2000). "Chronic vaginal candidiasis. Management in the postmenopausal patient". Drugs Aging 16 (5): 335–9. PMID 10917071. 

·  ^ Odds FC (1987). "Candida infections: an overview". Crit. Rev. Microbiol. 15 (1): 1–5. PMID 3319417. 

·  ^ David LM, Walzman M, Rajamanoharan S (October 1997). "Genital colonisation and infection with candida in heterosexual and homosexual males". Genitourin Med 73 (5): 394–6. PMID 9534752. 

·  ^ Moosa MY, Sobel JD, Elhalis H, Du W, Akins RA (2004). "Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium". Antimicrob. Agents Chemother. 48 (1): 161–7. doi:10.1128/AAC.48.1.161-167.2004. PMID 14693534. 

·  ^ "Thrush". www.askdrsears.com. http://www.askdrsears.com/html/8/T083100.asp. 

·  ^ Craigmill A (December 1991). "Gentian Violet Policy Withdrawn". Cooperative Extension University of California -- Environmental Toxicology Newsletter 11 (5). http://extoxnet.orst.edu/newsletters/n115_91.htm. 

·  ^ Cowen LE, Nantel A, Whiteway MS, et al (July 2002). "Population genomics of drug resistance in Candida albicans". Proc. Natl. Acad. Sci. U.S.A. 99 (14): 9284–9. doi:10.1073/pnas.102291099. PMID 12089321. 

·  ^ "International Code of Botanical Nomenclature". written at Königstein. 2000. http://www.bgbm.org/iapt/nomenclature/code/SaintLouis/0000St.Luistitle.htm. Retrieved on 2008-11-23. 

·  ^ Crook, William G. (1986). The yeast connection: a medical breakthrough. New York: Vintage Books. ISBN 0394747003. 

·  ^ Weil A (2002-10-25). "Concerned About Candidiasis?". Weil Lifestyle. http://www.drweil.com/u/QA/QA125503/. Retrieved on 2008-02-21. 

·  ^ Barrett S (2005-10-08). "Dubious "Yeast Allergies"". QuackWatch. http://www.quackwatch.org/01QuackeryRelatedTopics/candida.html. Retrieved on 2008-02-21.
·  ^ http://the.honoluluadvertiser.com/article/2007/Apr/19/il/FP704190309.html The Honolulu Advertiser: What is haole rot?

·  ^ tinea versicolor at Dorland's Medical Dictionary

·  ^ Morishita N; Sei Y. Microreview of Pityriasis versicolor and Malassezia species. Mycopathologia. 2006 Dec;162(6):373-6

·  ^ Prohic A; Ozegovic L. Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor. Mycoses. 2007 Jan;50(1):58-63.

·  ^ Morishita N; Sei Y. Microreview of Pityriasis versicolor and Malassezia species. Mycopathologia. 2006 Dec;162(6):373-6

·  ^ Weedon, D. 2002. Skin pathology. 2nd Ed. Churchil Livingstone. ISBN 0-443-07069-5

·  ^ Inamadar AC, Palit A (2003). "The genus Malassezia and human disease". Indian J Dermatol Venereol Leprol 69 (4): 265–70. PMID 17642908. http://www.ijdvl.com/article.asp?issn=0378-6323;year=2003;volume=69;issue=4;spage=265;epage=270;aulast=Inamadar. 

·  ^ "Adolescent Health Curriculum - Medical Problems - Dermatology - Papulosquamous Lesions (B4)". http://www.usc.edu/student-affairs/Health_Center/adolhealth/content/b4derm4.html. Retrieved on 2008-12-10. 

·  ^ "Tioconazole (Topical Route) - MayoClinic.com". http://www.mayoclinic.com/health/drug-information/DR601345. Retrieved on 2008-12-10. 

·  ^ Weedon, D. 2002. Skin pathology. 2nd Ed. Churchil Livingstone. ISBN 0-443-07069-5

·  ^ MedlinePlus Medical Encyclopedia: Tinea versicolor

·  ^ Ratnavel RC, Squire RA, Boorman GC (2007). "Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis". J Dermatolog Treat 18 (2): 88–96. doi:10.1080/16537150601092944. PMID 17520465. 

·  ^ Faergemann J, Gupta AK, Al Mofadi A, Abanami A, Shareaah AA, Marynissen G (January 2002). "Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor". Arch Dermatol 138 (1): 69–73. doi:10.1001/archderm.138.1.69. PMID 11790169. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=11790169. 

·  ^ Mohanty J, Sethi J, Sharma MK (2001). "Efficacy of itraconazole in the treatment of tinea versicolor". Indian J Dermatol Venereol Leprol 67 (5): 240–1. PMID 17664760. http://www.ijdvl.com/article.asp?issn=0378-6323;year=2001;volume=67;issue=5;spage=240;epage=241;aulast=Mohanty. 

·  ^ Damodaran S, Venkataraman S (March 1994). "A study on the therapeutic efficacy of Cassia alata, Linn. leaf extract against Pityriasis versicolor". J Ethnopharmacol 42 (1): 19–23. doi:10.1016/0378-8741(94)90018-3. PMID 8046939. http://linkinghub.elsevier.com/retrieve/pii/0378-8741(94)90018-3.
·  ^ a b Suhaimi, Nur Dianah (April 20 2008). "HFMD: 1,000 cases a week is unusual, says doc". Singapore: The Sunday Times (Straits Times). pp. pp. 1 - 2. 

·  ^ "Hand, Foot and Mouth Disease: Signs & Symptoms". mayoclinic.com. The Mayo Clinic. http://www.mayoclinic.com/health/hand-foot-and-mouth-disease/DS00599/DSECTION=2. Retrieved on 2008-05-05. 

·  ^ a b See also reports from Sarawak Health Department http://www.sarawak.health.gov.my/hfmd.htm#INFO9

·  ^ Centers for Disease Control and Prevention (CDC) (1998). "Deaths among children during an outbreak of hand, foot, and mouth disease--Taiwan, Republic of China, April-July 1998". MMWR Morb. Mortal. Wkly. Rep. 47 (30): 629–32. PMID 9704628. http://www.cdc.gov/mmwr/preview/mmwrhtml/00054640.htm. 

·  ^ a b Ho M, Chen ER, Hsu KH, et al (1999). "An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group". N. Engl. J. Med. 341 (13): 929–35. doi:10.1056/NEJM199909233411301. PMID 10498487. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=10498487&promo=ONFLNS19. 

·  ^ The Hindu : Kerala News : Outbreak of rare child disease in Malappuram

·  ^ Viral epidemic maintains grip in China, with three more deaths (accessed May 15th, 2008)

·  ^ Mass intestinal virus infection kills 19 children -- XinHuaNet.com (Retrieved on May 2, 2008.)

·  ^ Mass intestinal virus infection in east China up to 2,477, kills 21 -- XinHuaNet.com (Retrieved on May 2, 2008.)

·  ^ China on alert as virus spreads

·  ^ Spreading virus kills 28 children (Retrieved on May 7, 2008.)

·  ^ BBC NEWS | World | Asia-Pacific | China virus toll continues rise

·  ^ China on alert over deadly child virus (Retrieved on May 3, 2008.)

·  ^ Viet Nam News: HFMD cases prompt tighter health screening at airport (accessed May 15th, 2008)

·  ^ EV-71 Virus Continues Dramatic Rise (accessed May 23rd, 2008)

·  ^ http://www.bt.com.bn/en/home_news/2008/11/07/1_053_hfmd_cases_recorded

·  ^ "Hand-foot-mouth disease deaths rise to 15 in east China city". http://english.people.com.cn/90001/90776/90882/6635116.html. Retrieved on 2009-04-13.
·  ^ "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/molluscum/faq/everyone.htm#whogets. Retrieved on 2008-06-29. 

·  ^ "Pamphlets: Molluscum Contagiosum". American Academy of Dermatology. 2006. http://www.aad.org/public/publications/pamphlets/viral_mollscum.html. Retrieved on 2008-11-30. 

·  ^ a b Weller R, O'Callaghan CJ, MacSween RM, White MI (1999). "Scarring in Molluscum contagiosum: comparison of physical expression and phenol ablation". BMJ 319 (7224): 1540. PMID 10591712. http://www.bmj.com/cgi/content/full/319/7224/1540. 

·  ^ a b derm/270 at eMedicine

·  ^ MedlinePlus Encyclopedia 000826

·  ^ a b c Tyring SK (2003). "Molluscum contagiosum: the importance of early diagnosis and treatment". Am. J. Obstet. Gynecol. 189 (3 Suppl): S12–6. doi:10.1067/S0002-9378(03)00793-2. PMID 14532898. 

·  ^ Prodigy knowledgebase (July 2003). "Molluscum Contagiosum". National Health Service. http://www.prodigy.nhs.uk/molluscum_contagiosum/view_whole_guidance. Retrieved on 2006-07-06.  - UK NHS guidelines on Molluscum Contagiosum

·  ^ van der Wouden JC, Menke J, Gajadin S, et al (2006). "Interventions for cutaneous molluscum contagiosum". Cochrane Database Syst Rev (2): CD004767. doi:10.1002/14651858.CD004767.pub2. PMID 16625612. 

·  ^ a b c "Frequently Asked Questions: For Everyone. CDC Molluscum Contagiosum". United States Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/molluscum/faq/everyone.htm#howlongstay. Retrieved on 2008-12-08. 

·  ^ "Molluscum Contagiosum - Treatment Overview". WebMD. January 12, 2007. http://www.webmd.com/skin-problems-and-treatments/tc/molluscum-contagiosum-treatment-overview. Retrieved on 2007-10-21. 

·  ^ Burke BE, Baillie JE, Olson RD (2004). "Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in children". Biomed. Pharmacother. 58 (4): 245–7. doi:10.1016/j.biopha.2003.11.006. PMID 15183850. 

·  ^ Hayes AJ, Markovic B (2002). "Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity". Food Chem. Toxicol. 40 (4): 535–43. doi:10.1016/S0278-6915(01)00103-X. PMID 11893412. 

·  ^ Hayes AJ, Markovic B (2003). "Toxicity of Australian essential oil Backhousia citriodora (lemon myrtle). Part 2. Absorption and histopathology following application to human skin". Food Chem. Toxicol. 41 (10): 1409–16. doi:10.1016/S0278-6915(03)00159-5. PMID 12909275. 

·  ^ http://cks.library.nhs.uk/molluscum_contagiosum/evidence/supporting_evidence/treatments_used_in_secondary_care_for_molluscum_contagiosum

·  ^ Saryazdi, S. (2004) The comparative efficacy of benzoyl peroxide 10% cream and tretinoin 0.05% cream in the treatment of molluscum contagiosum. Abstract 10th World Congress on Pediatric Dermatology. Pediatric Dermatology 21(3), 399.

·  ^ http://www.emedsaver.com/index.php?pageID=0005&qryID=1&qry=Canthacur+Wart

·  ^ aidsmap.com | Molluscum contagiosum

·  ^ Molluscum contagiosum -Jochen Schmitt and Thomas L. Diepgen

·  ^ Papa C, Berger R (1976). "Venereal herpes-like molluscum contagiosum: treatment with tretinoin". Cutis 18 (4): 537–40. PMID 1037097. 

·  ^ "Molluscum Contagiosum". Adolesc Med 7 (1): 57–62. 1996. PMID 10359957. 

^ Hanna D, Hatami A, Powell J, et al (2006). "A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children". Pediatric dermatology 23 (6): 574–9. doi:10.1111/j.1525-1470.2006.00313.x. PMID 17156002. 

·  ^ Syed TA, Goswami J, Ahmadpour OA et al. (1998). "Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream". J Dermatol (25): 309–313. 

·  ^ "Cimetidine: A review of the recent developments and reports in cutaneous medicine". Dermatology Online Journal. 2003. http://dermatology.cdlib.org/92/reviews/cimetidine/scheinfeld.html. Retrieved on 2008-11-30. 

·  ^ "Molluscum Contagiosum". eMedicine from WebMD. 2007-5-31. http://www.emedicine.com/derm/TOPIC270.HTM. Retrieved on 2008-11-30. 

·  ^ Hammes S, Greve B, Raulin C (2001). "Molluscum contagiosum: Treatment with pulsed dye laser" (in German). Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 52 (1): 38–42. PMID 11220237. 

·  ^ Hughes P (February 1998). "Treatment of molluscum contagiosum with the 585-nm pulsed dye laser". Dermatol Surg 24 (2): 229–30. doi:10.1016/S1076-0512(97)00178-7. PMID 9491117. 

·  ^ Lindau MS, Munar (2004). "Use of duct tape for treatment of recurrent molluscum contagiosum" (in English). Pediatric Dermatology 21 (5): 609. 

·  ^ Focht DR, Spicer C, Fairchok MP (2002). "The Efficacy of Duct Tape vs Cryotherapy in the Treatment of Verruca Vulgaris (the Common Wart)" (in English). Archives of Pediatrics and Adolescent Medicine 156 (10): 971.
·  ^ a b c d Couch, Alan John; (1983). "The Development of, and Host Response to, Ovine Contagious Pustular Dermatitis". A thesis submitted to the Faculty of Science of the University of New England, Armidale, N.S.W., in partial fulfilment of the requirements of the degree of Bachelor of Science with Honours. http://members.pcug.org.au/~acouch/cpd.pdf. Retrieved on 2008-08-22. 

·  ^ a b c d e f g Winter, Agnes; Charmley, Judith (1999). The Sheep Keeper's Veterinary Handbook. Crowood Press Ltd (Marlborough, UK). ISBN 1-86126-235-3. 

·  ^ a b Fenner, Frank J.; Gibbs, E. Paul J.; Murphy, Frederick A.; Rott, Rudolph; Studdert, Michael J.; White, David O. (1993). Veterinary Virology (2nd ed.). Academic Press, Inc. ISBN 0-12-253056-X. 

·  ^ Carter, G.R.; Wise, D.J. (2006). "Poxviridae". A Concise Review of Veterinary Virology. http://www.ivis.org/advances/Carter/Part2Chap10/chapter.asp?LA=1. Retrieved on 2006-06-13.
^ Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
·  ^ http://health.rutgers.edu/hpv/

·  ^ Champion, R.H., et al. Rook's Textbook of Dermatology. Blackwell Science. 1998. pp. 1029-1051.

·  ^ Champion, R.H., et al. Rook's Textbook of Dermatology. Blackwell Science. 1998. pp. 1029-1051.

·  ^ a b Lowy DR, Schiller JT (2006). "Prophylactic human papillomavirus vaccines.". J. Clin. Invest. 116 (5): 1167–73. doi:10.1172/JCI28607. PMID 16670757. http://www.jci.org/articles/view/JCI28607. Retrieved on 2007-12-01. 

·  ^ a b Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004-08-20). "Against which human papillomavirus types shall we vaccinate and screen? The international perspective.". Int J Cancer 111 (2): 278-85. 

·  ^ a b "FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers". 2008-09-12. http://www.fda.gov/bbs/topics/NEWS/2008/NEW01885.html. Retrieved on 2008-10-12. 

·  ^ a b Cortez, Michelle Fay and Pettypiece, Shannon. "Merck Cancer Shot Cuts Genital Warts, Lesions in Men". Bloomberg News. (Bloomberg.com) 13 Nov 2008.

·  ^ Syrjanen, K. HPV infections and lung cancer. Journal of Clinical Pathology 2002;55:885-891.

·  ^ Gypsyamber, D, et al. Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer NEJM. 356;19. May 10, 2007.

·  ^ Mosby's Medical, Nursing, & Allied Health Dictionary (5th edn), Anderson KN, Anderson LE, Glanze WD, eds, Mosby

·  ^ Warts at About.com

·  ^ http://www.aafp.org/afp/20050815/647.html

·  ^ http://www.aafp.org/afp/20050815/647.html

·  ^ HALASZ C. L. G., Treatment of common warts using the infrared coagulator. The Journal of dermatologic surgery and oncology ISSN 0148-0812. 1994, vol. 20, no4, pp. 252-256 (21 ref.)

·  ^ Horn TD, Johnson SM, Helm RM, Roberson PK (2005). "Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial". Arch Dermatol 141 (5): 589–94. doi:10.1001/archderm.141.5.589. PMID 15897380. http://archderm.ama-assn.org/cgi/content/short/141/5/589. 

·  ^ Champion, R.H., et al. Rook's Textbook of Dermatology. Blackwell Science. 1998. p. 1044

·  ^ http://www.aafp.org/afp/20050815/647.html

·  ^ http://www.health.harvard.edu/fhg/updates/update0303d.shtml

·  ^ http://www.podiatrytoday.com/article/2598

·  ^ a b Gibbs S, Harvey I, Sterling JC, Stark R (2003). "Local treatments for cutaneous warts". Cochrane Database Syst Rev (3): CD001781. doi:10.1002/14651858.CD001781. PMID 12917913. 

·  ^ http://www.wartner-us.com/

·  ^ Focht DR, Spicer C, Fairchok MP (October 2002). "The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart)". Arch Pediatr Adolesc Med 156 (10): 971–4. PMID 12361440. http://archpedi.ama-assn.org/cgi/pmidlookup?view=long&pmid=12361440.  lay-summary

·  ^ de Haen M, Spigt MG, van Uden CJ, van Neer P, Feron FJ, Knottnerus A (2006). "Efficacy of duct tape vs placebo in the treatment of verruca vulgaris (warts) in primary school children". Arch Pediatr Adolesc Med 160 (11): 1121–5. doi:10.1001/archpedi.160.11.1121. PMID 17088514. http://archpedi.ama-assn.org/cgi/pmidlookup?view=long&pmid=17088514. 

·  ^ Wenner R, Askari SK, Cham PM, Kedrowski DA, Liu A, Warshaw EM (2007). "Duct tape for the treatment of common warts in adults: a double-blind randomized controlled trial". Arch Dermatol 143 (3): 309–13. doi:10.1001/archderm.143.3.309. PMID 17372095. http://archderm.ama-assn.org/cgi/pmidlookup?view=long&pmid=17372095. 

·  ^ "Study: Duct tape wart cure overstated". http://www.usatoday.com/news/health/2007-03-19-duct-tape_N.htm.
^ a b c d Fleas, HYG-2081-97 William F. Lyon, Ohio State University entomology page. Accessed 28 December 2006
^ a b Fleas - P.G. Koehler and F. M. Oi. Printed July 1993, revised February 2003. Provided by the University of Florida
^ Order Siphonaptera - Fleas - BugGuide.Net Accessed 28 December 2006
^ [1]
^ Piper, Ross (2007), Extraordinary Animals: An Encyclopedia of Curious and Unusual Animals, Greenwood Press.
^ a b Grimaldi, D. and Engel, M.S. (2005). Evolution of the Insects. Cambridge University Press. ISBN 0-521-82149-5.
^ Natural Flea Control, 1987, Mother Earth News, Retrieved 2007-12-18
^ Warnings About Essential Oils[2]
^ Fleas
^ Fleas: Integrated pest management in and around the home. [3].
^ Sheep parasites Retrieved on 10 November 2008
^ John Travis (2003-08-23) ([dead link] – Scholar search). The naked truth? Lice hint at a recent origin of clothing. 164. Science News. pp. 118. http://www.sciencenews.org/articles/20030823/fob7.asp. 
^ David L Reed, Jessica E Light, Julie M Allen and Jeremy J Kirchman (2007). "Pair of lice lost or parasites regained: the evolutionary history of anthropoid primate lice". BMC Biology 5: 7. doi:10.1186/1741-7007-5-7. 
^ http://www.detentionslip.org/2009/02/schools-are-no-longer-nitpicky-about.html Allowing children to attend.
^ "African tumbu fly". Merck Veterinary Manual. http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/71725.htm. Retrieved on 2007-08-18. 
^ a b Adisa, Charles Adeyinka; Augustus Mbanaso (February 2004). "Furuncular myiasis of the breast caused by the larvae of the Tumbu fly (Cordylobia anthropophaga)". BMC Surgery 4: 5. doi:10.1186/1471-2482-4-5. PMID 15113429. PMC: 394335. http://www.biomedcentral.com/1471-2482/4/5. Retrieved on 2009-03-17. 
^ a b Rice, Paul L.; Neva Gleason (January 1972). "Two cases of myiasis in the United States by the African tumbu fly, Cordylobia anthropophaga (Diptera, Calliphoridae)". American Journal of Tropical Medicine and Hygiene 21 (2): 62–5. PMID 5007189. http://www.ajtmh.org/cgi/pmidlookup?view=long&pmid=5007189. Retrieved on 2009-03-17. 
^ Ockenhouse, Christian F.; Curt P. Samlaska, Paul M. Benson, Lyman W. Roberts, Arn Eliasson, Susan Malane and Mark D. Menich (February 1990). "Cutaneous myiasis caused by the African tumbu fly (Cordylobia anthropophaga)". Archives of Dermatology 126 (2): 199–202. doi:10.1001/archderm.126.2.199. PMID 2301958. http://archderm.ama-assn.org/cgi/content/abstract/126/2/199. Retrieved on 2009-03-17. 
^ a b c d Geary, Merilyn J.; Bernard J. Hudson, Richard C. Russell and Andrew Hardy (1999). "Exotic myiasis with Lund's fly (Cordylobia rodhaini)". Medical Journal of Australia 171 (11-12): 654–5. PMID 10721359. http://www.mja.com.au/public/issues/171_11_061299/geary/geary.html. Retrieved on 2009-03-17. 
^ Zijlma, Anouk. "About the putzi fly". About.com. http://goafrica.about.com/od/healthandsafety/qt/putzifly.htm. Retrieved on 2007-08-18. 
^ a b c d John, David; William Petri (2006). Markell and Voge's Medical Parasitology (9th ed.). St. Louis, Missouri: Elsevier. ISBN 0-7216-4793-6. OCLC 62475633. http://books.google.com/books?id=-QSZD783cdsC. [page needed]
^ Sherman, R. A.; M. J. R. Hall and S. Thomas (2000). "Medicinal maggots: an ancient remedy for some contemporary afflictions". Annual Review of Entomology 45: 55–81. doi:10.1146/annurev.ento.45.1.55. PMID 10761570. http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.ento.45.1.55?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov. Retrieved on 2009-03-17. 
^ http://www.ncbi.nlm.nih.gov/pubmed/15113429?dopt=AbstractPlus
^ Online 'Mendelian Inheritance in Man' (OMIM) 266300
^ Hanson Kerry M.; Gratton Enrico; Bardeen Christopher J. (2006). "Sunscreen enhancement of UV-induced reactive oxygen species in the skin". Free Radical Biology and Medicine 41 (8): 1205–12. doi:10.1016/j.freeradbiomed.2006.06.011. PMID 17015167. 
^ Garland C, Garland F, Gorham E (1992). "Could sunscreens increase melanoma risk?". Am J Public Health 82 (4): 614–5. doi:10.2105/AJPH.82.4.614. PMID 1546792. http://www.ajph.org/cgi/reprint/82/4/614. 
4) Millington GWM. (2006) Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 31: 407-412.

·  ^ melanocytic nevus at Dorland's Medical Dictionary

·  ^ Howard M Reisner; Rubin, Emanuel (2008). Essentials of Rubin's Pathology (Rubin, Essential Pathology). Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 513. ISBN 0-7817-7324-5. 

·  ^ mole at Dorland's Medical Dictionary

·  ^ a b c d "Moles". American Academy of Dermatology. http://www.aad.org/public/publications/pamphlets/common_moles.html. Retrieved on 2008-08-02. 

·  ^ Kaskel P, Kind P, Sander S, Peter RU, Krähn G (October 2000). "Trauma and melanoma formation: a true association?". Br. J. Dermatol. 143 (4): 749–53. doi:10.1046/j.1365-2133.2000.03770.x. PMID 11069451. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0007-0963&date=2000&volume=143&issue=4&spage=749. 

·  ^ Burkhart CG (2003). "Dysplastic nevus declassified: even the NIH recommends elimination of confusing terminology". Skinmed 2 (1): 12–3. doi:10.1111/j.1540-9740.2003.01724.x. PMID 14673319. http://www.lejacq.com/articleDetail.cfm?pid=SKINmed_2;1:12. 

·  ^ a b "What You Need To Know About Melanoma - Melanoma: Who's at Risk?". National Cancer Institute. http://www.nci.nih.gov/cancertopics/wyntk/melanoma/page7. Retrieved on 2008-05-18. 

·  ^ Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM (1992). "Benign pigmented nevi in children. Prevalence and associated factors: the West Midlands, United Kingdom Mole Study". Arch Dermatol 128 (9): 1201–6. doi:10.1001/archderm.128.9.1201. PMID 1519934. 

·  ^ Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1991). "Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds". J. Natl. Cancer Inst. 83 (23): 1726–33. doi:10.1093/jnci/83.23.1726. PMID 1770551. http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=1770551. 

·  ^ van Schanke A, van Venrooij GM, Jongsma MJ, et al (2006). "Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures". Cancer Res. 66 (5): 2608–15. doi:10.1158/0008-5472.CAN-05-2476. PMID 16510579. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=16510579. 

·  ^ Moles linked with slower ageing

·  ^ Granter SR, McKee PH, Calonje E, Mihm MC, Busam K (March 2001). "Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'". Am. J. Surg. Pathol. 25 (3): 316–23. PMID 11224601. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0147-5185&volume=25&issue=3&spage=316. 

·  ^ Hall J, Perry VE (1998). "Tinea nigra palmaris: differentiation from malignant melanoma or junctional nevi". Cutis 62 (1): 45–6. PMID 9675534. 

·  ^ "What You Need To Know About Melanoma - Signs and Symptoms". National Cancer Institute. http://www.nci.nih.gov/cancertopics/wyntk/melanoma/page8. Retrieved on 2008-05-18. 

·  ^ http://www.skincancer.org/Healthy-Skin-Beauty/The-Ugly-Duckling-Sign-An-Early-Melanoma-Recognition-Tool.html

·  ^ Mascaro JM Jr, Mascaro JM. The dermatologist's position concerning nevi: a vision ranging from 'the ugly duckling' to 'little red riding hood'. Arch Dermatol 1998; 134:1484–5.

·  ^ Mascaro JM Jr, Mascaro JM. The dermatologist's position concerning nevi: a vision ranging from 'the ugly duckling' to 'little red riding hood'. Arch Dermatol 1998; 134:1484–5.

·  ^ http://dermnetnz.org/doctors/dermoscopy-course/introduction.html

·  ^ "Melanoma Home Page". National Cancer Institute. http://www.nci.nih.gov/cancertopics/types/melanoma. Retrieved on 2008-05-18.
·  ^ benign fibrous histiocytoma at Dorland's Medical Dictionary

·  ^ MeSH Benign+fibrous+histiocytoma

·  ^ dermatofibroma at Dorland's Medical Dictionary

·  ^ Hanly AJ, Jordà M, Elgart GW, Badiavas E, Nassiri M, Nadji M (June 2006). "High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors". Archives of pathology & laboratory medicine 130 (6): 831–4. PMID 16740036. http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=130&page=831.
^ papilloma at Dorland's Medical Dictionary
^ a b c d Moles, Freckles, Skin Tags, Benign Lentigines, and Seborrheic Keratoses from the Cleveland Clinic website
^ Seborrheic keratosis: Symptoms, from the Mayo Clinic website
^ http://www.emedicine.com/derm/topic99.htm
^ http://www.emedicine.com/derm/TOPIC407.HTM
^ http://www.dermadoctor.com/article_Seborrheic-Keratoses_91.html
^ Seborrheic keratosis: Causes, from the Mayo Clinic website
^ Hafner C, Hartmann A, Vogt T (2007). "FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin". J. Invest. Dermatol. 127 (7): 1572–3. doi:10.1038/sj.jid.5700772. PMID 17568799. 
^ Seborrheic, from Merriam-Webster's online medical dictionary
^ Suffix "-osis" from the Merriam-Webster website
·  ^ a b c d e f g New Zealand Dermatological Society (2007). "Squamous cell papilloma". New Zealand Dermatological Society. http://www.dermnetnz.org/lesions/squamous-papilloma.html. Retrieved on December 19 2007. 

·  ^ a b c Nikon Microscopy (2007). "Squamous Cell Papilloma". Nikon Microscopy. http://www.microscopyu.com/galleries/pathology/squamouscellpapilloma.html. Retrieved on December 19 2007. 

·  ^ a b Papilloma, Conjunctival at eMedicine

·  ^ National Library for Health (2007). "Squamous cell papilloma". National Library for Health. http://www.library.nhs.uk/skin/ViewResource.aspx?resID=197171. Retrieved on December 19 2007.
http://en.wikipedia.org/wiki/Bowen%27s_disease
·  ^ http://www.emedicine.com/derm/topic206.htm

·  ^ Schwartz RA (February 2004). "Keratoacanthoma: a clinico-pathologic enigma". Dermatol Surg 30 (2 Pt 2): 326–33; discussion 333. doi:10.1111/j.1524-4725.2004.30080.x. PMID 14871228. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1076-0512&date=2004&volume=30&issue=2%20Pt%202&spage=326.
·  ^ Esther RJ, Lamps L, Schwartz HS (1999). "Marjolin ulcers: secondary carcinomas in chronic wounds". J South Orthop Assoc 8 (3): 181–7. PMID 12132863. 

·  ^ Simmons MA, Edwards JM, Nigam A (December 2000). "Marjolin's ulcer presenting in the neck". J Laryngol Otol 114 (12): 980–2. PMID 11177375. 

·  ^ Phillips TJ, Salman SM, Bhawan J, Rogers GS (May 1998). "Burn scar carcinoma. Diagnosis and management". Dermatol Surg 24 (5): 561–5. PMID 9598012. 

·  ^ Smidt LS, Smidt LF, Chedid MB, Bavaresco CS, Chedid MF (October 2005). "Radical surgical treatment for Marjolin ulcer occurring after chronic osteomyelitis". South. Med. J. 98 (10): 1053. PMID 16295826. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0038-4348&volume=98&issue=10&spage=1053. 

·  ^ a b Chong AJ, KleinMB (March 2005). "Images in clinical medicine. Marjolin's ulcer". N. Engl. J. Med. 352 (10): e9. doi:10.1056/NEJMicm040020. PMID 15758002. 

·  ^ Paredes F (February 1998). "[Marjölin ulcer]" (in Portuguese). Acta Med Port 11 (2): 185–7. PMID 9567417.
^ Prajapati V, Barankin B (May 2008). "Dermacase. Actinic keratosis". Can Fam Physician 54 (5): 691, 699. PMID 18474700. PMC: 2377206. http://www.cfp.ca/cgi/pmidlookup?view=long&pmid=18474700. 
^ a b Quaedvlieg PJ, Tirsi E, Thissen MR, KrekelsGA (2006). "Actinic keratosis: how to differentiate the good from the bad ones?". Eur J Dermatol 16 (4): 335–9. PMID 16935787. http://www.john-libbey-eurotext.fr/medline.md?issn=1167-1122&vol=16&iss=4&page=335. 
^ actinic keratosis at Dorland's Medical Dictionary
^ Ericson MB, Wennberg AM, Larkö O (February 2008). "Review of photodynamic therapy in actinic keratosis and basal cell carcinoma". Ther Clin Risk Manag 4 (1): 1–9. PMID 18728698. 
^ Hadley G, Derry S, Moore RA (June 2006). "Imiquimod for actinic keratosis: systematic review and meta-analysis". J. Invest. Dermatol. 126 (6): 1251–5. doi:10.1038/sj.jid.5700264. PMID 16557235. 
^ "World Health Organisation assigns CUV1647 generic name" (PDF). Clinuvel. 2008. http://www.clinuvel.com/resources/pdf/asx_announcements/2008/20080617WHOGenericName.pdf. Retrieved on 2008-06-17. 
^ Clinuvel » Investors » FAQs
^ Australian Life Scientist - Tackling skin cancer in organ transplant patients
^ Peplin
^ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=214105
^ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=214105
^ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=214105
^ MedlinePlus Encyclopedia Basal cell carcinoma
^ "Basal Cell Carcinoma - Symptoms, Treatment and Prevention". http://www.healthscout.com/ency/1/199/main.html. 
^ www.bccancer.bc.ca/HPI/CE/skincancer/skincancercourses/readings/earlydiagnosisreadings/BasalCellCarcinoma.htm
^ http://dermis.multimedica.de/dermisroot/en/18520/diagnose.htm
^ www.bccancer.bc.ca/HPI/CE/skincancer/skincancercourses/readings/earlydiagnosisreadings/BasalCellCarcinoma.htm
^ www.bccancer.bc.ca/HPI/CE/skincancer/skincancercourses/readings/earlydiagnosisreadings/BasalCellCarcinoma.htm
^ www.bccancer.bc.ca/HPI/CE/skincancer/skincancercourses/readings/earlydiagnosisreadings/BasalCellCarcinoma.htm
^ Martin RC, et al. Cancer. 2000 Mar 15;88(6):1365-9. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence.
^ http://dermatology.cdlib.org/125/UCDcases/fibroepithelioma/su.html
^ http://www.skincancerguide.ca/basal/what_is_basal_cell_cancer.html
^ Epstein EH, Shepard JA, Flotte TJ (Jan 2008). "Case records of the Massachusetts General Hospital. Case 3-2008. An 80-year-old woman with cutaneous basal-cell carcinomas and cysts of the jaws". N Engl J Med 358 (4): 393–401. doi:10.1056/NEJMcpc0707893. PMID 18216361. 
^ Wolf DJ, et al. Surgical margins for basal cell carcinoma. Arch Dermatol. 1987 Mar;123(3):340-4.
^ http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf
^ Silverman, et al. J Dermatol Surg Oncol. 1992 Jun;18(6):471-6. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
^ Scalvenzzi M et al. Dermoscopic patterns of superficial basal cell carcinoma. Int J Dermatol. 2008 Oct;47(10):1015-8.
^ Cuellar F, et al. Dermoscopy of early recurrent basal cell carcinoma. Arch Dermatol. 2008 Sep;144(9):1254.
^ Maloney,ME et al. Surgical Dermatopathology. p. 110
^ ARASH KIMYAI-ASADI, et al. Margin Involvement after the Excision of Melanoma In Situ: The Need for Complete En Face Examination of the Surgical Margins. Lancet Oncol. 2008 Dec;9(12):1149-56.
^ Kimyai-Asadi A, et al. Accuracy of Serial Transverse Cross-Sections in Detecting Residual Basal Cell Carcinoma at the Surgical Margins of an Elliptical Excision Specimen. J Am Acad Dermatol. vol. 53, 469 - 474, 2005.
^ Sigurdsson, et a. Acta Ophthalmologica Scandinavica. Basal cell carcinoma of the eyelid. Risk of recurrence according to adequacy of surgical margins Volume 76 Issue 4, Pages 477 - 480
^ http://www3.interscience.wiley.com/journal/118489368/abstract.
^ http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf
^ http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf pages 6 and 7
^ Dhingra N. Et al. Confident complete excision of lid-margin BCCs using a marginal strip: an alternative to Mohs' surgery. Br J Ophthalmol. 2007 Jun;91(6):794-6. Epub 2007 Jan 17
^ Bentkover SH, et al. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg. 2002 Apr-Jun;4(2):114-9
^ http://www.co-otolaryngology.com/pt/re/cooto/abstract.00020840-200808000-00013.htm;jsessionid=JbDTFGy1YBfZ2BkdYn5LppdsCRnwCLBph1z1KtJyWSp71tTYvLjV!1204955331!181195628!8091!-1
^ Nagore E. Et al. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol. 2003 Mar;17(2):167-70.
^ J. Lane, et al. Surgical Margins in the Treatment of Nonmelanoma Skin Cancer and Mohs Micrographic Surgery Current Surgery, Volume 62, Issue 5, Pages 518-526.
^ Maloney, ME, et al, Surgical Dermatopathology. Determining Cancer at Surgical margin. Page 113.
^ http://emedicine.medscape.com/article/1295550-overview
^ Staub G. Et al. Excision skin margin and recurrence rate of skin cancer: a prospective study of 844 cases. Ann Chir Plast Esthet. 2008 Oct;53(5):389-98. Epub 2007 Oct 24
^ http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Skin/NonMelanoma/ManagementPolicies/start.htm
^ Griffiths RW, et al. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper? J Plast Reconstr Aesthet Surg. 2007;60(1):41-7. Epub 2006 Sep 1.
^ Wolf DJ, et al. Surgical margins for basal cell carcinoma. Arch Dermatol. 1987 Mar;123(3):340-4.
^ Sigurdsson, et a. Acta Ophthalmologica Scandinavica. Basal cell carcinoma of the eyelid. Risk of recurrence according to adequacy of surgical margins. Volume 76 Issue 4, Pages 477 - 480.
^ Hauben DJ, Zirkin H, Mahler D, Sacks M. The biologic behavior of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma. Part II. Plast Reconstr Surg. 1965;69:110.
^ Griffiths RW, et al. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper? J Plast Reconstr Aesthet Surg. 2007;60(1):41-7. Epub 2006 Sep 1.
^ http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf
^ Bentkover SH, et al. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg. 2002 Apr-Jun;4(2):114-9
^ http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102272107.html
^ The Skin Cancer Foundation - The Skin Cancer Foundation Seal of Recommendation
^ Butler DF, Parekh PK, Lenis A. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study. Dermatol Surg. 2009 Jan;35(1):24-9. Epub 2008 Nov 19.
^ Peplin's skin cancer gel trial a success - Breaking News - Business - Breaking News
^ Peplin
^ Peng Q et al (Jan 2008) "Lasers in Medicine" Rep. Prog. Phys. 71 056701
^ http://www.webmd.com/cancer/cryosurgery-for-nonmelanoma-skin-cancer
^ Barlow, J, et al. .J Am Acad Dermatol. 2006 Jun;54(6):1039-45. Treatment of basal cell carcinoma with curettage alone.
^ Skin Cancer Foundation: Basal Cell Carcinoma
^ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=214105
^ a b Cutaneous squamous cell carcinoma
^ http://www.aad.org/public/publications/pamphlets/sun_squamous.html
^ http://www.skincarephysicians.com/skincancernet/squamous_cell_carcinoma.html
^ Cosmos Online - Skin cancer vaccine within reach (http://www.cosmosmagazine.com/news/2327/skin-cancer-vaccine-within-reach)
^ http://www.emedicine.com/derm/TOPIC144.HTM
^ Gross, K.G., et al. Mohs Surgery, Fundamentals and Techniques. 1999, Mosby.
^ "World Health Organisation assigns CUV1647 generic name" (PDF). Clinuvel. 2008. http://www.clinuvel.com/resources/pdf/asx_announcements/2008/20080617WHOGenericName.pdf. Retrieved on 2008-06-17. 
^ Clinuvel » Investors » FAQs
^ PharmaAsia - Clinuvel’s Drug Begins Global Phase II Skin Cancer Trials
·  ^ Melanoma Death Rate Still Climbing

·  ^ Cancer Stat Fact Sheets

·  ^ Ries LAG, et al, eds. SEER Cancer Statistics Review, 1975–2000. Bethesda, MD: National Cancer Institute; 2003: Tables XVI-1-9.

·  ^ Parkin D, Bray F, Ferlay J, Pisani P. "Global cancer statistics, 2002". CA Cancer J Clin 55 (2): 74–108. PMID 15761078. Full text

·  ^ Lucas, R. Global Burden of Disease of Solar Ultraviolet Radiation, Environmental Burden of Disease Series, July 25, 2006; No. 13. News release, World Health Organization

·  ^ Treatment of Skin Cancer

·  ^ Urteaga O, Pack G (1966). "On the antiquity of melanoma". Cancer 19 (5): 607–10. doi:10.1002/1097-0142(196605)19:5<607::AID-CNCR2820190502>3.0.CO;2-8. PMID 5326247. 

·  ^ Bodenham D (1968). "A study of 650 observed malignant melanomas in the South-West region". Ann R Coll Surg Engl 43 (4): 218–39. PMID 5698493. 

·  ^ Laennec RTH (1806). "Sur les melanoses". Bulletin de la Faculte de Medecine de Paris 1: 24–26. 

·  ^ Norris, W. A case of fungoid disease., Edinb. Med. Surg. 1820, 16: 562-565.

·  ^ Cooper, Samuel (1840). First lines of theory and practice of surgery. London: Longman, Orme, Brown, Green and Longman. 

·  ^ Who is Most at Risk for Melanoma?

·  ^ Wang S, Setlow R, Berwick M, Polsky D, Marghoob A, Kopf A, Bart R (2001). "Ultraviolet A and melanoma: a review". J Am Acad Dermatol 44 (5): 837–46. doi:10.1067/mjd.2001.114594. PMID 11312434. 

·  ^ Leslie MC, Bar-Eli M.Regulation of gene expression in melanoma: new approaches for treatment.J Cell Biochem. 2005 Jan 1;94(1):25-38.PMID: 15523674

·  ^ Bhoumik A, Singha N, O'Connell MJ, Ronai ZA.Regulation of TIP60 by ATF2 modulates ATM activation.J Biol Chem. 2008 Jun 20;283(25):17605-14.

·  ^ Bhoumik A, Jones N, Ronai Z.Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity.Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4222-7.

^ Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V.The role of ATF-2 in oncogenesis.Bioessays. 2008 Apr;30(4):314-27.

·  ^ Huang Y, Minigh J, Miles S, Niles RM.Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition.J Mol Signal. 2008 Feb 12;3:3.PMID: 18269766

·  ^ Oliveria S, Saraiya M, Geller A, Heneghan M, Jorgensen C (2006). "Sun exposure and risk of melanoma". Arch Dis Child 91 (2): 131–8. doi:10.1136/adc.2005.086918. PMID 16326797. 

·  ^ Lee J, Strickland D (1980). "Malignant melanoma: social status and outdoor work". Br J Cancer 41 (5): 757–63. PMID 7426301. 

·  ^ Pion IA, Rigel DS, Garfinkel L, Silverman MK, Kopf AW (January 1995). "Occupation and the risk of malignant melanoma". Cancer 75 (2 Suppl): 637–44. doi:10.1002/1097-0142(19950115)75:2 (inactive 2009-04-03). PMID 7804988. 

·  ^ Khlat M, Vail A, Parkin M, Green A (1992). "Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay". Am J Epidemiol 135 (10): 1103–13. PMID 1632422. 

·  ^ Wolf P; Donawho C K; Kripke M L (1994). "Effect of Sunscreens on UV radiation-induced enhancements of melanoma in mice". J. Nat. Cancer. Inst. 86: 99–105. doi:10.1093/jnci/86.2.99. PMID 8271307. 

·  ^ Bliss J, Ford D, Swerdlow A, Armstrong B, Cristofolini M, Elwood J, Green A, Holly E, Mack T, MacKie R (1995). "Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE)". Int J Cancer 62 (4): 367–76. doi:10.1002/ijc.2910620402. PMID 7635560. 

·  ^ Miller A, Mihm M (2006). "Melanoma". N Engl J Med 355 (1): 51–65. doi:10.1056/NEJMra052166. PMID 16822996. 

·  ^ Rhodes A, Weinstock M, Fitzpatrick T, Mihm M, Sober A (1987). "Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals". JAMA 258 (21): 3146–54. doi:10.1001/jama.258.21.3146. PMID 3312689. 

·  ^ Berwick M, Wiggins C (2006). "The current epidemiology of cutaneous malignant melanoma". Front Biosci 11: 1244–54. doi:10.2741/1877. PMID 16368510. 

·  ^ Davies H.; Bignell G. R.; Cox C.; (June 2002). "Mutations of the BRAF gene in human cancer". Nature 417: 949–954. doi:10.1038/nature00766. http://www.nature.com/nature/journal/v417/n6892/full/nature00766.html. 

·  ^ Greene MH. (1998). "The genetics of hereditary melanoma and nevi". Cancer 86 (11): 2464–2477. doi:10.1002/(SICI)1097-0142(19991201)86:11 (inactive 2009-04-03). PMID 10630172. 

·  ^ Halachmi S, Gilchrest BA. (2001). "Update on genetic events in the pathogenesis of melanoma". Curr Opin Oncol 13 (2): 129–136. doi:10.1097/00001622-200103000-00008. PMID 11224711. 

·  ^ CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) from Entrez Gene

·  ^ http://clincancerres.aacrjournals.org/cgi/content/abstract/1078-0432.CCR-08-2678v1

·  ^ http://www.melanomafoundation.org/prevention/abcd.htm

·  ^ Friedman R, Rigel D, Kopf A (1985). "Early detection of malignant melanoma: the role of physician examination and self-examination of the skin". CA Cancer J Clin 35 (3): 130–51. doi:10.3322/canjclin.35.3.130. PMID 3921200. 

·  ^ http://www.aad.org/public/exams/abcde.html

·  ^ http://www.skincancer.org/Healthy-Skin-Beauty/The-Ugly-Duckling-Sign-An-Early-Melanoma-Recognition-Tool.html

·  ^ Mascaro JM Jr, Mascaro JM. The dermatologist's position concerning nevi: a vision ranging from 'the ugly duckling' to 'little red riding hood'. Arch Dermatol 1998; 134:1484–5.

·  ^ Mascaro JM Jr, Mascaro JM. The dermatologist's position concerning nevi: a vision ranging from 'the ugly duckling' to 'little red riding hood'. Arch Dermatol 1998; 134:1484–5.

·  ^ a b http://dermnetnz.org/doctors/dermoscopy-course/introduction.html

·  ^ Autier P (2005). "Cutaneous malignant melanoma: facts about sunbeds and sunscreen". Expert Rev Anticancer Ther 5 (5): 821–33. doi:10.1586/14737140.5.5.821. PMID 16221052. 

·  ^ Can Melanoma Be Prevented?

·  ^ Garland C, Garland F, Gorham E (1992). "Could sunscreens increase melanoma risk?". Am J Public Health 82 (4): 614–5. doi:10.2105/AJPH.82.4.614. PMID 1546792.http://www.ajph.org/cgi/reprint/82/4/614. 

·  ^ http://www.highbeam.com/doc/1G1-117775410.html

·  ^ http://findarticles.com/p/articles/mi_m0PDG/is_3_3/ai_n6056512

·  ^ Exposure to sunlamps, tanning beds, and melanoma risk Journal Cancer Causes and Control. Springer, Netherlands. ISSN 0957-5243 (Issue Volume 19, Number 7 / September, 2008. pp.659-669.

·  ^ http://www.dermatoscopes.com/

·  ^ Swanson N, Lee K, Gorman A, Lee H (2002). "Biopsy techniques. Diagnosis of melanoma". Dermatol Clin 20 (4): 677–80. doi:10.1016/S0733-8635(02)00025-6. PMID 12380054. 

·  ^ Homsi J, Kashani-Sabet M, Messina J, Daud A (2005). "Cutaneous melanoma: prognostic factors". Cancer Control 12 (4): 223–9. PMID 16258493. Full text (PDF)

·  ^ a b Balch C, Buzaid A, Soong S, Atkins M, Cascinelli N, Coit D, Fleming I, Gershenwald J, Houghton A, Kirkwood J, McMasters K, Mihm M, Morton D, Reintgen D, Ross M, Sober A, Thompson J, Thompson J (2001). "Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma". J Clin Oncol 19 (16): 3635–48. PMID 11504745. Full text

·  ^ Malignant melanoma: staging at Collaborative Hypertext of Radiology

·  ^ http://www.labpath.com/new7.html

·  ^ www.moffitt.org/moffittapps/ccj/v15n3/pdf/216.pdf

·  ^ Balch C, Urist M, Karakousis C, Smith T, Temple W, Drzewiecki K, Jewell W, Bartolucci A, Mihm M, Barnhill R (1993). "Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial". Ann Surg 218 (3): 262–7; discussion 267–9. doi:10.1097/00000658-199309000-00005. PMID 8373269. 

·  ^ Mikhail, G. Mohs Micrographic Surgery. 1991, Saunders, pp. 13–14

·  ^ Bene, NI, et al. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases Dermatol Surg. 2008 May;34(5):660-4.Cure rate as high as 98% for small melanoma in situ, and as high as 95% noted for lentigo maligna variant of melanona in situ has been reported with Mohs surgery.

·  ^ Kirkwood J, Strawderman M, Ernstoff M, Smith T, Borden E, Blum R (1996). "Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684". J Clin Oncol 14 (1): 7–17. PMID 8558223. 

·  ^ Kirkwood J, Ibrahim J, Sondak V, Richards J, Flaherty L, Ernstoff M, Smith T, Rao U, Steele M, Blum R (2000). "High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190". J Clin Oncol 18 (12): 2444–58. PMID 10856105. 

·  ^ Kirkwood J, Ibrahim J, Sondak V, Ernstoff M, Ross M (2002). "Interferon alfa-2a for melanoma metastases". Lancet 359 (9310): 978–9. doi:10.1016/S0140-6736(02)08001-7. PMID 11918944. 

·  ^ Weight RM, Viator JA, Dale PS, Caldwell CW, Lisle AE. (2006). "Photoacoustic detection of metastatic melanoma cells in the human circulatory system". Opt Lett. 31 (20): 2998–3000. doi:10.1364/OL.31.002998. PMID 17001379. 

·  ^ Bajetta E, Del Vecchio M, Bernard-Marty C, Vitali M, Buzzoni R, Rixe O, Nova P, Aglione S, Taillibert S, Khayat D (2002). "Metastatic melanoma: chemotherapy". Semin Oncol 29 (5): 427–45. doi:10.1053/sonc.2002.35238. PMID 12407508. 

·  ^ Buzaid A (2004). "Management of metastatic cutaneous melanoma". Oncology (Williston Park) 18 (11): 1443–50; discussion 1457–9. PMID 15609471. 

·  ^ Danson S, Lorigan P (2005). "Improving outcomes in advanced malignant melanoma: update on systemic therapy". Drugs 65 (6): 733–43. doi:10.2165/00003495-200565060-00002. PMID 15819587. 

·  ^ Mikhail, G. Mohs Micrographic Surgery. 1991, Saunders, pp. 13–14

·  ^ Bene, NI, et al. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases Dermatol Surg. 2008 May;34(5):660-4.

·  ^ Usefulness of the Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: The 'Square' Procedure" (J Am Acad Dermatol 1997;37:758-63)

·  ^ Bastiaannet E, Beukema J, Hoekstra H (2005). "Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications". Cancer Treat Rev 31 (1): 18–26. doi:10.1016/j.ctrv.2004.09.005. PMID 15707701. 

·  ^ Sotomayor M, Yu H, Antonia S, Sotomayor E, Pardoll D. "Advances in gene therapy for malignant melanoma". Cancer Control 9 (1): 39–48. PMID 11907465. Full text (PDF)

·  ^ Press release from the NIH

·  ^ "What You Need To Know About Melanoma - Nutrition". National Cancer Institute.http://www.nci.nih.gov/cancertopics/wyntk/melanoma/page28. Retrieved on 2008-05-18.
·  ^ synd/98 at Who Named It?

·  ^ Alibert JLM (1806) (in French). Descriptions des maladies de la peau observées a l’Hôpital Saint-Louis, et exposition des meilleures méthodes suivies pour leur traitement. Paris: Barrois l’ainé. p. 286. http://infohawk.uiowa.edu/F?func=direct&doc_number=000636854&l_base=uiowa.
·  ^ Kaposi, M (1872). "Idiopathisches multiples Pigmentsarkom der Haut". Arch. Dermatol. Syph. 4: 265–273. doi:10.1007/BF01830024. 

·  ^ Phillips AM, Jones AG, Osmond DH, Pollack LM, Catania JA, Martin JN (July 2008). "Awareness of Kaposi's Sarcoma-Associated Herpesvirus Among Men Who Have Sex With Men". Sex Transm Dis. doi:10.1097/OLQ.0b013e318182c91f (inactive 2008-09-09). PMID 18665016. 

·  ^ Iscovich, J (Oct 22 1998). "Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study". AIDS 12 (15): 2067–72. doi:10.1097/00002030-199815000-00019. http://www.aidsonline.com/pt/re/aids/abstract.00002030-199815000-00019.htm;jsessionid=Gy0NY0Y2b5lXKwJTGkQv1C1SdhTymxKmhpM4Hkrdvvz3pyXQ9GPV!-1804036389!-949856145!8091!-1. 

·  ^ Fenig, E (October 1998). "Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel". Am J Clin Oncol 21 (5): 498–500. doi:10.1097/00000421-199810000-00016. http://www.amjclinicaloncology.com/pt/re/ajco/abstract.00000421-199810000-00016.htm;jsessionid=Gy0Jys29KWqzWg4RWhQN9vCyvP3tMPn24WG35BQbdLHGlhJc1y7S!-1804036389!-949856145!8091!-1. 

·  ^ Cook-Mozaffari, P (December 1998). "The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic". Br J Cancer 78 (11): 1521–8. PMID 9836488. 

·  ^ Olsen, SJ (October 1998). "Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985" (PDF). AIDS 12 (14): 1921–5. doi:10.1097/00002030-199814000-00024. http://dceg.cancer.gov/pdfs/olsen1219211998.pdf. 

·  ^ Qunibi, W (Feb 27 1998). "Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia". Transplantation 65 (4): 583–5. doi:10.1097/00007890-199802270-00024. http://www.transplantjournal.com/pt/re/transplantation/abstract.00007890-199802270-00024.htm;jsessionid=Gy4Gq82dl1t9ppllm80G1PDjkbpmqFFkp2ypLSLnW2DthLg22DcM!220059229!-949856144!8091!-1. 

·  ^ Luppi, Mario (Nov 9 2000). "Bone marrow failure associated with human herpesvirus 8 infection after transplantation". N Engl J Med 343 (19): 1378–85. doi:10.1056/NEJM200011093431905. PMID 11070102. 

·  ^ Beral V, Peterman TA, Berkelman RL, Jaffe HW (January 1990). "Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?". Lancet 335 (8682): 123–8. doi:10.1016/0140-6736(90)90001-L. PMID 1967430. http://linkinghub.elsevier.com/retrieve/pii/0140-6736(90)90001-L. 

·  ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.

·  ^ Dezube, BJ (October 1996). "Clinical presentation and natural history of AIDS--related Kaposi's sarcoma". Hematol Oncol Clin North Am 10 (5): 1023–9. doi:10.1016/S0889-8588(05)70382-8. PMID 8880194. 

·  ^ Nichols, CM (November 1993). "Treating Kaposi's lesions in the HIV-infected patient". J Am Dent Assoc 124 (11): 78–84. PMID 8227776. http://jada.ada.org/cgi/content/abstract/124/11/78. Retrieved on 2007-06-11. 

·  ^ Danzig, JB (June 1991). "Gastrointestinal malignancy in patients with AIDS". Am J Gastroenterol 86 (6): 715–8. PMID 2038993. 

·  ^ Garay, SM (January 1987). "Pulmonary manifestations of Kaposi's sarcoma". Chest 91 (1): 39–43. doi:10.1378/chest.91.1.39. PMID 3792084. http://www.chestjournal.org/cgi/reprint/91/1/39. Retrieved on 2007-06-11. 

·  ^ Russell, Sabin (2007-10-11). "Unsettling re-emergence of 'gay cancer'". San Francisco Chronicle. http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2007/10/11/MNEESOFRG.DTL. Retrieved on 2007-10-12. 

·  ^ Phillips AM, Jones AG, Osmond DH, Pollack LM, Catania JA, Martin JN (July 2008). "Awareness of Kaposi's Sarcoma-Associated Herpesvirus Among Men Who Have Sex With Men". Sex Transm Dis. doi:10.1097/OLQ.0b013e318182c91f (inactive 2008-09-09). PMID 18665016.